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Chlamydia pneumoniae is a Gram negative bacterium responsible for a number of human 
respiratory diseases and linked to some chronic inflammatory diseases. The major outer membrane 
protein (MOMP) of Chlamydia is a conserved immunologically dominant protein located in the outer 
membrane, which together with its surface exposure and abundance, has led to MOMP being the 
main focus for vaccine and antimicrobial studies in recent decades. In the absence of structural data 
for MOMP, the fatty acid transporter of E. coli, FadL, was used for the development of a plausible 
homology model, which suggested a 14-stranded b-barrel. X-ray crystallography has revealed a low-
resolution crystal structure at 4 Å, from non-optimised crystals, that showed a β-barrel structure 
with an occluded pore.  
Initial research focussed on producing recombinant stable and active MOMP for higher resolution 
structural studies. In this work, MOMP’s yield was greatly improved through the use of SB3-14 for 
solubilisation, identified through detergent screening using FSEC and Western blotting. Optimisation 
of the purification procedure led to crystallisation screening of DDM exchanged MOMP. The 
resulting crystals were analysed using a synchrotron radiation source. Diffraction patterns indicated 
that a small selection of crystals were protein, yielding new crystallisation conditions that can be 
optimised in future research.  
Confirmed as a β-barrel protein, MOMP is often considered to have a porin-like function. Homology 
modelling with FadL, as well as the low resolution structure, indicate an occluded barrel and is 
suggestive of a more active transport role for MOMP, namely for fatty acids which are known to be 
scavenged from the host. The ability of MOMP to transport fatty acids was assessed using a novel 
functional growth assay in E. coli, developed in this work. Although MOMP was shown to be 
expressed in the outer membrane, using fluorescence microscopy, interestingly, transport of fatty 
acids was not observed.  
However, MOMP has a more widely accepted role in the Chlamydial outer membrane complex 
through the formation of intermolecular disulphide bonds, although the exact interactions formed 
are currently unknown. It was hypothesised in this work, due to the large number of cysteines 
available for disulphide bonding, that interactions occur with cysteine rich pockets as opposed to 
individual residues. Molecular dynamics simulations in conjunction with the crystal structure 
provided an impetus for rational cysteine mutant design. The localisation of MOMP in the E. coli 
membrane was assessed with super resolution fluorescence microscopy, which in support of this 
novel hypothesis showed a decrease in membrane clustering with cysteine rich regions containing 
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1.1.   Chlamydia pneumoniae 
Chlamydia pneumoniae is a Gram negative obligate intracellular bacterium (Grayston, 2000) 
responsible for 10% of community-acquired pneumonia in humans (Grayston et al., 1989) as 
well other respiratory diseases such as sinusitis and bronchitis. C. pneumoniae also has an 
often-debated role in inflammatory diseases such as atherosclerosis (Belland et al., 2004; 
Saikku et al., 1988; Sorrentino et al., 2015), reactive arthritis (Carter et al., 2012; Rahman et 
al., 1992; Zeidler and Hudson, 2016) and asthma (Hahn and McDonald, 1998; Webley and 
Hahn, 2017). The majority of C. pneumoniae infections occur from early childhood through 
to teenage years, leading to a high prevalence within the population with antibodies found 
in 75% of a Tawainese population and 63% in Spanish citizens (Wang and Grayston, 1990). 
This highlights the importance of early intervention for adequate control and in reducing 
Chlamydia prevalence worldwide. Due to the poor efficacy observed with antibiotic 
treatments, this is most likely achievable through development of a robust vaccine. The 
overall aim of this project is toward the elucidation of the structure and functional 
properties of the major outer membrane protein (MOMP) of C. pneumoniae, which has 
been identified as a promising vaccine candidate despite little being known of its structure 
and function.  
1.2. The biphasic lifecycle of Chlamydia 
Unique to Chlamydia is its biphasic lifecycle, which is depicted in Figure 1.1. Starting with 
the smaller electron dense infectious form known as the elementary body (EB), Chlamydia 
circulates the host system until contact with a mucosal epithelial cell occurs. The type III 
secretion system (T3SS), which is considered to be essential for virulence in a range of Gram 
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negative bacteria, is often described as a ‘molecular syringe’ which acts to insert bacterial 
effector proteins directly into the host (Betts-Hampikian and Fields, 2010). The 
metabolically inactive EB, which contains a nucleus condensed by histone proteins HctA and 
HctB, becomes internalised following delivery of a T3SS protein into the host cell which 
initiates actin recruitment (AbdelRahman and Belland, 2005). The EB is then initially 
surrounded by a protective membrane known as the Chlamydial vacuole which then 
matures within the vicinity of the host nucleus, Golgi apparatus and endoplasmic reticulum 
in order to obtain components necessary for development, such as sphingomyelin, 
cholesterol and iron (Carabeo et al., 2002; Schoborg, 2011) eventually forming an inclusion. 
Within this inclusion EBs transition to an intermediate body (IB) before finally differentiating 
into the metabolically active form, the reticulate body (RB), where the cell size begins to 
increase as metabolic proteins are upregulated and cells initiate division by binary fission 
(Wyrick, 2010). These three forms are shown in the electron micrograph of C. trachomatis in 
Figure 1.2. After around 60-72 hours for C. pneumoniae and 9-11 regenerations, the RB start 
to redifferentiate back into the EB, which accumulate and eventually exit the cell via 
exocytosis or whole cell lysis, facilitating infection of more host cells (Brunham and Rey-
Ladino, 2005; Hatch et al., 1984). Under stress conditions, the RB can enter into a reversible 
persistent state known as aberrant bodies and, whilst unable to replicate, the cells remain 
viable until the stimulus is removed, therefore leading to chronic infection (Matsumoto and 
Manire, 1970). Interferon gamma (IFNγ) is the most notable stimulant, but also nutrient 
deprivation, the herpes simplex virus, and iron starvation have all been shown to induce this 
persistent form (Wyrick, 2010). The genetic regulation of these persistent forms is 
particularly difficult to study, as the cell phenotype can vary hugely depending on the 
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stimulus. Due to this biphasic lifecycle, it is necessary for a comprehensive vaccine to target 


























1.3.  Chlamydia metabolism 
Chlamydia gene expression is temporally regulated between the two stages of the 
developmental lifecycle due to the differing roles of the EB and RB cells, in survival and 
replication respectively, which has been previously investigated with microarray analysis 
and quantitative-PCR (Q-PCR). Typically, the RBs are recognised as the more metabolically 
active form, whilst the EB’s function is in host dissemination. Chlamydial genes belong to 
one of four main classes; early, mid, late and tardy phase expression, with an additional 
persistent stage for aberrant bodies, for which the regulatory cycles for C. pneumoniae are 
comprehensively displayed in Figure 1.3 (Roulis et al., 2013). C. pneumoniae takes between 
60-96 hours to fully complete a cell cycle, compared to just 36-48 hours for C. trachomatis. 
Omp1, the gene encoding MOMP also referred to in some instances as ompA, along with 
Figure 1.2. The stages of the C. trachomatis developmental cycle. A, One hour post 
infection (hpi) the EB attaches to infected host endometrial epithelial cells. B, 8-12 hpi an 
early inclusion forms containing RB. C, Mid-development cycle containing intermediate 
bodies (IB). D, Late developmental inclusion containing mainly EB. Scale is 2 µm. (Wyrick, 
2010) 
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those encoding other outer membrane proteins such as OmcA and PorB, is downregulated 
following internalisation of the EB allowing the RB to focus on expression of proteins 
required for cell replication and metabolism (Roulis et al., 2013). During this early stage 
genes that are involved in DNA and protein biosynthesis, such as groEL3, dnaX2, and xerC, 
are expressed, followed by those required for biotin synthesis (bioB) in the mid-phase and 
glycolysis (pyk) in the late stage (Roulis et al., 2013). In preparation for release during the 
tardy stage at 60-72 hpi, hctB for DNA condensation and omp1 are then upregulated along 
with omcA, omcB, and porB, signifying that MOMP’s main role is focussed around the 
function of the EB rather than the RB. Omp1 is also clustered with thirteen other genes, 
namely other OMPs and a component of the T3SS, yscC, which is suggestive of linked 
transcription regulation (Nicholson et al., 2003). As Chlamydia have a reasonably small 
genome size of just one million base pairs (bp) compared to 4.6 million in E. coli (Stephens 
et al., 1998), some biosynthetic pathways are truncated, such as the tricarboxylic acid (TCA) 
cycle, whilst others are missing altogether, as in the case of the nicotinamide adenine 
dinucleotide (NAD) biosynthetic pathway (Käding et al., 2014). As a result, Chlamydia is in 
possession of Npt1 and Npt2 which are able to scavenge NAD/NADH and ATP from the host 
cells, with the former also present in the EB stage of the lifecycle indicating that acquisition 
can occur during both stages of the biphasic lifecycle, although it is currently unknown how 
these substrates cross the inclusion membrane (Fisher et al., 2013). Chlamydia has also 
been shown to drive host cell metabolism in order to obtain the desired substrates, for 
example through the upregulation of tryptophan biosynthesis enzymes in the early stage 
and glucose metabolism genes in the mid stage resulting in a 2-3 fold increase in substrates 
(Käding et al., 2014).  
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Figure 1.3. Temporal gene expression in C. pneumoniae. Genes in bold indicate those with different expression to C. trachomatis, and bold 
underlined genes are indicative of variations between C. pneumoniae strains. (Roulis et al., 2013) 
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1.4. The Chlamydia outer membrane 
Similar to other Gram negative bacteria, C. pneumoniae consists of an inner membrane (IM), 
separated from the outer membrane (OM) by the periplasmic space (Stephens and Lammel, 
2001). Within the OM of Chlamydial species, the lipopolysaccharide (LPS) is truncated, 
resulting in a terminal 3-deoxy-D-manno-octulosonic acid (KDO) trisaccharide, identified by 
nuclear magnetic resonance (NMR) spectroscopy (Rund et al., 1999) as shown in Figure 1.4A 
and instead referred to as a lipooligosaccharide (LOS). The typical structure of LPS in Gram 
negative bacteria, as shown in Figure 1.4B, extends beyond the KDO groups to include a 
core containing a variety of sugar moieties and the O-antigen region, which is often 
associated with pathologies such as sepsis (Steimle et al., 2016) and acts to protect the 













Figure 1.4. A, the chemical structure of LOS in C. trachomatis L2. NMR was used to 
determine the phosphorylated carbohydrate backbone and matrix assisted laser 
desorption/ionisation mass spectrometry (MALDI-MS) to determine the acylation pattern 
(Rund et al., 1999). B, a schematic displaying the typical structure of LPS in Gram negative 
bacteria. Note the orange hexagons at the beginning of the core section are where 
Chlamydial LOS is truncated. Adapted from Steimle et al., 2016.  
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Peptidoglycan (PG), typically found between the two membranes of Gram negative bacteria, 
is a sugar polymer consisting of alternate glycan residues; N-acetylglucosamine (GlcNAc) and 
N-acetylmuramic acid (MurNac), whose purpose is to confer cell structural stability. These 
two residues are connected via β-(1,4)-glycosidic bonds which then becomes inserted into 
the growing polymer chain through a transglycosylation reaction, before transpeptidation 
between the pentapeptide side chains and the MurNaC crosslinks the strands to complete 
the net-like layer within the periplasmic space (Ghuysen and Goffin, 1999). During 
pentapeptide chain assembly both L- and D-amino acids, such as D-alanine and D-glutamic 
acid, are incorporated. As mammalian cells can only utilise L-amino acids, the enzymes that 
synthesise and integrate these D-amino acids into PG act as unique targets to antibiotics 
such as D-cycloserine and β-lactams (Liechti et al., 2014). 
However, in the past three decades scientists have debated heavily over the 'Chlamydia 
anomaly', whereby Chlamydia was both susceptible to penicillins and PG-targeting enzymes 
such as lysozyme and lysostaphin (How et al., 1984), as well as being in possession of the 
genetic elements required for PG synthesis (McCoy and Maurelli, 2006), but where 
contrarily only minimal levels of PG had actually been detected. This perplexing incongruity 
was recently clarified by Liechti et al using fluorescent microscopy. This experiment 
employed a click-chemistry reaction whereby a component essential for PG pentapeptide 
crosslinking, D-alanyl-D-alanine (DA-DA), was labelled with an azide group that was then 
selectively captured in conjunction with an Alexa fluorophore (Liechti et al., 2016). This 
technique revealed that the majority of the labelled PG of C. trachomatis L2 was localised at 
the cellular division plane (the septum) of the dividing RBs, as shown in Figure 1.5, indicative 
of a novel role for PG in growth and cytokinesis in Chlamydia (Liechti et al., 2016). Upon 
entry into the host cells an inclusion body forms creating an osmotically stable environment, 
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inside which the RBs undergo metabolic processes and division, and therefore a rigid 
envelope is not required during the RB stage of the lifecycle. The limitation of PG to the 
septal growth regions of RBs and the apparent absence of a protective PG layer 
encompassing the cell within EBs has now refocussed efforts into understanding how 
Chlamydia may obtain its structural stability, particularly in the circulating EBs of the 
biphasic lifecycle, since the PG layer is essential in other bacteria for the maintenance of cell 










For a number of years, it has been known that the Chlamydia species possess a Chlamydial 
outer membrane complex (COMC), a mesh of cysteine rich OMPs linked through 
intermolecular disulphide bonding, also referred to as the P-layer within the outer 
membrane of the EB cells (Bavoil et al., 1984; Hatch et al., 1984; Hatch, 1996; Newhall et al., 
Figure 1.5. Localisation of PG in C. trachomatis infected mouse fibroblast cells. Labelling of 
PG with alkyne- DA-DA analogue probe EDA-DA. Click-chemistry was used to bind the probe 
to Alexa 488 (green), DAPI (blue) used to stain the nuclei, and antibody (red) to label MOMP 
for identification of EB and RB cells. A, Boxes show the location of the Chlamydial inclusion. 
B-D, Magnification of Chlamydial inclusion areas. PG can be seen as a ring bisecting the 




1983), 61% of which is made up of MOMP (Caldwell et al., 1981). It is the COMC that is likely 
to replace PG in providing Chlamydia with its required structural stability, during the EB 
stage of the lifecycle. Recently, a total of 17 cysteine-rich proteins were identified in the C. 
trachomatis L2 COMC, using mass spectrometry (Table 1.1), in which MOMP and OmcB 
were reportedly most abundant (Liu et al., 2010). To further demonstrate the significance of 
disulphide bonding in formation of the mesh layer, another OMP lacking cysteine residues, 
PmpD, did not form part of the COMC despite being expressed in the EB outer membrane 





As MOMP has been identified as one of the leading proteins in the COMC, it is almost 












ctl0050 MOMP 43,036 394 9 2.28 200
ctl0702 OmcB 60,783 553 24 4.34 134
ctl0250 PmpG 108,032 1012 15 1.48 46
ctl0251 PmpH 108,119 1006 15 1.49 35
ctl0248 PmpE 105,500 965 15 1.55 18
ctl0043 PulD/YscC 100,574 921 7 0.76 15
ctl0626 OprB 49,929 442 9 2.04 12
ctl0887 CTL0887 48,560 174 4 2.30 11
ctl0082 PorB 37,839 340 8 2.35 9
ctl0703 OmcA 10,013 88 13 14.77 9
ctl0071 PmpB 184,085 1749 19 1.09 9
ctl0671 PmpC 187,729 1774 14 0.79 8
ctl0249 PmpF 113,209 1032 13 1.26 8
ctl0541 CTL0541 42,241 381 8 2.10 8
ctl0493 OMP85 88,943 792 4 0.51 4
ctl0645 CTL0645 47,018 408 13 3.19 2
ctl0863 Pal 21,532 188 4 2.13 1
Table 1.1. The 17 COMC proteins identified in C. trachomatis L2. Proteins were identified 
using liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) are 
ordered based on their abundance (average spectral counts). Expanded from Liu et al., 
2010.   
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Currently, there are no available structures for MOMP in the Protein Data Bank (PDB) from 
any of the Chlamydia species, and therefore structural predictions are largely based on 
homology modelling. This in turn proves difficult when hypothesising which cysteine 
residues are likely to have key roles in disulphide bond formation. Sequence data can aid 
identification of cysteine proximity for determination of intramolecular disulphide bonds, 
but as there is a paucity of 3D structural data for both MOMP and the additional sixteen 
proteins identified in the COMC, bioinformatics analysis of any likely intermolecular contacts 
is extremely challenging.  
1.5. Genetic studies in Chlamydia 
The study of structures such as the COMC, as well as the structure-function relationships of 
Chlamydia’s prominent proteins has been hindered by the complex biphasic developmental 
cycle. In order to investigate the COMC, the EB phase of the life cycle requires isolation from 
the morphologically distinct RB stage, which in itself is a complex process due to their 
overlapping expression patterns. Not only this, but the presence of the stabilising COMC in 
EBs is likely to prevent the uptake of foreign DNA. Additionally, due to Chlamydia’s parasitic 
nature, host cells are required for bacterial growth and proliferation, again adding a layer of 
complexity to Chlamydial research not only due to infection and growth, but also in 
facilitating the transfer of DNA across a multitude of membranes, including that of the host, 
the inclusion, and the Chlamydial outer and inner membranes. Although inefficient, DNA 
transformation is now achievable via calcium chloride treatment and electroporation, even 
in EBs although at an extremely low frequency, and improvement upon this procedure will 
enable the application of other techniques such as transposon mutagenesis, which can 
provide insight into the function of the Chlamydial genes (Bastidas and Valdivia, 2016). 
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Random chemical mutagenesis is an additional method being explored (Heuer et al., 2007) 
which coupled with whole genome sequencing can identify the genetic variants produced 
leading to the creation of a mutant library (Kokes et al., 2015). However, despite these 
successes, genetic manipulation is still lagging. One obstacle is the restrictions placed on 
antibiotic selection in research for the generation of recombinant strains, due to their 
importance in treating clinical cases of Chlamydial infection, with an additional setback 
being the requirement to surpass more than one lipid bilayer as well as to limit toxicity to 
the host cells (Bastidas and Valdivia, 2016). Transformation with a recombinant plasmid is 
also problematic due to the presence of native plasmids in some species, with over five 
copies per cell, and as a result plasmid replication factors favour the smaller native plasmids 
thus decreasing the transformation efficiency.  
1.6. The Major Outer Membrane Protein 
MOMP of C. pneumoniae, also commonly and incorrectly referred to as OmpA in Chlamydia, 
is a 40 kDa β-barrel protein accounting for 60% (w/w) of the total protein mass found in the 
OM of EBs (Perez-Melgosa et al., 1991). Although 2-3% of the Gram negative bacterial 
genome encodes transmembrane β-barrel proteins, they account for only 1% of the solved 
protein structures from Gram negative bacteria (Freeman et al., 2011). Being the most 
abundant OMP in the Chlamydial membrane, it is suspected that MOMP plays an important 
role in the human immune response and, therefore, in recent years research has been 
heavily focussed on determining the exact structure of MOMP in order to design more 
effective treatments against Chlamydia (Kari et al., 2009; Olsen et al., 2015; O’Meara et al., 
2017; Xia et al., 2013). MOMP appears to be unique to Chlamydia due to the paucity of 
homologous proteins and is considered conserved among the three human species, with 
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between 64-98% identity and only minor differences in sequence lengths, which range from 
389 to 402 amino acids (aa) (as shown in Appendix 1 Figure A1.1). As a result, research 
conducted on MOMP from one Chlamydial species is likely to be significantly beneficial to 
the study of the other MOMPs. However, due to the difficulties in expression and 
purification of stable and folded recombinant MOMP, resulting from the high cysteine 
content and the requirement to extract MOMP from its native bilayer with detergents, 
there are currently no published crystal structures available for this protein across the 
whole species, leading researchers to rely on other means for structural determination, 
including in silico prediction methods.  
1.6.1. Secondary structure 
It has long been hypothesised that MOMP is a β-barrel outer membrane protein, due to its 
porin-like function identified in 1984 by Bavoil et al. This was confirmed much later with the 
help of investigative analytical technique circular dichroism (CD) (Cai et al., 2009; Sun et al., 
2007; Wen et al., 2016; Wyllie et al., 1998), with experiments in the far-UV providing 
valuable information regarding the protein secondary structure, which in this case was 
predominantly β-sheet consistent with a β-barrel structure. The CD acquired data was 
compared, by a series of algorithms, with a database of model reference proteins to assign 
the most probable features; Sun et al predicted a β-sheet content of 38-44% for native 
MOMP (nMOMP). Wen et al analysed both native and recombinant MOMP (rMOMP) using 
CD, which revealed a peak at 215 nm on both spectra, indicative of β-sheet secondary 
structure (Wen et al., 2016). This data supports other predictive methods used to discern 
MOMP’s secondary structure, such as hydrophobicity plotting and artificial neural 
networking (Rodríguez-Marañón et al., 2002). However, the number of β-strands is still 
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contested and will continue to be until a high-resolution crystal structure emerges. 
Nevertheless, it is widely believed to be in the region of 14-18 strands. This is similar to 
other well characterised OMPs, such as E. coli proteins; FadL, a 14-stranded barrel, which 
functions as a fatty acid transporter (van den Berg et al., 2004); OmpF, a 16-stranded 
trimeric porin (Cowan et al., 1992); and LamB, an 18-stranded trimeric maltose porin 
(Schirmer et al., 1995). Shared homology to these proteins may provide some insight into 
MOMP’s possible function.  
1.6.2. Variable domains 
Whilst MOMP is considered conserved, different serovars and species have been classified 
based on regions within the MOMP sequence known as variable domains (VDs), for which 
there are four, flanked by the conserved constant domains (CDs). Addition of monoclonal 
antibodies (MAbs) to C. trachomatis serovar F, analysed with an immuno-dot blot assay, 
revealed that VDII and VDIV are surface accessible on MOMP (Wang et al., 2006) and, 
therefore, are therefore likely to promote mutation in order to evade the immune system. 
Statistical analysis of the genetic differences observed in the VDs of C. trachomatis serovars 
revealed that almost 94% of mutations were nonsynonymous, as opposed to approximately 
half of the mutations in the CDs which were silent, confirming that the variability is mainly 
targeted to the VDs (Nunes et al., 2009). C. trachomatis serovar C MOMP was later analysed 
by a number of bioinformatics methods, which predicted that the VDs exist external to the 
transmembrane b-strand region (Feher et al., 2013). Mutation of surface exposed regions of 
MOMP may be an evolutionary mechanism adopted by Chlamydia to assist in immune 
evasion, but until a high resolution crystal structure emerges the exact location of these 
domains within the barrel structure will remain speculative.  
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Additionally, MOMP is characteristically cysteine rich, containing nine cysteine residues, of 
which eight are conserved between C. pneumoniae and C. trachomatis, constituting 2.3% of 
the total protein. Whilst both species have the same number of cysteines, C. pneumoniae 
has one at position C342 whilst C. trachomatis has one at C101. The formation of 
intermolecular disulphide bonds between the cysteine residues has been suggested to be 
responsible for the high osmotic stability observed in EBs, as discussed in Section 1.4, which 
may compensate for the apparent lack of PG (Perez-Melgosa et al., 1991). The amino acid 
sequence of C. pneumoniae AR39 MOMP is displayed in Figure 1.6A, where these key 
regions are highlighted and also displayed on the MOMP homology model (Figure 1.6B), 













Figure 1.6. The predicted variable domains of MOMP. A, Amino acid sequence of C. pneumoniae AR39 MOMP. NPA/NPS motifs, underlined; 
cysteine residues, red; putative VD I-IV, bold; five CDs located between VDs. B, Mapped variable domains on the C. pneumoniae MOMP 




1.6.3. Oligomeric state 
MOMP’s native oligomeric state is generally hypothesised as trimeric, as previously 
determined by migration patterns on SDS-PAGE gels (Feher et al., 2013; Sun et al., 2007). 
Although the band observed by Sun et al at 67 kDa does not correlate with a trimeric 
molecular weight for MOMP, whose monomeric MW is approximately 40 kDa, they have 
identified other OMPs with well characterised trimers exhibiting similar migration patterns. 
These include OmpF and PhoE from E. coli, both with MW’s of 39 kDa, which migrate in a 
similar manner (Sun et al., 2007). Supported by the research conducted by Newhall et al in 
1983, which indicated that trimeric MOMP was stabilised with disulphide bonds through 
reducing and non-reducing SDS-PAGE gels, this complements the suggestion that MOMP 
forms clusters through intermolecular disulphide bonding, which is believed to provide 
structural stability to the Chlamydial cell during its infectious stage (discussed in greater 
depth in Chapter 5). 
1.6.4. Homology modelling of MOMP 
Homology modelling for MOMP has been somewhat problematic over the years, mainly due 
to the paucity of highly homologous proteins, exacerbated by the lack of structural data for 
the most closely related protein PorB of Chlamydia, which shares 22% identity. Therefore, it 
is necessary to extend the search to a wider field of β-barrel proteins with a lower degree of 
similarity and identity. One such homology model proposed by Atanu in 2013 was based on 
the E. coli fatty acid transporter, FadL, with 16.9% identity and 39.6% similarity (sequence 
alignment shown in Appendix 1 Figure A1.2), selected due to the availability of high quality 
structural data to 2.6 Å along with the greatest homology to MOMP. The main features of 
this model, as shown in Figure 1.7A, are a 14-stranded barrel with an externally exposed α-
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helical loop, an N-terminal occluded region of 37 aa at the interior of the barrel at the 
periplasmic side, which has been named the ‘plug domain’, and the NPS and NPA motifs 
common to transport proteins, the location of which are also shown in Figure 1.7A. 
Additionally, all nine cysteine residues are predicted to be within β-strands, supporting the 
hypothesis that MOMP forms intermolecular disulphide bonds (Atanu et al., 2013). 
According to this model, only VDII is externally located in the α-helical loop region, with the 
remaining three domains situated within the barrel (Figure 1.6B). Whilst it is generally 
considered that the VDs are responsible for antigenicity and are therefore surface exposed, 
research conducted by Baehr et al on C. trachomatis MOMP indicated that only VDII and 
VDIV were susceptible to protease treatment, which suggests otherwise (Baehr et al., 1988), 
and thus the model was not fit around these constraints. This model is somewhat different 
to that suggested by Feher et al, published in the same year, which instead features 16 β-
strands, with neither a protruding α-helical loop region nor a plug domain occluding the 
barrel (Figure 1.7B). As opposed to the method adopted by Atanu et al, which identified a 
single homologous E. coli protein through structure-based prediction software packages 
IntFold and Phyre to derive a model, Feher et al utilised the topology prediction software 
TMBpro, which in this instance resulted in some ambiguity in the C-terminal region. 
Nevertheless, TMBpro is a valuable tool as the pipeline pulls information solely from 
transmembrane protein data and is not reliant on sequence similarity. It is imperative that 
all prediction and modelling algorithms are updated regularly as previous constraints 
restricted β-barrels to an even number of strands. However, based on experimental 
evidence, the crystal structure of a voltage-dependent anion channel (VDAC) was published 
in 2008 showing a structure with 19 β-strands (PDB code: 2JK4), thus throwing these widely 
followed constraints into question. The differences between these two models, published 
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within a few months of each other, again highlights the difficulties faced in structure 
prediction of proteins with no reliable or biologically relevant homologues. In this work, the 
homology model produced by Atanu et al will be referenced and used, as it specifically 
relates to C. pneumoniae AR39 MOMP, which is the MOMP to be used throughout this 







1.6.5. Current structural information regarding MOMP 
Currently a low-resolution crystal structure for rMOMP of C. pneumoniae has been solved 
using molecular replacement (MR) to 4 Å (Figure 1.8) (Atanu, 2014), following collection of 
small wedges of data which were then merged using crystallographic software BLEND (Foadi 
et al., 2013). The collection of small 10-15 ° wedges prevents large scale radiation damage, 
Figure 1.7. A, C. pneumoniae AR39 MOMP homology model based on FadL of E. coli. A 
14-stranded β-barrel with the alpha helical loop shown on the extracellular side in orange 
and the barrel occlusion in yellow at the periplasmic side. NPA and NPS motifs are also 
labelled, with arrows suggesting a possible solute transport route. (Atanu et al., 2013). B, 
C. trachomatis MOMP homology model constructed using TMBpro. A 16-stranded β-
barrel showing the root mean square deviations (RMSD) for backbone heavy atoms to the 
average chains, with low as green and high as red. Strand (S) and loop (L) numbers are 
indicated. (Adapted from Feher et al., 2013).  
A B 
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permitting the collection of a greater number of data sets before the crystal lattice becomes 
irreparably damaged, which is especially useful for delicate samples or microcrystals that 
are smaller than 10 µm. Previous synchrotron radiation circular dichroism (SRCD) 
experiments established MOMP’s β-sheet secondary structure (Atanu, 2014), which was 
confirmed through X-ray diffraction (XRD), with the barrel shape clearly visible within the 
density (Figure 1.9A). The structure was solved by MR using the FadL homology model, 
previously described in Section 1.6.4, with Figure 1.9A demonstrating a view into the barrel 
from what would be the periplasmic side, where it is clear that the barrel contains an 
occluded region near the N-terminus of MOMP. Not only is this structure supportive of the 
14-stranded homology model but also of the hypothesis that MOMP does not act as a 
general porin but may have a more specific role in ligand transport. As hypothesised from 
the homology model, MOMP also has a large extracellular loop, possibly involved in ligand 
transport as observed in E. coli’s FadL and TodX, the toluene transporter of Pseudomonas 
putida (Hearn et al., 2008), in addition to a number of smaller loop regions. From Figure 
1.9B, a number of regions with undefined density have been identified, indicative of a 
number of flexible regions such as the external loops, previously modelled. Being low 
resolution data, it could be argued that MR with a homology model largely biases the 
resulting model found. However, MR on data merged with BLEND also was conducted with a 
number of known E. coli contaminants, such as OmpF, OmpA and OmpC, whereby the fit to 
the density and the resulting packing were deemed unsuitable (Atanu, 2014). Mass 
spectrometry was also used to analyse the crystal drop composition, which determined 
approximately 70% MOMP, with the remainder OmpF (Atanu, 2014). As OmpF does not 
possess an occluded barrel, and the MR electron density fit and cell packing was unsuitable, 
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it was highly likely the crystal structure observed arose from MOMP rather than any 
contaminant protein.  
Whilst this data confirms the presence of the plug domain within the lumen of the barrel, in 
addition to the 14-stranded structure, as opposed to the 16-stranded model hypothesised 
by Feher et al in 2013, the structure was only resolved to 4 Å and, therefore, the side chain 
orientations were not completely characterised. Detailed information regarding the side 
chain orientations, as well as the external loop regions and internal plug will provide 
essential information regarding MOMP’s possible function, as well as enhance the design of 
vaccines and antimicrobials targeted towards MOMP. Therefore, this research will focus on 
obtaining a higher resolution crystal structure to infer greater detail of MOMP’s structure 
and function. 
 
Figure 1.8. 4 Å crystal structure solved by MR using the FadL homology model. MOMP was 
isolated with sarkosyl before solubilisation in DDM and buffer exchange into OG for 
crystallisation. Data was collected in 10-15 ° wedges from crystals grown in 11.5 % PEG 
4000, 0.1 sodium chloride, 0.1 lithium sulphate, 0.1 ADA, at pH 6.5 on the I04 beamline at 
DLS, and merged using BLEND. The structure suggests a 14-stranded β-barrel, as 










1.6.6. Functional studies of MOMP 
The functional role of MOMP remains to be determined, but as previously mentioned, both 
the surface exposure and the abundance of MOMP within the Chlamydial membrane is 
suggestive of a possible role for MOMP in host-Chlamydia interactions, such as adhesion 
and consequently in stimulation of a host immune response (Caldwell and Schachter, 1982; 
Hafner et al., 2008; Redgrove and McLaughlin, 2014). Adhesion of EBs to a viable host cell is 
a vital step in the Chlamydial pathogenesis pathway and likely occurs via clathrin-mediated 
endocytosis (Hybiske and Stephens, 2007). Building a comprehensive understanding of the 
components involved in this process will pave the way to more effective disease prevention, 
treatment, and management. MOMP’s potential role as an adhesin was identified by Su et 
al in 1990 through the study of two externally exposed variable domains, VDII and VDIV, 
which were suggested to contribute to cell electronegativity. The addition of MAbs, specific 
for these two domains, disrupted the electrostatic interaction between EBs and host cells, 
A B 
Figure 1.9. Electron density map (2Fo-Fc = 2s) of the low resolution MOMP structure. A, 
periplasmic view into the barrel. The plug domain occluding the barrel lumen is indicated by 
the red circle. B, side view of the undefined density at the extracellular side. The two red 
ovals indicate the undefined density, likely due to flexible loop regions. (Atanu, 2014).  
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whilst heat denaturation prevented the hydrophobic interaction between a conserved 
hydrophobic nonapeptide on VDIV and the host cell, indicating that MOMP might function 
as an adhesin (Su et al., 1990). It was also possible that the MAbs blocked other interactions 
between MOMP and the host membrane, or that they sterically inhibited another important 
component in adhesion. A later study determined that C. pneumoniae utilises the mannose-
6-phosphate/insulin-like growth factor 2 (M6P/IGF2) receptor on epithelial cells for 
attachment and, although not yet determined, a likely candidate for this interaction is 
MOMP due to its high-mannose oligosaccharide moiety, which is similar to the native ligand 
(Puolakkainen et al., 2005). Whilst MOMP may be a prime candidate as an adhesin 
molecule, due to its abundance, since this research in 2005 the focus has shifted to other 
Chlamydial OMPs as the main adhesins, namely OmcB, the second most abundant OMP, 
which binds heparin sulphate-like glycosaminoglycans to form electrostatic interactions 
during the initial stage of EB invasion (Mölleken and Hegemann, 2008) followed by the 
irreversible interaction of polymorphic membrane protein 21 (Pmp21) with the host 
epidermal growth factor receptor (EGFR) on epithelial cells to mediate invasion (Mölleken et 
al., 2013). Determining the mechanism by which Chlamydia attaches and infects host cells 
will prove invaluable in disease prevention strategies.  
MOMP has long been considered a porin due to its β-barrel structure, which is an inherent 
feature for this function. Porins are a type of channel located in the outer membrane of 
Gram negative and some Gram positive bacteria that allow the passive diffusion of small 
solutes (<600 Da), including nutrients and waste products. Archetypal porins, such as OmpF 
of E. coli, form trimers and due to MOMP’s suggested trimeric state it is feasible that MOMP 
may also possess porin activity. Although it had been shown by Bavoil et al in 1984 that 
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Chlamydia contained water filled pores, it wasn’t until 1998 and the research of Wyllie et al 
that suggested this activity was due to MOMP, whereby addition of a neutralising MAb 
reduced the amplitude of the channel openings in planar lipid bilayers incorporated with 
nMOMP. A liposomal assay of rMOMP of C. trachomatis expressed in E. coli demonstrated 
the porin-like ability of MOMP to transport all 20 of the amino acids (Jones et al., 2000). 
Later, Sun et al examined the porin activity of nMOMP from C. trachomatis reconstituted 
into proteoliposomes, for which pore forming activity was indicated but at a rate fifty times 
lower than that of OmpF from E. coli, when testing the small sugar L-arabinose (Sun et al., 
2007). PorB, which is also a contributor to the COMC, has been identified as a Chlamydial 
porin using a liposomal swelling assay which revealed the ability to transport small 
monosaccharides such as arabinose and glucose (Kubo and Stephens, 2002). Alternatively, it 
has been hypothesised that MOMP is an active transporter based on its homology with 
FadL, the fatty acid transporter of E. coli, as discussed previously in Section 1.6.4 (Atanu et 
al., 2013). In this model, both the NPS and NPA motifs, which have been demonstrated to 
have roles in hydrophobic solute transport and water selective permeation in aquaporins 
(Guan et al., 2010), respectively, are suggested to have a role in solute coordination through 
the barrel, as shown with arrows in Figure 1.7A (Atanu et al., 2013). Whilst it was initially 
hypothesised that the NPA motif had a role in the FadL plug domain flexibility, knockout of 
this sequence did not affect the plug orientation in X-ray crystal structures (Hearn et al., 
2007). This was supportive of the lateral diffusion model for FadL, whereby fatty acids enter 
the barrel and are then extruded through a hole in the barrel side into the membrane. 
However, as there is currently no indication of a lateral opening in MOMP, mutagenesis 
studies in conjunction with transport assays of these motifs will be useful for determining 
their importance in MOMP’s functionality. Valuable knowledge would also be gained from 
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functional assays in order to determine which solutes could be transported by MOMP and, if 
essential to Chlamydial survival, could be blocked by targeting inhibitor molecules to 
MOMP’s extracellular side. Whilst MOMP’s main function may be as a major component of 
the COMC for maintenance of EB structural stability, which will be investigated and 
discussed further in this research, it is also possible that MOMP has a dual role, similar to 
PorB. 
1.7. Aims and Objectives 
Currently, there is very little literature surrounding structure-function characterisation of 
Chlamydial MOMPs due to difficulties in producing recombinant protein in a folded, active 
state. This research has been focussed on the production of rMOMP and the use of X-ray 
crystallography to solve MOMP’s structure to a higher resolution, in an ongoing effort to 
discern the finer details of MOMP’s β-barrel structure, including the loop and plug domains, 
as well as to identify the correct register of β-strands and hence accurately localise cysteine 
residues particularly with an external orientation that may contribute to intermolecular 
disulphide bonding. Knowledge of the orientation and position of the NPA and NPS motifs 
also could provide some insight into MOMP’s possible function as a ligand transporter. Due 
to MOMP’s homology with the fatty acid transporter of E. coli, FadL, a ligand transport assay 
using E. coli knockout mutants is developed, as part of this thesis work, to determine if 
MOMP can act as a fatty acid transporter. The role of the many cysteine residues is also 
investigated through mutagenesis studies, designed to both improve MOMP’s solubility for 
crystallography efforts and also to observe the effect on MOMP clustering in the 
membrane, using high resolution fluorescence microscopy. These experiments will enhance 
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our understanding of MOMP’s possible transport activity and mechanism, and its role in the 
structural integrity of Chlamydia.  
Each of the subsequent research chapters will introduce specific literature, methods, and 















































































2 Materials and Methods 
2.1 Materials 
2.1.1 E. coli strains 
Strain name Genotype Parent strain 
BL21 (DE3) F- ompT hsdSB(rB-mB-) dcm gal λ(DE3 [lacI lacUV5-T7 gene 1 
ind1 sam7 nin5]) 
B834 





Δ(araD-araB)567 ΔlacZ4787(::rrnB-3) λ- rph-1 Δ(rhaD-
rhaB)568 hsdR514 ΔfadL::kan ΔfadR::chlor 
BW25113 
C41 (DE3) F- ompT hsdSB(rB- mB-) dcm gal λ(DE3 [lacI lac-T7 gene 1 
ind1 sam7 nin5]) 
BL21 (DE3) 
JW2341 F- Δ(araD-araB)567 ΔlacZ4787(::rrnB-3) λ- ΔfadL752::kan 
rph-1 Δ(rhaD-rhaB)568 hsdR514 
BW25113 
LS6164 fadR- ΔfadL5 K12 
Stellar F- endA1 supE44 thi-1 recA1 relA1 gyrA96 phoA Φ80d lacZ 
ΔM15 Δ(lacZYA-argF) U169 Δ(mrr-hsdRMS-mcrBC) ΔmcrA 
λ–  
HST08 
Top10 F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZ ΔM15 
ΔlacX74 recA1 araD139 Δ(ara leu) 7697 galU galK rpsL 





























pBADrha Ford et al., 
2014 
MOMPH6 CmR His-6 R1407 
pBADa This work MOMPH6 CmR and ApR His-6 R1411 















MOMPH8 His-8 R1401  
MOMPH10 His-10 R1402  
MOMP C136A His-6 R1420 
Invitrogen MOMP C201A His-6 R1409  
MOMP C203A His-6 R1419  
MOMP C201A/C203A His-6 R1410  
MOMP C136A/C201A His-6 R1421  
MOMP C136A/C203A His-6 R1423  













MOMP C201A R1416 
MOMP C203A R1417 










Table 2.2. Plasmids used for expression. CmR, carbenicillin; ApR, ampicillin. An R number is 
assigned after the construct has been correctly sequenced. The original pET101/D-TOPO 
vector containing MOMPH6 was kindly gifted by Dr E. Oveido-Orta, University of Surrey. 
The linearised pOPIN-3C-Halo vector was kindly gifted by the Oxford Protein Production 
Facility, Research Complex at Harwell.   
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2.1.3 Antibodies  
 
Antibody Type Dilution Application Source 
Anti-his HRP conjugated 
monoclonal mouse 
Primary 1/10,000 Western 
blotting 
Roche 
6X his epitope tag 
monoclonal mouse IgG 
Primary 1/1500 Western 
blotting 
Pierce 
Anti-mouse IgG (H+L) -HRP 
conjugated 




6X his-tag polyclonal rabbit Primary  1/500 TIRF AbCam 
Anti-E. coli OmpA 
polyclonal rabbit 




Alexa-488 anti-rabbit Secondary 1/500 TIRF and 
STORM 
LifeTechnologies  
Alexa-647 anti-his Primary 1/100 STORM LifeTechnologies  



















Table 2.3. List of antibodies used and their application. 
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2.1.4 Solutions and buffers 
 
Solution name Composition Purpose 
X4 SDS-PAGE 
sample buffer 
250 mM Tris-HCl pH 6.8, 8% (w/v) SDS, 40% (v/v) 





25 mM Tris, 192 mM glycine, 0.1% (w/v) SDS, pH 8.3 SDS-PAGE 
Coomassie blue 
stain 
0.25% (w/v) Coomassie Blue R250, 45% (v/v) 




30% (v/v) methanol, 10% (v/v) glacial acetic acid SDS-PAGE 
X1 NuPage Mes 
SDS running 
buffer 
50 mM MES, 50 mM Tris Base, 0.1% (w/v) SDS, 1 mM 






0.05 M Tris pH 7.5, 0.15 M NaCl, 0.1% (v/v) Tween-20 Western 
blotting 
TAE agarose gel 
buffer 
40 mM Tris, 20 mM glacial acetic acid, 1 mM EDTA Agarose gel 
electrophoresis 
Lysis buffer 20 mM Tris, 300 mM NaCl, 1 mM MgCl2, 100 mg/ml 
lysozyme, 50 mg/ml DNase I, protease inhibitor, pH 





20 mM Tris, 300 mM NaCl, 10% (v/v) glycerol, 1 mM 

















20 mM Tris, 300 mM NaCl, 10% (v/v) glycerol, 1 mM 
DTT, X% (w/v) detergent 
Purification 
Buffer A 10 mM imidazole, 20 mM Tris, 300 mM NaCl, 10% 
(v/v) glycerol, 1 mM DTT, 0.1% (w/v) DDM 
His-trap affinity 
chromatography 
Buffer B 500 mM imidazole, 20 mM Tris, 300 mM NaCl, 10% 






20 mM Tris, 300 mM NaCl, 10% (v/v) glycerol, 1 mM 






20 mM Tris, 300 mM NaCl, 10% (v/v) glycerol, 1 mM 





Dialysis buffer 20 mM Tris, 300 mM NaCl, 10% (v/v) glycerol, 5 mM 





20 mM Tris, 150 mM NaCl, 10% (v/v) glycerol, 5 mM 




Table 2.4. List of solutions and buffers used, their composition and application.  
Concentrations given as X are variable and specified in the relevant chapters.  
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2.1.5 Equipment  
Equipment Purpose Location 
Innova 44 shaker incubator Bacterial culture DLS 
Amersham Biosciences Ultrospec 10 cell 
density meter  
OD600 measurement DLS 
Helios α Thermospectronic 
spectrophotometer 
OD600 measurement UoR 
Heraeus Megafuge 1.0R centrifuge  Small scale cell pelleting UoR 
Sorvall RC5B Centrifuge Medium scale cell pelleting UoR 
Sorvall evolution RC centrifuge  Large scale cell pelleting DLS 
Stansted Fluid Power FPG12800 pressure 
cell homogeniser 
Cell lysis UoR 
Constant Cell Disruptor Systems Cell lysis DLS 
Beckman Coulter L-90k ultracentrifuge Medium scale membrane 
preparation 
UoR 
Beckham Coulter-Optima L-100 XP 
ultracentrifuge 
Large scale membrane 
preparation and purification 
DLS 
GE Peristaltic pump Column loading DLS 
GE 5 ml HisTrap column Purification DLS 
GE ÄKTA purifier  Purification DLS 
Spectromax microplate reader BCA assay protein detection  DLS 
Beckman Coulter-Optima Max-TL 
benchtop ultra-centrifuge  
Detergent screening DLS 
Shimadzu HPLC FSEC for detergent screening DLS 
GE Superose 6 10/300 L column FSEC for detergent screening DLS 
GE Superdex 200 column  SEC for detergent exchange DLS 
GE HiPrep 26/10 desalting column Detergent exchange DLS 
Beckman Coulter Allegra X-22R centrifuge  Protein concentration DLS 
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TTP Labtech Mosquito robot  Crystallisation DLS 
Molecular Dimensions incubator  Crystallisation plate incubator DLS 
Leica DFC295 light microscope Monitoring crystal growth DLS 
Invitrogen iBind Western blotting DLS 
Invitrogen iBlot Western blotting DLS 
Image Quant LAS 4000  Imaging SDS-PAGE gels DLS 
Syngene G.box v1.5.2.0 Imaging SDS-PAGE gels and 
spot plates 
UoR 
Eppendorf MasterCycler PCR UoR 
NanoDrop spectrophotometer Protein/DNA quanitification UoR and DLS 
SnapGene Viewer v4.1.1 Plasmid map creation Freely 
available 
online 





VMD v.1.9.2  Visualisation of MD simulations University of 
Oxford 
Gromacs v4.6  MD simulations University of 
Oxford 
Nikon Eclipse Ti inverted microscope Epifluorescence and TIRF 
microscopy 
UoR 
NIS-Elements AR 4.5  Epifluorescence and TIRF 
microscopy image acquisition 
UoR 





Zeiss Elyra microscope  STORM data collection CLF, Harwell 
Zeiss Black 2012 STORM data collection and 
analysis 
CLF, Harwell 






Table 2.5. List of equipment, their purpose and location. 
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All chemicals and reagents used were supplied by Sigma Aldrich unless otherwise stated.  
Method A refers to protocols followed at the University of Reading, whilst Method B refers 
to those followed at Diamond Light Source.  
2.2 Methods 
2.2.1 Molecular biology 
2.2.1.1 Primer design 
Forward and reverse primers used in construct design and mutagenesis are listed in Table 
2.6. For the selection of primers, an optimum melting temperature (Tm) of between 58-65 
°C, with a difference less than 4 °C between the forward and reverse primers, is the most 
important parameter to consider. The gene of interest (GOI) homologous sequence should 
also be between 18-25 bp in length, with a GC content ideally between 40-60%. Calculation 
of Tm and GC% were only in regard to the GOI homologous region. For In-Fusion, it is 
essential to have 15 bp of overlap with the desired construct, with the remaining 
oligonucleotide homologous to the GOI. The primers shown in Table 2.6 were purchased 
from Eurofin MWG-Biotech and resuspended in nanopure water (nH2O) to a final 
concentration of 200 pmol/µl. Working stocks were used at 10 pmol/µl. All primer 





Table 2.6. Oligomers used for mutagenesis, In-Fusion, and sequencing. Bold, mutated bases; italics, non-homogeneous regions for In-Fusion; 
underlined, inserted regions. All Tms and GC content calculated using ApE software, except for site directed mutagenesis which used the 
following formula to account for mismatched bases: Tm = 81.5 + 0.41(%GC) – (675/N) - % mismatch, as specified by the QuikChange XL II 
handbook.  













For CTACGCGTACCGGTCATCACCACCACCATCATCACCATC 39 87
Rev GATGGTGATGATGGTGGTGGTGATGACCGGTACGCGTAG
For CAGCAGGATCACATATGAAAAAACTCTTAAAGTCGGCGTTAT 27 + 15 58 33
Rev GGGTACCATGGCATATCAATGGTGATGGTGATGATGAC 15 + 23 57 43
For CATTTTGCCTTCCTGTTTTTGCTC 24 57 42
Rev TGTAGATAACTACGATACGGGAGGG 25 58 48
For CAGCAGGATCACATATGAGCCAGAAAACCCTGTTTACA 15 + 23 58 43
Rev GGGTACCATGGCATATCAGAACGCGTAGTTAAAGTTAGTACC  15 + 27 58 41
For AGGAGATATACCATGAAAAAACTCTTAAAGTCGGCGTTATTATC 15 + 29 56 31
Rev CAGAACTTCCAGTTTGAATCTGAACTGACCAGATACG 15 + 22 54 45
For TAATACGACTCACTATAGGG 20 48 40
Rev CTAGTTATTGCTCAGCGGT 19 53 47
N/A rhaB For CTGTCAGTAACGAGAAGGTCGC 22 58 55 Sequencing
N/A pBAD (pTrcHis) Rev CTTCTGCGTTCTGATTTAATCTG 23 53 39 Sequencing

















pET101 MOMP His 8





















2.2.1.2 QuikChange II XL site directed mutagenesis using polymerase chain reaction 
(PCR) 
PCR was performed using Agilent Technologies QuikChange II XL site directed mutagenesis 
(SDM) kit. The reaction mixture was made up to 25 µl using both 50 ng and 100 ng DNA 
templates, X10 reaction buffer, forward and reverse primers, and QuikSolution. The reaction 
mixture was mixed, pulse centrifuged then supplemented with Pfu ultra DNA polymerase 
before being immediately placed in the PCR cycler (Eppendorf MasterCycler). The extension 
time was adjusted to 2 minutes per Kb. Cycling parameters are shown in Table 2.7. The 
resulting PCR products were incubated at 37 °C with DpnI endonuclease (0.5 µl per 15 µl 
PCR reaction) for 2h and analysed via agarose gel electrophoresis.  
PCR products of the correct size were then transformed into Top10 or Stellar E. coli cells and 
plated onto LB plates containing 0.6% (w/v) glucose and the appropriate antibiotic. Plasmids 
from three to five transformants were prepared and sent for sequencing with Eurofins 
MWG to confirm the correct mutation. Overnight cultures were used to make glycerol 








Table 2.7. Modified PCR cycling parameters for QuikChange II XL mutagenesis. 
Step Temperature	(°C) Time Cycles




Final	extension 68 7	min	 1
18
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2.2.1.3 Amplification of insert 
CloneAmp™ HiFi PCR premix was used to amplify the GOI for insertion into the vector of 
interest. Two concentrations of template DNA were used to obtain the optimum PCR 
product; 20 ng and 50 ng. The master mix preparation is shown in Table 2.8. An initial five 
cycle temperature gradient for annealing of the GOI was run before 25 cycles at a fixed 
temperature; full details of the cycling parameters are shown in Table 2.9. Samples were 








Table 2.9. PCR cycling conditions used for amplification of the GOI. Initially, to improve 
annealing to the GOI homologous region, three annealing temperatures were chosen; at the 
primer Tm, and 2 °C above and below, which was cycled five times. The following 25 cycles 
were done at a higher annealing temperature of 62 °C. A final ten minute extension at 72 °C 
was performed to ensure complete filling of any protruding strands.  
Table 2.8. PCR master mix recipe for amplification of inserts. Two different template DNA 
concentrations were used to obtain the optimum PCR product. Each 25 µl reaction mixture 
was done in triplicate to test three different annealing temperatures.  










Extension 72 600 1
5
25
20ng template 50ng template
CloneAmp HiFi PCR premix 12.5 12.5
Primer 1 (10pmol/µl) 0.75 0.75
Primer 2 (10pmol/µl) 0.75 0.75




2.2.1.4 Gel and PCR purification 
PCR products and linearised vectors were initially verified using 0.7% (w/v) agarose gels 
(Section 2.2.1.7). If present as a single band, samples were PCR purified using the 
NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel). If multiple bands were present, the 
DNA was loaded onto an agarose gel and run at 60 v for 2h. The gel was imaged using a UV 
protective screen before excision of the band of interest under UV light. This was then 
purified using the same kit, following the gel purification procedure. The DNA concentration 
was measured using a NanoDrop spectrophotometer at 260 nm.  
2.2.1.5 Inverse PCR 
Inverse PCR was used to linearise DNA without the use of restriction digestion enzymes. 
Primers were designed to flank the desired insertion point, following the criteria set out in 
Section 2.2.1.1, and the PCR reaction was prepared following the CloneAmp HiFi Premix 
procedure. The PCR product was DpnI treated, checked on an agarose gel for the correct 
size, and purified.   
2.2.1.6 In-Fusion Cloning Reaction 
The In-Fusion HD cloning kit (Clonetech) was used for the In-Fusion cloning reaction. 
Linearised vector was created via inverse PCR. CloneAmp™ HiFi PCR premix was used to 
amplify the GOI. Both linearised vector and PCR produced inserts were purified prior to use. 
The In-Fusion cloning reactions were set up at room temperature using molar ratios 
calculated using Clonetech’s online tool. These reaction mixtures were then incubated at 50 
°C for 15 minutes before placing on ice until transformation. 2.5 µl of reaction mix was 
transformed with Stellar cells (Clonetech), which were plated onto LB plates containing 0.6% 
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(w/v) glucose and the appropriate antibiotic (pOPINE3CHalo, 50 µg/ml ampicillin; pBADrha, 
34 µg/ml chloramphenicol; pBADa, 100 µg/ml ampicillin), and incubated overnight at 37 °C. 
2.2.1.7 Agarose gel electrophoresis 
DNA was analysed with 0.7% (w/v) agarose gels for both plasmid templates and PCR 
products. Agarose was resuspended in TAE buffer, dissolved with gentle heating, and 
supplemented with 0.2X GelRed.  Hyperladder 1 Kb (Bioline) was used as a molecular weight 
marker. Template plasmid (2 µl) or PCR product (4 µl) was mixed with 1 µl BlueJuice loading 
dye (Invitrogen) and subsequently loaded onto the horizontal gel. The DNA was separated 
for 80 minutes at 80 v (Biorad powerpack 300) and visualised using Syngene G.box V1.5.2.0.  
2.2.1.8 Nucleic acid quantification using a Nanodrop spectrophotometer 
DNA concentration was estimated using a Nanodrop Spectrometer (ThermoScientific) by 
absorbance of UV-visible light at 260 nm.  
2.2.1.9 Transformation 
Competent cells, stored at -80 °C in microcentrifuge tubes, were thawed on ice. 1.5 μl of 
DNA (50-100 ng) was added to 25 μl of competent cells in fresh microcentrifuge tubes and 
mixed by gentle tapping. The resulting mixtures were incubated on ice for 30 minutes and 
then transferred to a 42 °C water bath for 45 seconds, then were immediately returned to 
ice for 5 minutes. 225 μl of LB media was added to the transformed cells, which were then 
incubated at 37 °C for 1h. 10-100 μl of each transformed cell culture was spread on LB agar 
plates supplemented with 0.6% (w/v) glucose and the appropriate antibiotic (100 µg/ml 
ampicillin, 34 µg/ml chloramphenicol, 50 µg/ml kanamycin) and incubated overnight at 37 
°C.  
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2.2.1.10 Plasmid mini prep 
10 ml of LB supplemented with the appropriate antibiotic and 0.6% (w/v) glucose was 
inoculated with a single colony and grown overnight at 30 °C, in a shaking incubator at 225 
rpm. The plasmid miniprep was then prepared using the QiaPrep Spin Miniprep kit (Qiagen) 
and checked on an agarose gel. The DNA concentration was measured using a NanoDrop 
spectrophotometer at 260 nm. 
2.2.1.11 Glycerol stocking 
Glycerol stocks of positively transformed cells were generated from overnight cell cultures 
with a final concentration of 15% (v/v) glycerol. Stocks were mixed in sterile cryogenic tubes 
until an even suspension was achieved before being frozen at -80 °C.  
2.2.1.12 Sequencing 
Constructs were sequenced by Eurofins Genomics, using the sequencing primers specified in 
Table 2.6. 
2.2.2 Protein expression and purification 
2.2.2.1 Competent cell prep 
Competent cell stocks were streaked onto plain LB plates and incubated overnight at 37 °C. 
A single colony was inoculated into 10 ml LB and incubated overnight at 30 °C in a shaking 
incubator at 225 rpm. The overnight culture was diluted 100-fold into fresh LB and 
incubated at 37 °C in a shaking incubator at 225 rpm, until an OD600 of 0.4-0.5 had been 
reached, as measured using a Helios α Thermospectronic spectrophotometer. Cells were 
immediately placed on ice and pelleted at 3,000 rpm, using a Heraeus Megafuge 1.0R 
centrifuge with swing out rotor, for 15 minutes at 4°C. The supernatant was removed and 
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the pellet resuspended in 5 ml of ice cold 100 mM CaCl2. The cells were incubated on ice for 
15 minutes before being centrifuged again under the same conditions. The pellet was then 
resuspended in 1 ml of 100 mM CaCl2 and incubated on ice for 1.5-2h. Ice cold glycerol was 
added to a final concentration of 15% (v/v) before 100 µl aliquots were dispensed into 
sterile microcentrifuge tubes, flash frozen in liquid nitrogen and stored at -80 °C.  
2.2.2.2 Growth curve 
A single colony of transformed E. coli cells was inoculated into 10-20 mL of LB supplemented 
with the appropriate antibiotic and 0.6% (w/v) glucose and incubated overnight at 30 °C, 
shaking at 225 rpm. The overnight culture was diluted 100-fold into 20 ml of fresh LB 
supplemented with the appropriate antibiotic, in triplicate, and incubated in a shaking 
incubator at 37 °C until an OD600 of ~0.5. Cultures were induced with 1 mM (final 
concentration) of isopropylthiogalactoside (IPTG) and grown at 25 °C, shaking at 225 rpm for 
an additional 6h to 10h, with OD600 readings taken every hour following induction.  
2.2.2.3 Medium scale protein expression (at Reading) 
A single colony of transformed E. coli cells was inoculated into 10 mL of LB supplemented 
with 100 μg/ml ampicillin and 0.6% (w/v) glucose and incubated overnight at 30 °C, shaking 
at 225 rpm. The overnight culture was diluted 100-fold into 250-500 mL of LB in 2 L 
FisherScientific flasks supplemented with 100 μg/ml ampicillin and incubated at 37 °C, 
shaking at 225 rpm until an OD600 of ~0.5 was reached. Cultures were induced with 1 mM of 
IPTG and grown at 25°C, shaking at 225 rpm for between 3h and 16h. The OD600 was 
measured and cells pelleted for 20 minutes, 10,000 rpm (15,191 x g) at 4 °C, using a Sorvall 
RC5B centrifuge and F16/250 rotor. The pellet was resuspended in lysis buffer before 
passage through a pressure cell homogeniser (Stansted Fluid Power FPG12800) twice at 
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20,000 psi. The lysed cells were centrifuged for 20 minutes at 12,000 rpm (17,210 x g) 4°C, 
using a Sorvall RC5B centrifuge and SS34 rotor to sediment inclusion bodies. The 
supernatant was then pelleted at 15,000 rpm (26,890 x g) 4 °C for 45 minutes, using a 
Sorvall SS-34 rotor in a Beckman Coulter L-90k ultracentrifuge. The outer membranes were 
then resuspended in resuspension buffer, according to their OD600 measurement at the time 
of harvesting; 0.5 ml of buffer per OD unit per 100 ml of original culture. Samples were then 
analysed by SDS-PAGE and Western blotting, and stored at -20 °C.   
2.2.2.4 Large scale expression (at Diamond Light Source) 
A single colony of transformed E. coli cells was inoculated into a 500 ml Erlenmeyer flask 
containing LB media supplemented with 100 μg/ml ampicillin and 0.6% (w/v) glucose and 
incubated overnight at 30 °C in a shaking incubator at 225 rpm. The overnight culture was 
diluted 100-fold into 2 L baffled Erlenmeyer flasks, each containing 500 ml of LB media 
supplemented with 100 μg/ml ampicillin. Cultures were incubated in an Innova 44 incubator 
shaker at 37 °C until an OD600 of ~0.5 was reached. Cultures were induced with a final 
concentration of 1 mM IPTG and grown at 25 °C for an additional 16h to 20h.  
Cells were harvested by centrifugation for 10 minutes at 5,500 rpm (6,600 x g) 4 °C using a 
Sorvall evolution RC centrifuge (ThermoScientific) with an F8-6x1000y Fiberlite Piramoon 
tech inc. rotor. The pellet was then resuspended in lysis buffer and the cells passaged twice 
through a cell disruptor (Constant Cell Disruptor Systems) at 25,000 psi. The lysed cells were 
centrifuged for 20 minutes at 12,000 rpm (16,740 x g), 4 °C using a Beckham Coulter-Optima 
L-100 XP ultracentrifuge with a Type 45 Ti fixed-angle rotor, to sediment inclusion bodies. 
The supernatant was transferred to new centrifuge tubes and ultracentrifuged for 2h at 
41,000 rpm (195,426 x g) 4°C, using the same centrifuge and rotor. The pellet was 
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resuspended and homogenised with resuspension buffer in a 1:5 pellet to buffer ratio using 
a glass homogeniser. Membranes were then flash frozen using liquid nitrogen and stored at 
-80 °C. 
2.2.2.5 Solubilisation 
Membranes were removed from storage at -80 °C and thawed at room temperature. In 
order to remove contaminant soluble proteins, membranes were stirred slowly for 1h at 4 
°C in 2% sarkosyl solubilisation buffer. The solubilised solution was ultracentrifuged for 45 
minutes at 41,000 rpm (195,426 x g), 4 °C using a Beckham Coulter-Optima L-100 XP 
ultracentrifuge with a Type 45 Ti fixed-angle rotor. The supernatant, containing the sarkosyl 
soluble proteins, was discarded and the insoluble pellet containing the membrane portion 
was resuspended in solubilisation buffer using a glass homogeniser. The solution was then 
supplemented with 1% (w/v) SB3-14 and again stirred slowly for 2h at 4 °C. After 
ultracentrifugation under the same conditions, the supernatant containing the detergent 
soluble fraction was collected and used for nickel gravity flow purification.  
2.2.2.6 Nickel gravity flow purification 
Nickel Superflow resin (Qiagen) was pre-equilibrated using 10 CV of equilibration buffer at 4 
°C. SB3-14 solubilised protein was supplemented with approximately 1 ml resin per 1 L of 
original culture and 20 mM imidazole, followed by gentle stirring at 4 °C for 1 h. This was 
applied to a glass Econo-Column (Bio-Rad) and washed with 10 CV of 30 mM imidazole wash 
buffer and 10 CV of 50 mM imidazole wash buffer. MOMP was then eluted with 2-5 CV of 
200 mM imidazole elution buffer.  
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2.2.2.7 Desalting and buffer exchange into OG using a HiPrep column 
Following elution from the nickel resin, up to 15 ml of protein was filtered using a 0.45 µm 
syringe filter before being manually loaded onto a HiPrep 26/10 desalting column (GE 
Healthcare Life Sciences) preequilibrated with 2 CV of detergent exchange buffer. A flow 
rate of 2-4 ml/min, depending on the pressure (max 0.5 MPa), was set for 1 CV (53 ml) with 
the fraction of interest collected in a 50 ml falcon tube. Consecutive samples were run in a 
similar matter after observation of the conductivity peak at approximately 30-50 ml.  
2.2.3 Protein Analysis and Quantification 
2.2.3.1 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) 
Method A: 1 mm 12.5% SDS-PAGE gels were prepared following the Laemmli recipe 
(Laemmli, 1970). Samples were supplemented with X4 SDS-PAGE sample buffer, then 
heated to 100 °C for 10 minutes and briefly centrifuged before being loaded onto a gel. Gels 
were run with X1 SDS-PAGE running buffer at 200 v for 35 minutes (Bio-Rad Powerpac 300). 
Proteins were compared with PageRuler prestained protein ladder (ThermoScientific). 
Analysis of the gels was done using Coomassie blue and/or Western blotting. Gel images 
were captured using a Syngene G.box V1.5.2.0. 
 
Method B: Samples were supplemented with X4 NuPage LDS sample buffer (Novex) and X10 
NuPage sample reducing agent (Novex), then heated to 100 °C for 10 minutes and briefly 
centrifuged before being loaded onto a 1 mm 4-12% Bis-Tris precast gel (Novex). Gels were 
run with X1 NuPage Mes SDS running buffer at 200 V for 35 minutes (Invitrogen Life 
Technologies PowerEase 500). Proteins were compared using a SeeBlue Plus2 prestained 
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standard (Novex). Analysis of the gels was done using Coomassie blue and/or Western 
blotting. Gels were imaged using an Image Quant LAS 4000 (GE Healthcare Life Sciences).  
2.2.3.2 Coomassie blue staining 
SDS-PAGE gels were stained for 1h or overnight in Coomassie blue stain and then de-stained 
twice for 45 minutes each time. Gels were left in distilled H2O until imaged. Alternatively, 
InstantBlue (C.B.S. Scientific) was used to fix and stain for 15 minutes. 
2.2.3.3 Western blotting analysis 
SDS-PAGE gels were prepared as described (Section 2.2.3.1). For each blot, the antibodies 
used are described in the corresponding figure legends. A full list of antibodies is provided in 
Table 2.3. 
Method A: Two sponges, two pieces of filter paper and a nitrocellulose membrane were 
soaked in transfer buffer for 10 minutes to remove air bubbles. The stack for transfer was 
organised as follows; sponge, filter paper, SDS-PAGE gel, nitrocellulose membrane, filter 
paper, sponge. The tank was filled with 1 L of transfer buffer and run at 46 V (150 mA) for 
1h. The nitrocellulose membrane was blocked overnight at 4 °C with 20 ml TTBS containing 
5% (w/v) non-fat milk powder (Marvel). The blocked membrane was incubated for 30 
minutes at room temperature and then washed with TTBS. The primary antibody was 
applied to the membrane for 1h with gentle rocking, before washing again with TTBS. If 
primary antibody was unconjugated, a secondary conjugated antibody step was included 
with incubation for 1h, followed by washing. The membrane was then exposed to EMSA 
stable peroxide solution and luminol enhancer solution at a 1:1 ratio for 5 minutes. 
Membranes were imaged using a Syngene G.box V1.5.2.0. 
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Method B: Proteins were transferred from SDS-PAGE gels onto an iBlot polyvinylidene 
difluoride (PVDF) membrane, using the Invitrogen iBlot 2 dry blotting system, and run at 25 
V for 7 minutes. Immunodetection of the PVDF membrane was then done, using the 
automated iBind Western system, using appropriate primary and secondary antibodies. The 
membrane was incubated for a duration of 3h to overnight before being washed in distilled 
water. Proteins were detected with ECL reagents (Pierce) in a 1:1 ratio for 2 minutes and 
imaged using an Image Quant LAS 4000 (GE Healthcare Life Sciences). 
2.2.3.4 The bicinchoninic acid (BCA) Assay 
Total protein concentration was quantified using a Pierce BCA protein assay kit 
(ThermoScientific) following the microplate procedure. The absorbance was recorded at 562 
nm using a Spectromax microplate reader. A standard curve of the bovine serum albumin 
(BSA) standards was plotted, and the protein concentration of the membrane sample 
derived from the linear equation.  
2.2.3.5 Quantification of protein concentration using a Nanodrop 
Purified protein concentration was estimated using a Nanodrop Spectrometer 
(ThermoScientific) by absorbance at 280 nm. The molar extinction coefficient (M-1cm-1), 
molecular weight (kDa) and Abs 0.1% (=1 g/l) of his-tagged MOMP (UniProtKB P27455.1) 




2.2.4 Spot plate method for fatty acid functional assay 
A single colony from each of the transformed strains were grown overnight in MM with 
0.4% (w/v) glucose at 37 ˚C with shaking at 225 rpm. The overnight cultures were 
subcultured 1/10 into fresh MM containing 0.4% (v/v) glycerol and grown until an OD600 of 
0.5. Cells were induced with 0.02% (w/v) rhamnose for 3h before cells equating to an OD600 
value of 0.5 were harvested with centrifugation at 8,000 rpm for 3 minutes. The cells were 
then washed twice with MM, to remove the glycerol carbon source, before diluting in a 10-
fold series down to -7 on ice. On a variety of MM plates (MM; MM + 0.4% w/v glucose; MM 
+ 5mM sodium palmitate + 0.25% w/v Brij-58; MM + 0.25% w/v Brij-58, MM + 5mM sodium 
oleate + 0.25% w/v Brij-58) 5 µl of each dilution for each strain was spotted (one plate 
containing 101 to 10-3, the other 10-4 to 10-7) and incubated at 37 ˚C for 96h. A schematic of 
the layout can be seen in Figure 2.1. Images of the plates were taken after 96h using the 























2.2.5 Role of cysteine mutants in clustering of MOMP 
2.2.5.1 Molecular dynamics simulations 
 
In MD simulations, two 4 Å MOMP crystal structures were inserted into a box of size x=15 
nm, y=15 nm, z=9 nm at a distance of 42 Å from each other. An externally exposed residue 
Trp55 was labelled red, in the absence of the alpha helical loop structure, for visualisation 
purposes. One model remained stationary, whilst the other was rotated 90 ° about the Z 
axis for four different orientations to allow different faces of the protein to interact. A lipid 
bilayer consisting of DOPG and DPPE, in equal proportions, was then inserted into the box 
using python script Insane (Wassenaar et al., 2015). The lipid bilayer was equilibrated for 






Figure 2.1. Schematic of the grid system used for the spot plate method. The y-axis lists 
strains, the x-axis the decreasing cell concentration.  
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Gromacs v4.6 (Berendsen et al., 1995) for a duration of 10 µs, equating to 5x108 steps. 
Parameters were obtained from the Martini force field (Wassenaar et al., 2015). Results 
were visualised using VMD v.1.9.2 (Humphrey et al., 1996).  
2.2.5.2 Cysteine mutagenesis in pETMOMPH6 and pOPINHaloMOMP 
Cysteine residues were mutated to alanine in pETMOMPH6, using the QuikChange XL II SDM 
kit with the primers detailed in Table 2.6 and full protocol given in Section 2.2.1.2. As the 
pOPINHaloMOMP construct was not amenable to SDM, In-Fusion mutagenesis was utilised 
to insert the cysteine mutated sequences from the new pETMOMPH6 constructs (the full 
protocol is provided in Section 2.2.1.6). All pETMOMPH6 mutants were sequenced with the 
commercially available T7 forward and reverse sequencing primers, whilst the 
pOPINHaloMOMP mutants were sequenced using the T7 forward primer and, in the reverse 
direction, with a specially designed pOPIN3CHalo reverse primer (Table 2.6).  
2.2.5.3 Bacterial cultures 
C41(DE3) E. coli cells, transformed with mutated pOPINHaloMOMP or pETMOMPH6 
constructs, were inoculated into 10 ml of LB media containing 0.6% (w/v) glucose and 100 
µg/ml ampicillin and grown overnight at 30 °C with shaking at 225 rpm. Overnight cultures 
were subcultured into 20 ml of fresh LB with antibiotics at a 1/100 dilution and grown at 37 
°C. At an OD600 of ~0.5, cells were induced with 1 mM IPTG and the temperature reduced to 





2.2.5.4 Ibidi slide preparation and immunostaining 
An Ibidi 8-well glass bottom µ-slide (170 µm +/- 5 µm) was incubated with 0.01% poly-L-
lysine for 10 minutes, then washed three times with PBS. Bacterial cells, resuspended in 
PBS, were immobilised on the slides for 1h, followed by additional washing with PBS. Cells 
were fixed with 2% (v/v) formaldehyde-PBS for a further 10 minutes before being washed 
three times with PBS. The slide was stored in PBS at 4 ˚C until the day of imaging.  
For immunostaining, storage PBS was aspirated off and the slide incubated in 50 mM 
ammonium chloride for 10 minutes in order to quench any residual fixative. After washing 
with PBS, cells were permeabilised with 0.1% (v/v) Triton X-100 for 5 minutes, followed 
again by washing. Cells were then incubated for 45 minutes with 100 µg/ml lysozyme and 
washed with PBS. The slide was blocked for 1h in 0.5-3% (w/v) BSA-PBS blocking buffer 
before incubation with primary antibody or conjugated antibody in 0.5-3% (w/v) BSA-PBS 
for 1h. Wells were washed and incubated for 1h with secondary antibody. A set of control 
cells, not expressing MOMP, were not immunostained to assess for bacterial auto-
fluorescence. Wells were washed and stored in fresh PBS for imaging.  
2.2.5.5 TIRF and epifluorescence imaging conditions 
Samples plated on Ibidi slides were imaged by TIRF and epifluorescence, using a Nikon 
Eclipse Ti inverted microscope with a 100X oil-immersion objective and 1.50X NA TIRF 
objective. Samples were excited with both 488 (green) and 647 (red) lasers. Images were 
captured with an EMCCD camera (Andor) after a 20-200 ms exposure time and visualised 
using NIS-Elements AR 4.5 imaging software. Individual imaging conditions are stated in 
corresponding figure legends. Images were post processed with software packages ImageJ 
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(version 1.51) (Schneider et al., 2012) and its associated distribution Fiji (version 1.0) 
(Schindelin et al., 2012).  
2.2.5.6 STORM imaging conditions 
STORM experiments were carried out using the Octopus facility, at the Central Laser Facility 
(CLF), Harwell Campus, UK. Data were collected using a Zeiss Elyra microscope fitted with an 
Objective Plan-Apochromat 100x/1.46 oil DIC M27 objective lens using Immersol 518 F 
immersion oil (Zeiss). Fluorophores on both Ibidi and Superfrost microscope slides were 
excited using the 642 nm laser, raised to 4-8% to achieve a blinking state, before being 
lowered to 2% for data collection and detected with a LP 561/642 filter. 20,000 images were 
recorded with an exposure time of 20 ms, a camera gain of 100, and drift correction every 
500 frames, using an EMCCD camera (Andor).  
2.2.5.7 Cluster analysis from STORM images 
Collected data were processed in Zen Black 2012 software (Zeiss), using the PALM module 
where the peak intensity to noise ratio was set to reject dimly emitting fluorophores and 
overlap of molecules was accounted for, through a multi-object fitting algorithm. Model 
based drift correction was applied, using automatic segmentation and trails were grouped 
for Alexa-647 as follows; max on time 5 frames, max off gap 10 frames, and capture radius 
of 2 pixels, based on previously calibrated data (Willson et al., 2016; Pageon et al., 2016). 
Localisation precision was selected based on the precision histogram for each data set, 
typically in the range of 1-25 nm. The ASCII text files detailing spatial localisation 
information for each molecule were saved for each data set and used in clustering analysis 
with ClusDoC software (Pageon et al., 2016). Using the ClusDoC GUI, regions of interested 
(ROI) were manually defined by the user. The density-based spatial clustering of applications 
 54 
with noise (DBSCAN) algorithm was implemented on the ROIs using the following 
parameters; epsilon 20 nm, min points 3, plot cut off 10, threads 2, L (r) – r 50 nm, smooth 












Expression, purification and crystallisation of 















3 Expression, purification and crystallisation of recombinant MOMP in E. coli 
3.1 Introduction 
MOMP has often been the target of Chlamydial vaccines and antimicrobials, not only due to 
its surface exposed regions and high abundance within the OM of circulating EBs, but also 
because of its observed immunodominance (Wolf et al., 2001; Molina et al., 2010). Of the 
Chlamydia species, namely human pathogens C. trachomatis, C. psittaci, and C. pneumoniae, 
MOMP is highly conserved with over 63% sequence identity (see Appendix A1 Figure A1.1). 
However, due to the difficulties in the expression and purification of active and correctly 
folded recombinant protein, there are currently no 3D structures for any MOMP proteins in 
the PDB. Recombinant expression has largely been favoured over native protein production 
in purification attempts due to the difficulty of both cultivating Chlamydia within host HeLa 
cells and also in extracting the EBs, where the majority of MOMP expression occurs. Much 
of the difficulty surrounding recombinant expression and purification has arisen due to both 
the high cysteine content (on average 9 cysteine residues over a total of approximately 395 
aa) and the requirement to extract MOMP from its native membrane environment with 
detergent. As documented, MOMP forms intermolecular disulphide bonds within the COMC 
in order to provide structural stability (Liu et al., 2010); these disulphide bonds are likely 
problematic in obtaining stable monomeric MOMP for further structural analysis with 
techniques such as macromolecular crystallography (MX), cryo-electron microscopy (cryo-
EM), and NMR spectroscopy, discussed below.  
3.1.1 Methods of structure determination 
Cryo-EM, first developed in the 1980s, extends the capabilities of standard EM through the 
rapid vitrification of samples in their native conditions, be it single proteins, large 
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complexes, or whole cells, preventing the crystallisation of water and permitting more 
detailed data collection through improved signal-to-noise (Murata and Wolf, 2018). In 
standard EM, a sample is plated onto a small grid before illumination with an electron 
beam, whereby electrons are either able to pass through to the detector or become 
scattered, creating a shadow image. Whilst cryo-EM has certainly advanced in recent 
decades, due to the introduction of a more powerful detector system known as a direct 
electron detector (DED), the improvement in sample preparation for example graphene 
coated carbon grids to control protein adsorption, and the developments in image 
processing, it still has its limitations (Murata and Wolf, 2018). The most significant limitation 
with regard to structure solution of MOMP is the limit on protein size, which currently 
stands at around 100 kDa, with the resolution limits occasionally surpassing 3 Å. However, 
recently haemoglobin, a protein of 64 kDa, was solved to 3.2 Å using cryo-EM, although a 
high resolution structure previously resolved with single crystal XRD to 2.5 Å was used in 
model fitting (Khoshouei et al., 2017). Therefore, solely due to MOMP’s small size 
(approximately 40 kDa), cryo-EM is a not a suitable technique at this stage, although will 
potentially prove useful in future studies to assess the clustering behaviour arising from 
intermolecular disulphide bonding (discussed in Chapter 5).  
Conversely, solution NMR is typically limited to small proteins below 35 kDa, due to the 
difficulties in characterising the high number of atoms present in larger structures, which 
again limits the applicability for MOMP. Significantly, 1 mM of protein is typically required 
for solution NMR (Berg et al., 2002), which for MOMP equates to an extremely high 
concentration of 40 mg/ml. Given the difficulties associated with expression and purification 
of membrane proteins, solution NMR is very likely an unfeasible structural solution method 
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for MOMP solely due to the quantity required. However, recently solid-state NMR has been 
used to successfully study membrane proteins within a lipid bilayer or cell membrane 
without any restrictions on size, with the 81 kDa Anabaena sensory rhodophsin (ASR) 
protein recently solved using this method (Wang et al., 2013). NMR works on the basis that 
certain atomic nuclei possess a spin, which enables them to behave as a magnet. Upon 
application of an externally applied magnetic field the lower energy spin state is excited to a 
higher energy state, referred to as resonance, the spectrum of which can be recorded (Berg 
et al., 2002). As the naturally occurring 12C isotope is not NMR active due to the equal 
number of protons and neutrons and 14N produces a broad signal, this technique also 
requires isotopic labelling with 13C and 15N to obtain higher resolution data, typically 
achieved by supplementing E. coli growth media with isotopically labelled nutrients such as 
15NH4Cl and 13C-glucose (Cai et al., 1998). Despite successful reports of membrane protein 
structure solution with solid-state NMR, a number of limitations and challenges remain. 
Notably, reconstitution into either a lipid bilayer or detergent micelles results in a 
heterogeneous environment, which in turn contributes extra signals and reduces sensitivity, 
as well as taking up valuable space resulting in a lower intensity protein signal (Ladizhansky, 
2017). Additionally, as the name suggests, samples are required to be in a solid state for 
example as crystals, such as those used in the recent structure determination of the 
membrane protein YadA, whereby researchers utilised poorly diffracting microcrystals 
originally intended for X-ray diffraction (Shahid et al., 2012). Alternatively, proteins 
reconstituted into lipid bilayers can be spread across glass plates, as was the case in the 
structure solution of the membrane protein phospholamban involved in muscle excitation 
(Verardi et al., 2011).  
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In MX, concentrated protein samples are encouraged to crystallise using a variety of 
multicomponent screens, the 3D structures of which are then resolved using XRD. Data are 
typically collected using a high powered synchrotron source, such as Diamond Light Source 
(DLS) in the UK or the European Synchrotron Radiation Facility (ESRF) in France, whereby 
electrons emitted from a cathode gun are propagated to extremely high speeds using a 
series of particle accelerators before the GeV beam is then directed around a storage ‘ring’ 
by a series of magnets (Materlik et al., 2015). High quality data collection is also heavily 
reliant on the quality of the crystals, as their geometry and well-ordered nature creates a 
regular arrangement of atoms that are able to diffract incoming X-rays, producing specific 
diffraction patterns. Measurement of the intensity and angle of these diffracted spots using 
a range of tools relays information on the atom positioning, with more highly ordered 
crystals producing higher resolution data. A larger unit cell results in a greater quantity of 
reflections (Wlodawer et al., 2013). Resolutions of 2 Å are frequently documented in protein 
crystallography, whereby the backbone and most of the sidechains are clearly defined 
within the resulting electron density, although there are also over 600 structures within the 
PDB at resolutions better than 1 Å. However, MX is not without its limitations. Not 
unsurprisingly, in order for membrane proteins to crystallise they must be stable in solution 
and, therefore, must be transferred from their native bilayer environment to a detergent 
micelle. For crystals to form, the solution must be supersaturated for the protein to 
overcome its limit of solubility and form a critical nucleus. Typically, non-covalent crystal 
contacts, such as van der Waals (vdW) forces, hydrophobic interactions, ionic and hydrogen 
bonds, then begin to form, however, the hydrophobic regions on membrane proteins are 
mostly shielded by the detergent micelle, resulting in weaker protein-protein interactions 
and as such more fragile crystals (Moraes et al., 2014). Most importantly, the protein-
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detergent complex must be monodisperse, as incorrectly formed crystal contacts from 
contaminants will prevent further extension of the lattice and thus terminate growth. 
Typically, vapour diffusion is the most common method of crystallisation, whereby purified 
protein is mixed in a droplet of precipitant containing buffer and allowed to equilibrate in 
close proximity to a larger buffer reservoir, either in a well (sitting drop) or suspended from 
a coverslide (hanging drop) (Dessau and Modis, 2011), as shown in Figure 3.1, although 
lipidic cubic phase, bicelles, and microbatch are also procedures useful in membrane protein 










As a result of the limitations associated with both NMR and cryo-EM, particularly for the 
study of 40 kDa MOMP, MX is the biophysical technique of choice in this research that is 
most likely to produce high-quality structural details for both side chain and β-sheet 
Figure 3.1. Diagram showing sitting drop and hanging drop vapour diffusion set up. In 
sitting drop vapour diffusion, the drop containing protein and precipitant is elevated above 
the reservoir and secured with sealing tape. In hanging drop vapour diffusion, the drop is 
suspended upside down on a coverslip and sealed with high vacuum grease.  
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orientation for this protein. Despite the huge number of variables to consider, such as 
detergent, crystallisation screening (pH, buffer, additives, precipitant, temperature), phasing 
and data collection strategy, MX is applicable to any protein able to form crystals. 
Additionally, with advancements of nanolitre crystallisation robotics, lower sample volume 
is required, which is a particularly important consideration when studying membrane 
proteins that are difficult to express and purify. 
3.1.2 Optimisation of the purification and crystallisation of rMOMP 
Previous expression screening of rMOMP in a variety of E. coli strains, media, and 
temperatures was conducted in order to determine the optimum conditions for MOMP 
expression within the membrane (Atanu, 2014). A crucial factor was MOMP’s export to the 
OM, as incorrectly folded protein can become trapped as insoluble inclusion bodies within 
the cell cytosol, which requires refolding, a complex and rarely successful process. It was 
determined that the pET101-D/TOPO construct containing MOMP expressed in C41 (DE3) 
cells, under the control of the bacteriophage T7 RNA polymerase system, was optimal for 
rMOMP OM expression. This was likely due to the fact that C41 (DE3) is a strain derived 
from BL21 (DE3) containing an uncharacterised mutation that inhibits cell death during toxic 
protein expression (Miroux and Walker, 1996), which in combination with the pET101 
vector designed for high yields resulted in successful expression.  
As membrane proteins by nature are highly hydrophobic, their purification requires 
amphiphilic detergents in order to extract them from their native lipid environment and 
maintain them in a soluble and stable state (Moraes et al., 2014). This is achieved through 
aggregation of the detergent monomers into a micelle around each protein, be it monomer, 
dimer, trimer etc. The concentration at which detergents form this micelle is known as the 
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critical micellar concentration (CMC), and therefore detergents are typically used at a 
concentration much higher than this in order to ensure micelle formation during 
solubilisation. Detergents typically fall into three main categories; ionic, non-ionic, and 
zwitterionic, based on their hydrophilic head groups. Detergents such as SDS and sarkosyl 
are classed as ionic and are typically harsh due to their disruption of protein-protein 
interactions, which often results in protein denaturation. More gentle detergents, which 
disrupt protein-lipid interactions instead, include glucosides and maltosides which are 
classed as non-ionic due to their uncharged head groups. Finally, detergents with both a 
positive and negative charge but which are overall neutral are referred to as zwitterionic 
and include LDAO, FC-12, and CHAPS. As these detergents behave in a similar manner to 
ionic detergents, they are also capable of disrupting protein-protein interactions, although 
tend to be less harsh. Table 3.1 details the detergents used in this research, along with their 










Name Abbreviation Type CMC 
CHAPS N/A Zwitterionic 8 mM (0.49%) 
CYMAL-5 N/A Non-ionic 2.4-5 mM (0.12%) 
Elugent* N/A Non-ionic N/A 
Fos-choline-12 FC-12 Zwitterionic 1.5 mM (0.047%) 
Lauryl Maltose Neopentyl Glycol LMNG Non-ionic 0.01 mM (0.001%) 
Lauryldimethylamine-N-Oxide LDAO Zwitterionic 1-2 mM (0.023%) 
n-Dodecyl-N,N-dimethyl-3-
ammonio-1-propanesulfonate SB3-12 Zwitterionic 2.8 mM (0.094%) 
n-Dodecyl-β-D-Maltopyranoside  DDM Non-ionic 0.17 mM (0.0087%) 
n-Lauroylsarcosine sodium salt Sarkosyl Ionic 14.4 mM (0.42%) 
n-Octyl-β-D-glucopyranoside OG Non-ionic 18-20 mM (0.53%) 
n-Tetradecyl-N,N-dimethyl-3-
ammonio-1-propanesulfonate SB3-14 Zwitterionic 0.16 mM (0.007%) 
n-Undecyl-β-D-Maltopyranoside UDM Non-ionic 0.59 mM (0.029%) 
Octaethylene Glycol 
Monododecyl Ether C12E8 Non-ionic 0.09 mM (0.0048%) 
Octyl Glucose Neopentyl Glycol OGNG Non-ionic 1 mM (0.058%) 
Triton X-100 
N/A Non-ionic 0.23 mM (0.01-0.016%) 
 
Table 3.1. Detergents used in MOMP solubilisation, for both Western blotting and 
fluorescence-detection size exclusion chromatography (FSEC) screening, and their 
properties. *Mixture of alkyl glucosides (e.g. Triton X-100, OG). Data sourced from 
Anatrace in 2016.  
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Previously, MOMP was isolated with sarkosyl (Atanu, 2014), a detergent which is not 
capable of solubilising outer membranes (Filip et al., 1973) and thus removes a multitude of 
contaminant soluble proteins that may either co-associate with the protein of interest (POI) 
or become more difficult to remove in subsequent steps, leaving the membranes intact. 
Therefore, an additional detergent is required to extract MOMP from the membrane for 
solubilisation. As many detergents capable of extracting proteins from their native 
environment have not been successful in crystallisation attempts, it is also anticipated that a 
third detergent will be required for MOMP crystallisation. One of the most vital steps in 
membrane protein purification is solubilisation, as this greatly impacts the protein stability 
as well the final yield, which is especially important for membrane proteins due to their 
associated toxicity and the limited volume of the cell membrane. Previously, both 
recombinant and native MOMP have been solubilised in a range of detergents including 
DDM, OG, LDAO, SB3-14, and CHAPS, typically at a concentration of 1% (Atanu, 2014; 
Findlay et al., 2005; Pal et al., 2005), although success has also been reported with a cell-
free system using nanolipid particles (NLPs) (He et al., 2017). Owing to the huge range of 
detergents available, with many different properties, it is essential to screen a 
representative sample in a high throughput manner. One method of doing so involves 
fluorescent labelling of the POI, however, MOMP previously tagged with green fluorescent 
protein (GFP) was not correctly expressed in E. coli, and instead formed inclusion bodies 
(Atanu, 2014). It was concluded that the large size of the GFP tag (27 kDa) likely affected 
protein folding and export to the membrane, especially as MOMP itself had already 
demonstrated toxic behaviour. However, recently a 3 kDa tag referred to as P3NTA has been 
developed (Backmark et al., 2013). This P3NTA tag is a peptide based fluorescent probe 
consisting of a fluorescein label attached to a Strep peptide containing three terminal 
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cysteine residues linked to three nickel charged nitrilotriacetic acid (NTA) groups, as shown 






P3NTA binds to his-tagged proteins through the same principle applied during immobilised 
metal affinity chromatography (IMAC), which allows any his-tagged protein to be monitored 
by fluorescence-detection size exclusion chromatography (FSEC) without the need to co-
express a fluorescent label, thus preserving the POI’s structure and activity. Size exclusion 
chromatography (SEC) is a technique routinely used in protein purification to determine the 
heterogeneity of a sample. After equilibration, the protein sample is applied to the column, 
a porous matrix typically made up of cross-linked agarose and/or dextran, which can then 
be eluted based on size. From a SEC trace, a single symmetric Gaussian peak represents 
stable, folded, monodisperse protein, in contrast to numerous asymmetric peaks which are 
typically due to unfolded, unstable, and polydisperse protein (Kawate and Gouaux, 2006). 
The location of the peak can also assist in determining the protein’s MW, which is based on 
diffusion of the protein through the pores of the stationary phase. Larger proteins are 
prohibited from most of the pores and are thus eluted first, as opposed to the smaller 
Figure 3.2. Diagram showing the chemical structure of the fluorescent P3NTA tag. 
(Backmark et al., 2013) 
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proteins which diffuse into and are retained within the pores, eluting later. One of the main 
benefits of FSEC is the ability to identify small amounts of protein in crude preparations as 
opposed to purified protein, such as solubilised membranes, to a high sensitivity and 
specificity (Backmark et al., 2013). This permits screening during the earlier stages of protein 
production, such as during expression or solubilisation with detergents, to assist in small 
scale optimisation. As a result, this technique along with the small P3NTA probe will be used 
together with standard Western blotting in order to determine which detergent is the most 
effective at solubilising MOMP.  
Following successful solubilisation, it is then necessary to isolate the POI from any other 
contaminant proteins that may also co-crystallise or indeed hinder crystallisation of the POI. 
This can be done with a number of tags through affinity chromatography, and in this case 
MOMP is hexahistidine tagged for purification using IMAC, which is a very well documented 
and relatively simple technique (Block et al., 2009). In IMAC, a transition metal ion is 
chelated to an insoluble matrix, such as agarose, via an NTA group which binds to the metal 
with four valencies. The imidazole rings within the his-tag contain electron donor groups 
which are able to form two more coordination bonds with the immobilised metal, creating a 
stable and reversible interaction, as shown in Figure 3.3 (Bornhorst and Falke, 2000). As a 
result, only histidine containing proteins are immobilised on the resin, with the string of 
histidines within the tag forming a more specific and stronger interaction due to the two 
coordination bonds. Imidazole can be used to competitively bind the metal ion, as the 
imidazole ring will also form the same interaction as histidine, which at low concentrations 
can prevent non-specific contaminant binding during protein loading and at higher 
concentrations can be used to elute the POI. A number of different divalent cations can be 
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used in IMAC, such as Ni2+, Cu2+ and Zn2+, each with different binding properties, with nickel 
columns most routinely used to obtain a high yield, and cobalt to obtain a higher purity. As a 
sarkosyl step is included to remove contaminant proteins, his-tagged MOMP will be purified 
by Ni-NTA affinity chromatography in order to optimise the yield.  
 
Following purification, as previously stated, it is imperative that the protein be 
monodisperse for successful crystallisation. In order to do so, SEC is utilised, which follows 
the same principles as described for FSEC, whereby a singular narrow peak represents stable 
and monodispersed protein. The fractions corresponding to the peak of interest, also 
identified through the protein’s MW, can be collected, pooled, and purified. However, an 
additional benefit of SEC is that the buffer in which the sample exists can be exchanged 
during elution. This feature is ideal for crystallographic studies of membrane proteins, as the 
detergent used for solubilisation can be exchanged for a number of detergents that are 
more amenable to crystallisation. This method can also remove excess detergent micelles, 
Figure 3.3. Interaction between the his-tag and Ni2+ cation in IMAC. From left to right; two 
histidines, Ni2+, NTA group. Dotted lines represent the coordination bonds. (Bornhorst and 
Falke, 2000) 
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as well as alter other buffer components that may affect crystallisation such as the salt 
content, pH etc. Previously, 10 mg/ml of purified MOMP was sufficient for crystallisation 
(Atanu, 2014) and, therefore, this concentration will be used as a target for future 
purifications.  
As previously mentioned, successful crystallisation requires monodisperse and solubilised 
protein to be supersaturated within a solution in order for crystal contacts to form. An 
additional unknown variable within membrane protein crystallisation is the use of a 
detergent to maintain the protein in a stable and soluble state, where it is likely that crystal 
contacts are inhibited by the detergent, particularly those with long acyl chains that engulf 
more of the protein (Sonoda et al., 2010). Analysis of membrane protein structures solved 
with XRD, as deposited in the PDB, revealed the crystallisation conditions most common in 
producing strongly diffracting crystals. These data were collated and used in the design of 
two crystallisation screens specifically created for membrane proteins, known as MemGold I 
and II (Parker and Newstead, 2016), which were successful in producing the rMOMP crystals 
obtained previously (Atanu, 2014). The aim of screening is to cover the largest crystallisation 
space (the conditions used to produce crystals) possible, whilst conserving the amount of 
protein required. One method of comparing the chemical similarity of different screens is 
through the freely available C6 Web Tool, an online tool which compares two screens 
providing a metric between zero and one, with 0 indicating two identical screens and 1 
relating to those that are completely different (Newman et al., 2010). Comparison of the 
two MemGold screens reveals a score of 0.54, with a score above 0.4 suitable for screening, 
indicating that these two screens are an appropriate starting point for MOMP crystallisation 
optimisation. One of the most successful detergents in membrane protein crystallisation is 
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DDM, accounting for almost 50% of structures in the PDB although typically exhibiting a 
lower resolution (Parker and Newstead, 2016). However, success has also been 
demonstrated with some shorter chain detergents, such as OG and LDAO, crystals of which 
tend to diffract to higher resolutions, with OG accounting for the highest mean resolution of 
structures currently available (Parker and Newstead, 2016). Therefore, both due to the 
previous success with MOMP solubilisation and crystallisation in DDM, OG, and LDAO, these 
detergents will be the focus of MOMP crystallisation in the first instance. The low resolution 
crystal structure for rMOMP (Atanu, 2014) is described in Chapter 1 Section 1.6.5.  
3.2 Aims and Objectives 
Membrane proteins play vital roles in many cellular processes including but not limited to 
drug influx/efflux, signalling, cell recognition and adhesion. Despite this, only 4173 of the 
~120,000 protein structures solved with XRD in the PDB are membrane proteins, with only a 
quarter of these at a resolution better than 2 Å. This further highlights the difficulties 
associated with membrane protein expression, purification, and crystallisation, particularly 
as it has been estimated that membrane proteins account for approximately 20-30% of all 
proteins (Krogh et al., 2001). Due to the many roles of membrane proteins, detailed 
information regarding their structures and functions will prove invaluable in developing our 
understanding of not only normal cellular physiology but also disease mechanisms in both 
humans and bacteria.  
Previously, unoptimized MOMP crystals grown for over three months only diffracted to 4 Å. 
Whilst the overall size and shape of the barrel, and the presence of the internal plug region 
were determined, a higher resolution data set is required to confidently identify the side 
chain orientations, the exact composition of the β-strands, and the precise locations of the 
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extracellular loops. As a result, the aim of this research is to optimise the purification 
protocol for the production of C. pneumoniae rMOMP in E. coli and for subsequent 
crystallisation optimisation. A number of different detergents will be tested during 
solubilisation in order to maximise the total protein yield and decrease the volume of 
growth culture required. Purified protein will be used in sitting drop vapour diffusion 
crystallisation trials, in the first instance with commercial screens MemGold I and II due to 
their previous success in MOMP crystallisation. Any crystallisation hits from the screening 
will be optimised in an effort to obtain higher diffraction quality crystals. 
Continuing advancements in cryo-EM may soon permit data collection of smaller proteins, 
such as MOMP, which will prove particularly useful in membrane protein analysis due to the 
ability to image within whole cells, eliminating the complex purification and crystallisation 
procedure required for MX studies. However, at present XRD remains an excellent method 
for structural solution, producing high resolution data which can detail atomic positioning 




















For final optimised methods, refer to Chapter 2.  
 
3.3.1 Difference between cultures grown at the University of Reading and 
Diamond Light Source  
A single colony of C41 (DE3) E. coli cells, transformed with pETMOMPH6, was inoculated into 
either 10 ml (50 ml falcon tube) or 150 ml (500 ml flask) LB, with 100 μg/ml ampicillin and 
0.6% (w/v) glucose. Both of these cultures were growth overnight at 37 °C in a shaking 
incubator at 225 rpm, with an additional 150 ml culture grown at a lower temperature of 30 
°C. Following overnight growth, OD600 measurements were taken before each overnight 
culture was then used to subculture 10 ml fresh LB at a 1/100 dilution. This was done in 
triplicate for each overnight condition, along with supplementation with 0%, 0.5%, or 1% 
(w/v) glucose. Growth at 37 °C was monitored with OD600 measurements every hour until 
passing a value of 0.5. This comparative study was conducted at Diamond Light Source.  
3.3.2 Solubilisation with DDM 
Prior to optimisation, membranes, as prepared in Chapter 2 Section 2.2.2.4, were 
solubilised following the protocol described in Chapter 2 Section 2.2.2.5, initially with 2% 
(w/v) DDM in place of SB3-14.  
3.3.3 His-trap affinity chromatography 
Protein solubilised in DDM was purified by HisTrap affinity chromatography. Using a 
peristaltic pump (GE Healthcare Life Sciences, Pump P1, 3.1 mm tubing) the HisTrap column 
(HP 5 ml Global, GE Healthcare Life Sciences) was washed with nH2O for approximately 5 
minutes at a flow rate of 2 ml/min to remove the ethanol used for storage. The column was 
then equilibrated with Buffer A (Chapter 2 Table 2.4) for approximately 5 CV at 2 ml/min. 10 
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mM imidazole was added to the solubilised protein sample before loading onto the pre-
equilibrated HisTrap column at a flow rate of 2 ml/min. The ÄKTA purifier (GE Healthcare 
Life Sciences) was prepared by washing with nH2O before equilibration with Buffers A and B 
(Chapter 2 Table 2.4) in their respective lines. The HisTrap column was then applied to the 
ÄKTA system and run at a segmented gradient of 6.1% Buffer B for 10 CV followed by 100% 
Buffer B for 20 CV, producing a gradient of 30-500 mM imidazole. Fraction volumes of 4 ml 
were collected at a flow rate of 1 ml/min with a max pressure of 0.5 MPa. Based on the UV 
trace, fractions from peaks of interest were collected and analysed by SDS-PAGE. 
3.3.4 Site directed mutagenesis for his-tag extension 
Extension of the hexahistidine tag was completed using the commercial QuikChange XL II 
SDM kit, as described in Chapter 2 Section 2.2.1.2. MOMP His-8 and MOMP His-10 primers 
are detailed in Chapter 2 Table 2.6. PCR products were DpnI treated and checked on an 
agarose gel prior to transformation. Plasmids were prepared following the method 
described in Chapter 2 Section 2.2.1.10 before being sequenced with T7 reverse sequencing 
primers.  
3.3.5 Small scale detergent screening 
Using microcentrifuge tubes (eppendorfs), membranes were solubilised under a number of 
conditions (4 °C for 2h, 4 °C overnight, or room temperature for 1h) in the presence of a 
selected detergent at 1% (w/v) (DDM, OG, LDAO, FC-12, CHAPS, or v/v Triton X-100). 
Samples were taken before high speed centrifugation (BC) at 50,000 rpm (153,700 x g) for 
45 minutes at 4 °C, using a Beckman Coulter-Optima Max-TL benchtop ultra-centrifuge with 
a TLA-55 fixed-angle rotor. Samples of the soluble fraction (SF) were taken following 
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centrifugation. BC and SF samples were then analysed by Western blotting to compare 
solubility.  
3.3.6 Detergent screening using fluorescence-detected size exclusion 
chromatography (FSEC) 
Membrane samples were thawed and diluted to a final concentration of 3 mg/ml in 
solubilisation buffer (Chapter 2 Table 2.4) to a total volume of 1 ml, with each aliquot 
containing one of the following detergents at 1%; DDM, OG, LDAO, SB3-12, SB3-14, LMNG, 
OGNG, UDM, Cymal 5, C12E8, or 5% Elugent (full details of detergent properties are shown 
in Section 3.1.2 Table 3.1). The membranes were solubilised at 4 °C for 1h with gentle 
agitation, before centrifugation at 50,000 rpm (153,700 x g) for 45 minutes at 4 °C. In glass 
vials, 102.6 µl of solubilised protein was mixed with 7.4 µl of P3NTA probe, creating a final 
concentration of 1.5 µM probe, before being loaded in the Shimadzu high-performance 
liquid chromatography (HPLC) machine equipped with fluorescence detection. Samples 
were resolved on a Superose 6 10/300 L column (GE Healthcare Life Sciences) with a flow 
rate of 0.3 ml using degassed FSEC flow buffer (Chapter 2 Table 2.4), washing in between 
samples with degassed nH2O. 
3.3.7 Small scale Nickel resin binding trial 
Nickel Superflow resin (Qiagen) was added to SB3-14 solubilised membranes along with 
varying concentrations of imidazole (10-90 mM in 20 mM increments) and stirred at 4 °C for 
1h. The samples were then pelleted at 8,000 rpm for 3 minutes and the supernatant stored 
as ‘unbound’ sample (U), before being washed in elution buffer (Chapter 2 Table 2.4) 
containing 300 mM imidazole, and named ‘eluted’ sample (E). The unbound and eluted 
samples were then analysed with SDS-PAGE and Western blotting. 
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3.3.8 Detergent exchange 
During nickel gravity flow purification, increasing concentrations of OG were introduced into 
the wash and elution buffers in order to detergent exchange from SB3-14, which is not 
amenable to crystallography, into OG. Along with 0.01% (w/v) SB3-14, the 30 mM and 50 
mM imidazole wash buffers were supplemented with 0.6% and 0.9% (w/v) OG, respectively. 
In the 200 mM elution buffer, SB3-14 was excluded and instead replaced with 1.17% (w/v) 
OG, equating to two times CMC.  
3.3.9 Dialysis and concentration 
Following SDS-PAGE analysis of the fractions from HisTrap affinity chromatography, 
fractions were selected and pooled together if they displayed a band at the appropriate 
MW, or alternatively the eluted protein from the nickel gravity flow procedure was used. 
Dialysis tubing (Spectra/Por Dialysis Membrane, MWCO 6-8,000) was soaked for a few 
minutes in nH2O. One end was clamped tightly shut, the protein solution added from the 
opposite end, and then clamped forming a sealed tube with minimal air. This was placed 
inside a beaker containing 1 L of dialysis buffer (Chapter 2 Table 2.4) and left gently stirring 
at 100 rpm overnight at 4 °C.  
The dialysed protein was concentrated using an appropriate Amicon Ultracentrifugal 
concentrator (100 kDa for DDM purified MOMP, and 50 kDa for SB3-14 solubilised MOMP 
and OG detergent exchanged MOMP), using a Beckman Coulter Allegra X-22R centrifuge at 
3,500 rpm (2,800 x g) 4 °C for 5 minutes. The protein was resuspended after each 
centrifugation until an appropriate concentration and volume was obtained. Protein 
concentration was estimated by absorbance at 280 nm using a Nanodrop Spectrometer. 
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3.3.10 Size exclusion chromatography (SEC) 
Purified and concentrated protein, buffer exchanged from SB3-14 into DDM, was 
centrifuged for 10 minutes, 13,000 rpm (~18,000 x g) at 4 °C to pellet any precipitants. The 
protein was then buffer exchanged into 1.17% (w/v) OG using an ÄKTA system fitted with a 
Superdex 200 10/300 GL column (GE Healthcare Life Sciences) after loading into a 500 µl 
injection loop, using detergent exchange buffer (Chapter 2 Table 2.4). A flow rate of 0.4 
ml/min was set for 1 CV (25 ml) with 0.2 ml fractions collected in a 96 well microtube plate. 
Fractions located within the peak trace were pooled and concentrated with a 50 kDa 
Amicon protein concentrator.   
3.3.11 Crystallisation Screening 
Purified protein buffer exchanged into DDM, concentrated to ~8 mg/ml, was used for 
crystallisation trials in hydrophobic CrystalQuick 96-well sitting drop plates (Greiner). Prior 
to set up, protein samples were centrifuged at 13,000 rpm (~18,000 x g) for 10 minutes in 
order to pellet any aggregates. Sitting drop vapour diffusion screens using 100 nl protein 
and 100 nl reagent from the crystal screens MemGold I and MemGold II (Molecular 
Dimensions) were set up using a Mosquito robot (TTP Labtech). The plates were incubated 
at 20 °C in a Molecular Dimensions incubator and crystal formation was monitored 
periodically using a Leica DFC295 microscope.  
3.4 Results 
3.4.1 Optimisation of E. coli growth conditions between DLS and UoR 
Previously, a low resolution crystal structure for MOMP was resolved from recombinant 
protein expressed in E. coli (Atanu, 2014). In order to improve the resolution and gain more 
information regarding MOMP’s structure, this method of expression was replicated at the 
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two collaborating institutions. However, between laboratories at Diamond Light Source 
(DLS) and the University of Reading (UoR) there was an observable difference in the time 
taken for C41 (DE3) E. coli cells transformed with pETMOMPH6 to reach an OD600 of ~0.5, at 
which induction is deemed optimal. Despite following the same protocol, cells at DLS took 
approximately seven hours to reach an appropriate OD600, as opposed to those at UoR 
which took just three hours, the latter being more typical of this cell strain. At DLS, the 
OD600 values of different overnight culture conditions were examined before subculture into 
10 ml LB with varying glucose concentrations (0%, 0.5%, 1%, w/v). As shown in Table 3.2, 






After subculture into fresh LB, an OD600 measurement was taken every hour until the 
culture passed the induction stage of ~0.5, shown in Figure 3.4. From Figure 3.4 it was clear 
that a reduced overnight temperature of 30 °C (condition C) resulted in a shorter period of 
growth, of around three and a half hours, before reaching an OD600 of ~0.5. Cultures 
subcultured with condition A, 150 ml at 37 °C, demonstrated a considerably longer growth 
period of approximately seven and a half hours, with condition B, a smaller volume of 10 ml 
at 37 °C, also taking over six hours to reach an OD600 of ~0.5. Differing concentrations of 
Table 3.2. Comparison of overnight culture conditions. C41 (DE3) E. coli cells transformed 
with pETMOMPH6 were grown overnight in LB media following inoculation with a single 
colony. OD600 measurements were taken after 16 h of overnight growth. 
Condition Temp (ᴼC) Volume (ml) OD600
A 37 150 1.60
B 37 10 1.55
C 30 150 1.55
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glucose did not appear to have a significant effect upon growth under any of the conditions 
tested. Due to improved growth, an overnight temperature of 30 °C was used in all further 
protein expression studies at DLS. Additionally, due to the slight improvement in growth 
between 10 ml and 150 ml cultures, subsequent large scale cultures were grown in 2 L 




Figure 3.4. Graph showing the time taken to reach an OD600 of ~0.5 following subculture with different overnight cultures. C41 (DE3) E. 
coli cells transformed with pETMOMPH6 were grown overnight under a variety of temperatures and volumes (A-C) and glucose 
concentrations (1-3), before being subcultured into 10 ml fresh LB and grown at 37 °C, 225 rpm. Measurements were taken hourly until an 
OD600 of ~0.5-0.6 was passed. A (red), 37 °C 150 ml overnight culture; B (yellow), 37 °C 10 ml overnight culture; C (blue), 30 °C 150 ml 

























3.4.2 Poor solubility of MOMP with detergent DDM 
Following optimisation of the large-scale growth conditions at DLS, crude membranes were 
prepared from 6 L of culture, as described in Chapter 2 Section 2.2.2.4, then solubilised with 
2% (w/v) DDM following the his-trap affinity chromatography procedure (Section 3.3.3) in 
order to replicate the procedure previously successful in the production of rMOMP crystals 
(Atanu, 2014). The chromatograph obtained from the IMAC purification revealed an 
extremely small peak in fractions B1-B3, as shown in Figure 3.5A, eluted with an imidazole 
gradient between 30-500 mM. At each stage of the process, samples were taken for analysis 
with Western blotting, shown in Figure 3.5B. From these results, it was evident that the 
majority of MOMP was DDM insoluble, as indicated by the arrow in well 8, which shows a 
considerably thicker band in comparison to the soluble DDM fraction in well 7. Additionally, 
the sarkosyl isolation step, included in order to solubilise contaminant inner membrane and 
cytosolic proteins, whilst isolating the outer membranes in the insoluble fraction (Filip et al., 
1973), showed a strong band for MOMP in well 6 corresponding to the insoluble pellet. 
Repetition of this procedure, scaled up to 24 L of culture, did not increase the protein yield 
with a similar peak observed within the UV trace beginning at fraction B1, as shown in 













Figure 3.5. Purification of pETMOMPH6 membranes expressed 
in C41 (DE3) cells with DDM solubilisation. A, IMAC UV trace 
from 6 L of original culture. Only a small peak was eluted in 
fractions B1-B3. Dark blue, UV absorbance; green, imidazole 
concentration gradient. B, Western blot of samples taken 
during the IMAC purification of a 6 L membrane prep. 1, MW 
protein standard; 2, his-tagged protein standard; 3, blank; 4, 
crude membranes; 5, sarkosyl soluble fraction; 6, sarkosyl 
insoluble fraction; 7, DDM soluble fraction; 8, DDM insoluble 
fraction; 9, HisTrap column flow through. Protein was detected 
using 6X his epitope tag monoclonal mouse IgG primary 
antibody and anti-mouse IgG (H+L) -HRP conjugated secondary 
antibody. C, IMAC UV trace from 24 L of original culture. No 
improvement was observed between peak volumes for 6 L and 
24 L membrane preps.  
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3.4.3 His-tag extension of the pETMOMPH6 construct 
The hexahistidine tag at the C-terminus of MOMP in the pETMOMPH6 construct was 
extended to His-8 and His-10 by SDM in an effort to improve binding to the Ni-NTA column 
during protein purification. The mutations were confirmed through sequencing with the T7 
reverse sequencing primer (Chapter 2 Table 2.6) before constructs were transformed into 
both C41 (DE3) and BL21 (DE3) E. coli cells to test protein expression. Figure 3.6 shows a 
Western blot comparing whole cell expression of the three constructs, whereby it was 
evident that both MOMPH8 and MOMPH10 greatly reduced expression in both strains in 
comparison to the positive control, MOMPH6. MOMPH8 expressed in BL21 (DE3) cells had 
comparable levels to that of MOMPH6 in C41 (DE3), while MOMPH10 was not expressed in 
either strain. The Coomassie blue stained loading control is shown in Figure A3.1 in 
Appendix 3. As the pETMOMPH10 construct demonstrated no protein expression, it was 
again sequenced in the opposite direction using the T7 forward sequencing primer (Chapter 
2 Table 2.6) in order to identify any untoward mutations that may have been introduced 



















3.4.4 Detergent screening for optimal MOMP solubilisation using Western 
blotting 
Due to MOMP’s low expression, Western blotting was required to visualise the desired MW 
band and, despite the advice from Newby et al in 2009, the membranes were not diluted 
prior to solubilisation, again due to MOMP’s low expression levels. Additionally, the sarkosyl 
isolation step was not included in initial detergent screens, due to the variability observed 
between the starting concentrations of MOMP in each sample in preliminary tests (data not 
shown). Three conditions were tested; room temperature for one hour (Figure 3.7A), 4 °C 
for two hours (Figure 3.7B), and 4 °C overnight (Figure 3.7C), with the following detergents 
at 1%; DDM, OG, LDAO, FC-12, CHAPS, and Triton X-100. The only wells indicating solubilised 
Figure 3.6. Western blot showing expression of His-6, His-8, and His-10 pETMOMP 
constructs in whole cells. Constructs were transformed into both C41 (DE3) and BL21 
(DE3) E. coli cells. 1, His-tagged protein standard; 2, Blank; 3, C41 (DE3) control; 4, C41 
(DE3) His-6; 5, C41 (DE3) His-8; 6, C41 (DE3) His-10; 7, Blank; 8, BL21 (DE3) control; 9, BL21 
(DE3) His-6; 10, BL21 (DE3) His-8; 11, BL21 (DE3) His-10. Protein was detected using anti-
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MOMP are shown in Figure 3.7A, in wells 9 and 13, corresponding to FC-12 and Triton X-
100, respectively. In all of the BC samples solubilised at room temperature (Figure 3.7A), 
there were multiple bands for MOMP in addition to the expected monomeric band at ~40 
kDa, suggestive of both a dimeric form at ~80 kDa and degradation at the lower MW bands 
of ~25 kDa and 15 kDa. These additional bands were also faintly visible in Figure 3.7B and 





























Figure 3.7. Western blots of the detergent solubility screens under the following 
conditions; A, Room temperature for 1h, B, 4 °C for 2h, and C, 4 °C overnight. 1, His-
tagged protein standard; 2, DDM BC; 3, DDM SF; 4, OG BC; 5, OG SF; 6, LDAO BC; 7, LDAO 
SF; 8, FC-12 BC; 9, FC-12 SF; 10, CHAPS BC; 11, CHAPS SF; 12, Triton X-100 BC; 13, Triton X-
100 SF. BC refers to ‘before centrifugation’ and includes soluble and non-soluble proteins, 
and SF refers to solely the ‘soluble fraction’. Bold arrows indicate presence of MOMP. 
Protein was detected using 6X his epitope tag monoclonal mouse IgG primary antibody 
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Due to the poor solubility observed, Figure 3.7A-C, the sarkosyl isolation step was 
reintroduced in an attempt to remove as many contaminating proteins as possible, to allow 
more mild detergents, such as DDM, access to MOMP. The optimal sarkosyl concentration 
was investigated by testing a gradient of 2-10% (v/v), in 2% increments. Unlike before, the 
SF was not analysed, but instead the insoluble pellet containing MOMP, denoted P, was 
resuspended and analysed. As shown in Figure 3.8, all increments of sarkosyl successfully 
isolated MOMP, with equal protein levels observed between BC and P samples. Therefore, 
to avoid unnecessarily harsh treatment of MOMP, the lowest concentration of sarkosyl, 2% 
















A number of additional conditions were tested along with the sarkosyl isolation step in 
order to encourage solubilisation. The pH of the Tris buffer solution was increased from 7.5 
to 8 (room temperature readings, which equate to 8.1 and 8.58 at 4 °C) in order to raise the 
Figure 3.8. Western blot of a 2-10% sarkosyl isolation gradient. 1, His tagged ladder; 2, 
2% BC; 3, 2% P; 4, 4% BC; 5, 4% P; 6, 6% BC; 7, 6% P; 8, 8% BC; 9, 8% P; 10, 10% BC; 11, 
10% P. BC refers to before centrifugation and includes soluble and non-soluble proteins 
and P refers to insoluble protein in resuspended pellets. All % (v/v) values are in relation 
to sarkosyl. Protein was detected using 6X his epitope tag monoclonal mouse IgG 




pH above MOMP’s isolelectric point (pI) of 8.29, calculated using the online tool ProtParam 
to include the v5 epitope and hexa-histidine tag which are not cleaved off during the 
purification procedure (Gasteiger et al., 2005). The previous six detergents, shown in Figure 
3.7, were again used for solubilsation for 2h at 4 °C although no protein bands were 
observed in the soluble fractions with Western blotting, apart from that with FC-12 as 
before (data not shown). An additional detergent of zwitterionic nature, SB3-12, was used 
alongside DDM and FC-12 at a higher temperature of 30 °C overnight, and the sarkosyl 
isolation step was increased to 2h at room temperature, but again only FC-12 solubilised 
any MOMP (data not shown).  
3.4.5 Detergent screening using the novel P3NTA tag with fluorescence-detection 
size-exclusion chromatography (FSEC) 
For a higher throughput method of detergent screening, FSEC was carried out on crude 
membranes produced from pETMOMPH6 transformed C41 (DE3) cells grown in 12 L of LB. A 
range of detergents, some previously shown to be promising by Atanu in 2014 such as DDM, 
OG and LDAO, were tested in order to determine the most promising candidates for MOMP 
solubilisation.  
Figure 3.9 shows the results of this screening where the unbound probe peak at 19.5 ml is 
clearly visible for all samples (Figure 3.9A), along with the void volume at 9 ml, shown more 
clearly in Figure 3.9C for the LMNG sample, although not observed with DDM (Figure 3.9A). 
Within every trace, it was notable that the unbound P3NTA probe was not completely 
washed out from the previous sample, due to the truncated peak at 19.5 ml, which results 
in a gradual decrease back to baseline between 0 ml and 5 ml at the start of each trace, 
most clearly visible in Figure 3.9B.  
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Figure 3.9. FSEC traces of detergent solubilised MOMP labelled 
with P3NTA probe. A, All detergents screened, B, omission of 
DDM trace, and C, omission of P3NTA peak at 19.5 ml. 
Membranes were diluted to 3 mg/ml and solubilised with 1% 
detergent (Elugent at 5%) for 1h at 4 °C. Soluble fractions were 
supplemented with 1.5 µmol P3NTA and analysed by FSEC. The 
graph shows the fluorescence absorption for each sample. The 
peak visible at 17.5 ml for SB3-14 (*) corresponds to calibrated 
values for a protein of 36 kDa. Free P3NTA probe elutes at 19.5 







Notably, the DDM sample which is only shown in Figure 3.9A was at a considerably lower 
absorbance unit than the other samples, had no void volume, and only a small peak for 
unbound probe. Additionally, there is a very large inexplicable initial peak.  
A small peak was visible for SB3-14, a detergent used in both Campylobacter jejuni major 
outer membrane protein solubilisation (Ferrara et al., 2016) and in C. trachomatis MOMP 
solubilisation (Findlay et al., 2005; Pal et al., 2005), at 17.5 ml (Figure 3.9C, indicated by *) 
which corresponds to a MW of approximately 36 kDa from previously calibrated values for 
the P3NTA probe, and therefore was likely due to MOMP. A shorter peak at this location 
also was present in the C12E8 trace, partially overlapping the peak of SB3-14, which also 
was likely due to monomeric MOMP although at a much reduced quantity.  
The void volume present at 9 ml for the majority of samples was due to aggregated protein, 
with the 5% Elugent sample producing the highest and broadest peak, most likely resulting 
from the increased detergent concentration. There were a number of additional small peaks 
for other detergents in the trace, which were likely due to multimeric protein. After the 
peak located at 17.5 ml, the second most consistent protein peak was seen at 
approximately 15 ml for the following samples; LMNG, UDM, Cymal 5, C12E8, OGNG, and 
OG, and appears to correlate to a protein of 95 kDa. 
Despite the promising monomeric peak for the SB3-14 sample, a broader peak appeared 
just after the void volume between 10 ml and 16 ml, which was likely due to aggregated 
multimeric protein. Optimisation of these conditions, such as detergent concentration, 
temperature, duration of solubilisation etc. may reduce aggregation.  
Due to the novelty of the P3NTA tag, it was necessary to analyse these results through 
Western blotting to act as a comparison with previous detergent screening experiments, 
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along with an SDS-PAGE gel imaged with a fluorescent detector for visualisation of any 





















In Figure 3.10A there was a strong band at approximately 63 kDa, with another weaker 
band situated below at 45 kDa. The latter is likely due to monomeric MOMP, in addition to 
the 3 kDa tag, and the former possibly due to a histidine rich contaminant protein. The 
Figure 3.10. Detergent solubilised membrane samples previously analysed by FSEC. A, SDS-
PAGE with 1/200 P3NTA fluorescent probe and B, Western blot with anti-his antibody. 
Gels were run at 100 v for 120 minutes at 4 °C to prevent degradation of the P3NTA probe. 
1, Protein standard; 2, 1 mg/ml membranes; 3, DDM; 4, OG; 5, LDAO; 6, SB3-12; 7, SB3-14; 8, 
5% Elugent; 9, LMNG; 10, OGNG; 11, UDM; 12, Cymal 5; 13, C12E8. All detergents were at 
1% unless otherwise stated. The arrow indicates the location of MOMP. For Western 
blotting, protein was detected using 6X his epitope tag monoclonal mouse IgG primary 




highly fluorescent band present in the lower molecular weight region of the gel was a dye 
front caused by excess P3NTA. Figure 3.10B shows a Western blot of the same samples 
labelled with anti-his antibody, where only a single band corresponding to MOMP was 
visible, as indicated by the arrow in well 7. MOMP in this sample was solubilised with SB3-
14, the same detergent from the FSEC trace in Figure 3.9 that showed a reasonable peak at 
approximately 36 kDa. Interestingly, the 63 kDa bands that were clearly present in Figure 
3.10A were not visible in the Western blot. Over exposure of the blot resulted in a very faint 
band in well 7 for SB3-12 (not shown here). Additionally, in the crude membranes sample in 
well 3 there was a large smear near the top of the well, which was likely due to aggregated 
protein and a small faint band at approximately 40 kDa corresponding to MOMP. 
3.4.6 MOMP solubilisation with SB3-14 assessed with Western blotting 
After establishing SB3-14 as the most suitable detergent for native rMOMP solubilisation 
with FSEC, an additional solubilisation experiment was conducted in order to test two 
detergent concentrations of 1% and 2%, and two novel cysteine mutants, C201A and 
C201/203A. Western blotting was used as before in order to create a comparable measure. 
From the Western blot shown in Figure 3.11 it was evident that SB3-14 had dramatically 
improved MOMP solubility for both concentrations, compared to the detergents tested in 
Section 3.4.4. Notably, the same detergent failed to solubilise the two cysteine mutants, 
with 2% SB3-14 resulting in a higher molecular weight band for MOMP at approximately 50 
kDa in both mutants prior to centrifugation. Due to the adverse effect observed in the 
mutants, and the negligible difference observed in solubilisation between 1% and 2% SB3-










3.4.7 Optimisation of MOMP purification 
A 3 L membrane prep from C41 (DE3) cells expressing native MOMP was again purified 
following the his-trap affinity chromatography procedure outlined in Section 3.3.3, instead 
with solubilisation by zwitterionic detergent SB3-14. However, at 4 °C buffers A and B 
(Chapter 2 Table 2.4) containing 0.1% (w/v) SB3-14, in place of DDM, became extremely 
viscous in the thin tubing of the ÄKTA system which resulted in a gradual increase in 
pressure and concurrently required a decreased flow rate (from 2ml/min to 0.5ml/min). 
Despite warming the buffers to reduce viscosity, due to the narrow diameter of the tubing 
and therefore the rapid cooling of the fluid in the lines at 4 °C, the pressure issue could not 
be overcome, with the flow rate reaching a low of 0.5 ml/min, which quadrupled the 
predicted run time. Instead, the SB3-14 concentration was further decreased to 0.01% (w/v) 
and MOMP was washed and eluted from the his-trap column using a peristaltic pump with 
Figure 3.11. Western blot of SB3-14 solubility screen with native and mutant MOMP. 1, 
protein standard; 2, native 1% BC; 3, native 1% SF; 4, native 2% BC; 5, native 2% SF; 6, 
C201A 1% BC; 7, C201A 1% SF; 8, C201A 2% BC; 9, C201A 2% SF; 10, C201/3A 1% BC; 11, 
C201/3A 1% SF; 12, C201/3A 2% BC; 13, C201/3A 2% SF. BC refers to before centrifugation 
and includes soluble and non-soluble proteins, and SF refers to solely the soluble fraction. 
All percentages refer to SB3-14 (w/v) concentration. Protein was detected using 6X his 
epitope tag monoclonal mouse IgG primary antibody and anti-mouse IgG (H+L) -HRP 




30 mM and 40 mM imidazole wash buffers and 250 mM imidazole elution buffer. However, 








As a result, further purifications were carried out using nickel Superflow resin to avoid high 
pressure damage to the his-trap column. As the elution profile of the POI could not be 
visualised by this method, a small-scale trial was first conducted to determine the 
appropriate concentrations of imidazole to be used for the equilibration, washes, and final 
elution in order to achieve a higher purity.  
A low concentration of imidazole is typically added to the nickel resin binding buffer in order 
to prevent non-specific binding of contaminant proteins while still permitting near optimal 
binding of the POI. In order to monitor the binding efficiency of his-tagged MOMP, a small-
scale nickel resin binding trial was conducted whereby imidazole concentrations were 
increased incrementally, between 10 mM and 90 mM. The results are shown in Figure 3.13. 
From the Coomassie blue stained SDS-PAGE gel in Figure 3.13A it was evident that no 
Figure 3.12. Coomassie blue stained SDS-PAGE gel demonstrating the low purity achieved 
during initial purification of rMOMP solubilised with SB3-14. 1, Protein standard; 2, 
dialysed protein; 3, concentrator flow through; 4, concentrated sample. Due to the 
precipitation of SB3-14 at low temperatues, rMOMP bound to the his-trap column was 




supplementation with imidazole (well 4) resulted in the binding of many contaminant 
proteins. Cross validation with the Western blot, shown in Figure 3.13B, revealed that only 
imidazole concentrations of 10 mM and 30 mM still permitted MOMP binding, due to the 
bands located at approximately 40 kDa in wells 6 and 8. However, at the lower 
concentration of 10 mM, contaminant proteins were still visible in the SDS-PAGE gel (Figure 
3.13A). As the band corresponding to MOMP in the 30 mM sample appeared to be weaker, 
an intermediate imidazole concentration of 20 mM was used in future equilibrations with 













Figure 3.13. Small scale screen of appropriate imidazole concentration for equilibration 
with nickel resin. A, Coomassie blue stained SDS-PAGE gel and B, Western blot. 1, Protein 
standard; 2, Before centrifugation; 3, U0; 4, E0; 5, U10; 6, E10; 7, U30; 8, E30; 9, U50; 10, 
E50; 11, U70; 12, E70; 13, U90; 14, E90. Where U refers to unbound protein and E to eluted 
protein. All numbers refer to imidazole concentration in mM. Protein was detected using 6X 
his epitope tag monoclonal mouse IgG primary antibody and anti-mouse IgG (H+L) -HRP 









































Another small-scale purification of 3 L was carried out using nickel resin, whereby two wash 
steps of 40 mM and 60 mM imidazole were included, prior to elution in three stages with 
100 mM, 200 mM and 300 mM imidazole. Fractions were taken at each stage, with three 
taken for each elution concentration. The results of this test are shown in the Western blot 









 MOMP appeared to be binding to the resin, with no unbound protein present in the flow 
through fraction in well 3. From Figure 3.14, it is also evident that the majority of MOMP 
was eluted in the 100 mM fractions and the first two 200 mM fractions and, therefore, the 
300 mM elution step was omitted in future purifications. Additionally, a substantial amount 
of protein was lost during the 60 mM wash step (well 5) and a small quantity lost in the 40 
Figure 3.14. Small scale purification to determine the optimal imidazole concentration in 
40-60 mM wash and 100-300 mM elution buffers. 1, Protein standard; 2, Blank; 3, resin 
flow through; 4, 40 mM wash; 5, 60 mM wash; 6-8, 100 mM elutions 1-3; 9-11, 200 mM 
elutions 1-3; 12-14, 300 mM elutions 1-3. All values in mM refer to the imidazole 
concentration. Bracket indicates pooled MOMP. Protein was detected using 6X his epitope 





mM wash. Therefore, wash steps of 30 mM and 50 mM were tested in the subsequent 








From this Western blot, there appeared to be effective solubilisation of MOMP with SB3-14, 
due to the two equal bands in wells 4 and 5, corresponding to samples before centrifugation 
and the soluble fraction, respectively. Additionally, protein was not lost during the two new 
wash steps of 30 mM and 50 mM imidazole. As the majority of the protein was eluted 
during the two elution steps of 100 mM and 200 mM imidazole, of 5 CV each, a single step 
of 200 mM imidazole with a decreased elution volume of 2 CV was employed in future 
purifications. Decreasing the elution volume also served a dual purpose in decreasing the 
volume of dialysis buffer required and, therefore, conserving expensive detergent, as well as 
the time taken to concentrate MOMP. Figure 3.16 shows a Coomassie blue stained SDS-











Figure 3.15. Small scale purification to determine the optimal imidazole concentration in 
30-50 mM wash buffers. 1, Protein standard; 2, sarkosyl BC; 3, sarksoyl SF; 4, SB3-14 BC; 5, 
SB3-14 SF; 6, resin flow through; 7, 30 mM wash; 8, 50 mM wash; 9-11, 100 mM elutions 
1-3; 11-14, 200 mM elutions. All values in mM refer to the imidazole concentration; BC, 
before centrifugation; SF, soluble fraction. Protein was detected using 6X his epitope tag 





PAGE gel of purified MOMP obtained from solubilisation and purification with SB3-14, with 









3.4.8 Buffer exchange of SB3-14 solubilised MOMP into a crystallisation suitable 
detergent 
Following optimisation of the nickel resin purification procedure, it was important that 
MOMP was buffer exchanged into a detergent suitable for crystallisation and concentrated 
to approximately 10 mg/ml for crystal screening. Following elution from the nickel gravity 
flow column, MOMP was dialysed (dialysis buffer, Chapter 2 Table 2.4) to remove excess 
imidazole with 0.01% (w/v) SB3-14. The protein was then concentrated, using a 50 kDa 
centrifugal concentrator, which accounted for the micellar size of SB3-14 at ~30 kDa, with 
the intention of subsequent buffer exchange into OG using SEC. However, excess SB3-14 
was concentrated together with MOMP and resulted in ruinous denaturation, as observed 













Figure 3.16. Coomassie blue stained SDS-PAGE gel of MOMP purified with SB3-14. 1, 
protein standard; 2, purified MOMP. Protein was concentrated in a 20ml 50 kDa MW cut 




MOMP was buffer exchanged into OG during the wash and elution steps on the nickel 
gravity flow column, whereby further supplementation of SB3-14 was omitted after the 30 
mM wash step and the OG concentration (w/v) increased to 0.6%, 0.9%, and 1.17% during 
the two washes and the final elution step, respectively. The micellar size of OG is ~25 kDa 
and, therefore, a 30 kDa centrifugal concentrator was selected in order to both avoid 
concentration of OG and loss of MOMP with a 50 kDa MW cut off. However, precipitation 
began to occur after a concentration of 1 mg/ml and, therefore, centrifugations were 
limited to 5 minutes at 3,500 rpm (2,800 x g), as opposed to 10 minutes, to allow protein to 
be resuspended more frequently to prevent dramatic increases in concentration. 
Additionally, to prevent loss of protein and to limit the concentration of detergent, the 
purification was repeated but instead utilising a two-step concentration, initially using a 30 
kDa cut off to prevent protein loss before switching to a 50 kDa cut off in order to remove 
the majority of the excess detergent micelles. However, after concentrating to 200 µl, only 
220 µg of protein was obtained from a 12 L membrane prep.  
In order to limit the detergent micelle accumulated during the protein concentration step, a 
detergent of a higher molecular weight was used for buffer exchange, in this case DDM 
which is approximately 70 kDa. DDM was supplemented to the 30 mM and 50 mM wash 
buffers at 0.012% and 0.018%, respectively, and the elution buffer at 0.018% which equated 
to three times CMC, with 0.01% SB3-14 maintained in the two wash buffers only. 
Concentration to 200 µl, as before, resulted in 170 µg of protein from a 6 L prep. 
Hypothetically, scaling this up to compare with the 12 L membrane prep volume used 
previously indicated a ~35% increase in protein yield. Due to this, 18 L of membranes were 
purified following this method, which resulted in sufficient protein for two crystallisation 
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screens (MemGold I and II, Molecular Dimensions) in 96 well CrystalQuick plates (Greiner) at 
a final concentration of 7.6 mg/ml, both of which were incubated at 20 °C.  
As DDM is not an ideal detergent for crystallisation, an additional large sale membrane prep 
from 24 L of culture was purified in order to buffer exchange into OG using SEC, following 
buffer exchange and concentration in DDM during IMAC. The protein was concentrated to a 
volume of 500 µl (365 µg) before centrifugation for 10 minutes to pellet any precipitate that 
may have blocked the column. Although a monodisperse peak was observed and collected, 
it was very small (Figure 3.17) and, therefore, an extremely low concentration of protein 
was obtained with a 50 kDa MW cut-off concentrator (0.27 mg/ml in 60 µl; 17 µg). In order 
to obtain the 10 mg/ml required for crystallisation trials, this purification procedure would 




Figure 3.17. SEC UV trace of rMOMP buffer exchanged into 1.17% (w/v) OG having been 
solubilised in SB3-14 and buffer exchanged into DDM during IMAC purification. Notably, 
no void volume was observed, with a single monodisperse peak at ~16 ml corresponding to 
rMOMP. An ÄKTA system was fitted with a Superdex 200 column (GE healthcare, 10/300 
GL) and sample loaded using a 500 µl injection loop. A flow rate of 0.4 ml/min was set for 1 




Consequently, an alternative method was adopted. Instead of overnight dialysis to remove 
excess imidazole, a HiPrep desalting column was selected to both buffer exchange MOMP 
into OG from SB3-14 after nickel gravity flow purification, as well as to remove excess 
imidazole and decrease the NaCl concentration by half to limit salt crystal formation during 
crystallisation screening. The column permitted 15 ml of eluted protein per CV (53 ml) and a 
fast flow rate allowed buffer exchange to occur in under 30 minutes. From the UV trace 
shown in Figure 3.18, it is evident that the protein is eluted in the first 15 ml, as indicated by 
the broad peak (E1). The second lower absorbance hump between 15-25 ml (E2) also was 
collected and concentrated, but due to the speed at which the volume decreased, in 
addition to a very low protein concentration recorded by Nanodrop, it was concluded that 
this region did not contain MOMP. Figure 3.19 shows both the Coomassie blue stained SDS-
PAGE gel (Figure 3.19A) along with the Western blot (Figure 3.19B), which also indicates 
that the majority of MOMP is eluted in E1 (well 11) as opposed to E2 (well 14).  
To maintain a low pressure over the HiPrep column, it was disconnected from the ÄKTA 
system, during manual loading of the eluted protein via a syringe and, therefore, the 15 ml 
void volume was not recorded and is not visible in Figure 3.18. From the conductivity trace 
(shown in cyan, Figure 3.18) the excess salt and detergent were eluted between 30-50 ml. 
From a 6 L membrane prep, a final concentration of 0.1 mg/ml (100 µg total) was achieved 













Figure 3.18. Buffer exchange of rMOMP into 1.17% (w/v) OG using a HiPrep desalting 
column. 15 ml of SB3-14 solubilised rMOMP buffer exchanged into DDM during IMAC 
purification was manually applied to a HiPrep 26/10 desalting column (GE Healthcare Life 
Sciences). A flow rate of 2-8 ml/min, was set for 1 CV (53 ml) with the fraction of interest 
collected in 15 ml falcon tubes. UV trace, dark blue; conductivity trace, cyan. rMOMP 
















































Figure 3.19. Coomassie blue and Western blot of OG buffer exchanged rMOMP. 1, Protein 
standard; 2, sarkosyl BC; 3, sarksoyl SF; 4, SB3-14 BC; 5, SB3-14 SF; 6, resin flow through; 7, 
30 mM wash; 8, 50 mM wash; 9, 200mM elution; 10, HiPrep E1; 11, HiPrep E1 
concentrated; 12, HiPrep E1 concentrator flow through; 13, HiPrep E2; 14, HiPrep E2 
concentrated. All values in mM refer to the imidazole concentration; BC, before 
centrifugation; SF, soluble fraction. Protein was detected using 6X his epitope tag 
monoclonal mouse IgG primary antibody and anti-mouse IgG (H+L) -HRP conjugated 





Due to this success, the same procedure was scaled up to 24 L, and the HiPrep elutions 
pooled and concentrated. Once the protein was concentrated to 1.37 mg/ml (250 µg), it was 
left at 4 °C overnight and concentrated again the following day. Despite this, the 
concentration did not increase as expected and washing of the membrane revealed 
precipitated protein, likely due to remaining stationary overnight. As a result, the procedure 
was again repeated, instead storing the eluted fractions at 4 °C overnight and concentrating 
in three separate concentrators the following morning, both to speed up the process, thus 
limiting the time the POI was at 4 °C, and to prevent excessive concentration which may 
have led to aggregation. Despite these additional precautions, only a concentration of 0.3 
mg/ml (180 µg) was obtained.   
3.4.9 Analysis of DDM purified MOMP crystal screens using the microfocus 
beamline, I24, at Diamond Light Source 
Following incubation of DDM purified MOMP in the two MemGold crystal screens at 20 °C 
for 6 weeks, a number of potential hits were detected, an example of which is shown in 
Figure 3.20. These samples were taken to the I24 beamline at DLS which offers in situ plate 
screening using a microfocus beam suitable for crystals down to a size of 1.5 µm. Grid 
scanning of regions of interest produced diffraction patterns in the low-resolution region, a 
small subset of which appeared ordered and possibly due to protein (Figure 3.21A), whilst 
the majority exhibited disordered spots with smearing and curves (Figure 3.21B), likely 













Figure 3.20. Crystals observed in MemGold I after 6 weeks. The reservoir composition of 
well H1, pictured, was as follows; 0.1 M sodium chloride, 0.1 M sodium phosphate, pH 
7.0, 33% (v/v) PEG 300.   
 
Figure 3.21. Diffraction spots observed from in situ plate screening on beamline I24, DLS. 
A, well ordered diffraction spots, possibly due to protein crystals and B, disordered and 
curved diffraction pattern likely due to detergent crystals. rMOMP was solubilised with 
SB3-14 and detergent exchanged into DDM during IMAC purification before concentration to 
7.6 mg/ml. A number of crystals observed within both MemGold I and II crystallisation 
screens were grid scanned. A is from well D11 in MemGold II (0.02 M lithium chloride, 0.02 
M glycine, pH 10, 33% (w/v) PEG 1000) and B is from well H1 in MemGold I (0.1 M sodium 





3.5.1 Optimisation of E. coli growth conditions between DLS and UoR 
 
Previously, 10 mg/ml rMOMP was produced in E. coli from approximately 48 L of culture, 
which was solubilised with DDM and subjected to crystallisation trials with a number of 
different detergents (Atanu, 2014). As a result of the previous success of this large scale 
expression and purification procedure, it was replicated in order to duplicate the conditions 
from which crystal growth was observed and a low resolution structure obtained. This 
would then permit optimisation of crystallisation conditions in order to produce more 
robust crystals able to diffract to a higher resolution.  
Initially, small-scale expression tests were conducted at UoR in order to confirm MOMP 
expression with E. coli strains C41 (DE3) and BL21 (DE3). Under these conditions, C41 (DE3) 
cells transformed with MOMP grew to an OD600 of 0.5 within three hours of subculturing 
with a 1 in 100 dilution of overnight culture. However, when these growth conditions were 
replicated at the collaborating institute, DLS, growth following subculturing was significantly 
slower, taking an extra four hours to reach an OD600 of 0.5. It was initially hypothesised that 
this effect may have, in part, been due to the culture volumes used, with those at DLS 
typically being of a larger scale with less aeration and, therefore, overnight cultures were 
grown in volumes of 10 ml and 150 ml. However, it also was important to consider the types 
of incubators used between the two institutes. At DLS, small Innova 44 shaker incubators 
were used, as opposed to the 37 °C incubated room used at UoR, in which the shaker was 
placed at ground level. Therefore, it was anticipated that the incubator room at UoR was 
less accurately regulated and in fact independent measurements revealed an actual 
temperature of 29.5 °C at ground level. Therefore, to investigate this, one of the overnight 
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cultures with a volume of 150 ml was incubated at 30 °C. Additionally, basal expression of 
the protein, which is known to be toxic, could have reduced the growth rate. To investigate 
this, the growth media was supplemented with either 0.5% or 1% (w/v) glucose, in order to 
encourage catabolite repression through maintenance of low levels of cyclic adenosine 
monophosphate (cAMP). In glucose rich environments, a by-product of glucose metabolism 
is able to repress cyclic adenosine, the enzyme responsible for converting ATP to cAMP, 
resulting in low cAMP expression. However, in the absence of glucose, cAMP is freely 
produced and able to interact with catabolite activator protein (CAP), which forms a 
complex capable of binding upstream of the lac operon, thus stimulating transcription via 
the RNA polymerase and resulting in basal protein expression (Novy and Morris, 2001).  
While the OD600 measurements of the overnight growth cultures were all very similar, the 
growth curve indicated a dramatic difference in growth, with the culture grown at the lower 
temperature of 30 °C reaching an inducible level of growth after three hours. Both cultures 
inoculated with overnight cultures grown at 37 °C grew at a much slower rate, with the 150 
ml condition growing the slowest, likely due to reduced aeration. As a result, it was 
concluded that a reduced overnight culture temperature of 30 ˚C prevented progression 
into the stationary and/or death phase, instead resulting in rapid entry into the exponential 
phase upon sub-culturing, which permitted the cells to reach the OD600 of 0.5 required for 
induction in a shorter amount of time. It is noteworthy that the OD600 of the three overnight 
cultures did not appear to be significantly different. As OD600 is a measure of cell biomass 
and not cell number, it is possible that the overnight cultures grown at the higher 
temperature had either larger cells or a greater ratio of dead:live cells, as opposed to those 
at the lower temperature. The proximity of the curves in each condition group (A-C, Figure 
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3.4) indicated that glucose supplementation had minimal effect upon the time taken to 
reach an OD600 of 0.5 and, as a result, suggested that basal protein expression was likely 
non-existent or low enough to not induce a hindrance to cell growth.  
Consequently, a reduced temperature of 30 °C was used for all subsequent overnight 
cultures at DLS, with UoR cultures grown under the same conditions as before. Additionally, 
at the UoR, cultures of 250-500 ml were grown in 2 L flasks, compared to the previous large 
scale expression protocol used by Atanu (2014) at DLS, which contained 1 L of culture in the 
same type of flask. Instead, in order to increase aeration and thus healthy growth, only 500 
ml of culture was grown in 1 L flasks for large scale expression at DLS. 
3.5.2 Poor solubility of MOMP with detergent DDM 
rMOMP was previously solubilised with 2% (w/v) DDM, following the removal of 
contaminant proteins by sarkosyl treatment, which led to the purification of stable and 
monodisperse protein suitable for crystallisation trials (Atanu, 2014). As a result of this 
previous success, this protocol was replicated on a small scale with just 6 L of LB growth 
media, in comparison to the ~48 L culture volume used in large scale experiments, in order 
to assess the robustness of the protocol. From purification with a HisTrap column, only a 
minimal amount of protein was eluted, as indicated by the small peak in the UV trace. 
During each step of the procedure, small fractions were collected for analysis with Western 
blotting. From this, it was evident that a small proportion of protein was present in the 
sarkosyl soluble fraction, which was likely a result of inclusion body formation. However, the 
majority of rMOMP was insoluble in sarkosyl, as demonstrated by the strong band in the 
Western blot corresponding to 40 kDa, indicating that MOMP was expressed within the 
membrane, as desired. Despite the previous success reported with the use of DDM in 
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MOMP solubilisation, the majority of MOMP unexpectedly appeared to be within the DDM 
insoluble fraction. It was, therefore, anticipated that the low yield obtained from IMAC 
purification was due to poor solubility and as such lower than expected application of 
protein onto the column. It was hypothesised that the low yield was due to the small culture 
volume of just 6 L, as previous success required 48 L of culture. Therefore, the procedure 
was again repeated but with 24 L of LB media, in an attempt to increase the total quantity of 
rMOMP. However, interestingly the total protein yield remained the same as reported in 
the small-scale 6 L study. One hypothesis investigated was that, due to the size of DDM, the 
hexahistidine tag was not available to the Ni-NTA column, resulting in low retention and 
thus low yield. Testing of this hypothesis is addressed below (Section 3.5.3). Primarily the 
low solubility in DDM, as indicated by the Western blot, was deemed to be a major concern 
due to the high loss of protein. As a result, a number of alternative detergents were 
screened, in an effort to optimise MOMP solubility and possibly reduce the volume of 
culture required to obtain suitable quantities of protein appropriate for crystallisation 
screening.  
3.5.3 His-tag extension of the pETMOMPH6 construct 
Following the low yield obtained from both 6 L and 24 L of culture medium, the 
hexahistidine tag of the pETMOMPH6 construct was extended to His-8 and His-10 in an 
attempt to improve association with the Ni-NTA resin during IMAC. Following successful 
creation of the his-tag extensions using SDM, expression was tested in both C41 (DE3) and 
BL21 (DE3) E. coli cells. The Western blot of whole cells expressing each construct indicated 
that BL21 (DE3) cells with pETMOMPH6 construct produced the most rMOMP. It was 
expected that a stronger band corresponding to MOMP would be observed in BL21 (DE3) 
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cells, as previous experiments indicated that these cells were capable of much higher 
expression in comparison to mutant C41 (DE3), although much of this protein was found in 
inclusion bodies. The MOMP constructs containing the His-6 tag acted to serve as controls 
for expression, with both His-8 and His-10 tagged constructs resulting in lower levels of 
MOMP, although pETMOMPH8 expressed in BL21 (DE3) cells produced protein at 
comparable levels to that of pETMOMPH6 in C41 (DE3) cells. Notably, the His-10 tagged 
construct did not express MOMP in either strain. To determine if any additional mutations 
had been introduced that may have disrupted expression, MOMP was sequenced from the 
N-terminal direction with the T7 forward sequencing primer, although no additional 
mutations were detected. It was concluded that the additional two histidine residues likely 
terminated MOMP expression, as even incorrectly folded protein would result in inclusion 
bodies. This further highlighted the requirement to analyse whole cells and not just the 
membrane region, which in this instance indicated that His-10 tagged MOMP was not 
expressed. Analysis of solely the membrane fraction, whilst useful to determine correct 
export of MOMP, would not have demonstrated the detrimental effect of His-10 tag 
extension on expression. Despite the reduced expression of His-8 tagged MOMP in C41 
(DE3) cells, if interaction with the Ni-NTA column is improved then this reduced expression 
may be a suitable compromise for a higher yield of purified protein. Alternatively, His-8 
tagged MOMP expressed in BL21 (DE3) also may be a reasonable construct to pursue, due 
to comparable expression of MOMPH6 in C41 (DE3), although further analysis would be 
required in order to determine if MOMP was exported to the OM.   
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3.5.4 Detergent screening for optimal MOMP solubilisation using Western 
blotting 
Despite extension of the his-6 tag, it was reasoned that improved solubility would likely 
confer the greatest improvement in yield due to the large difference observed with DDM 
soluble and insoluble samples. As a result, membranes were prepared for small scale 
detergent screening, detected through Western blotting due to both the low expression of 
MOMP and the presence of E. coli contaminant proteins at the same MW. Initially, the 
sarkosyl isolation step was not included in the initial detergent screens, due to slight 
variations observed between samples, likely due to disparities in resuspension of the 
insoluble pellets, which may have distorted the effect of the solubilisation detergent. A 
range of conditions also was tested, to include two temperatures for different durations. It 
was hypothesised that solubilisation at room temperature may encourage a more fluid 
cellular membrane, permitting easier extraction of MOMP, although the duration was 
limited to just one hour due to the risk of denaturation. Solubilisation at 4 °C was assessed, 
as a typical temperature for the majority of membrane protein procedures, again to ensure 
stability and prevent denaturation. In order to examine if the detergent simply required a 
longer duration, in order to successfully solubilise MOMP, one of the 4 °C experiments was 
incubated overnight for at least 16 hours. Introducing an overnight step also would prove 
useful in the overall expression and purification procedure, whereby freshly prepared 
membranes could be isolated with sarksoyl and then solubilised with detergent overnight, 
removing the requirement to flash freeze membranes. This may have improved retention of 
stable and active protein through avoidance of thawing, although contrarily solubilisation 
for such a long duration may counteract this benefit.  
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As previously discussed, DDM, OG and LDAO were previously lauded for their success in 
membrane protein crystallisation. Typically, due to their expense, OG and LDAO are not 
routinely used in solubilisation but were tested in this instance in the interest of obtaining 
highly coveted purified MOMP. If successful, the additional detergent exchange step into a 
crystallisation suitable detergent would also not be required, further ensuring MOMP’s 
stability. CHAPs is a zwitterionic detergent with an unusual structure containing a steroid 
ring, similar to that found in bile salts, which is capable of disaggregating protein complexes 
while maintaining the secondary and tertiary structure (Rodi et al., 2014). Thus, CHAPs was 
also tested in preliminary detergent screens to determine its efficiency at extracting 
disulphide bonded MOMP clusters. FC-12, also a zwitterionic detergent containing twelve 
hydrophobic methylene groups, often is viewed negatively in membrane protein research 
with suggestions that, due to its harsh nature, proteins soluble in FC-12 and SDS but not 
DDM are likely misfolded (Thomas and Tate, 2014). However, there has recently been a 
report detailing the success achieved with FC-12 in both solubilisation and crystallisation of 
E. coli OmpF, although at low resolution of between 3.5-5 Å (Kefala et al., 2010). Despite 
this, due to the limited success of FC-12 solubilisation in membrane proteins, the advice of 
Thomas and Tate was followed herein, whereby FC-12 solubilised protein was considered 
most likely misfolded and thus served as a comparison to correctly folded and exported 
protein soluble in alternative detergents. Similarly, Triton X-100 is a detergent well known 
for its ability to permeabilise the membrane at low concentrations of just 0.1% (v/v) and, 
therefore, a higher concentration of 1% was expected to be able to extract MOMP, although 
again, due to its harsh nature, was expected to result in denaturation. 
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From initial detergent screening with the described conditions and detergents, only FC-12 
and Triton X-100 showed a band corresponding to MOMP in the soluble fraction using 
Western blotting analysis and only with screening conducted at room temperature. 
Furthermore, within this blot were additional bands at 80 kDa, likely due to dimeric MOMP, 
and also at lower MWs of 35 kDa and 20 kDa, which were likely due to degradation 
products. Due to the presence of both aggregates and degradation products, it was likely 
that the solubilised protein observed was misfolded protein, which possibly begun to 
denature under the warmer room temperature conditions. The weak band (at ~ 40 kDa) also 
indicated that only a small amount of MOMP exported to the OM was misfolded. 
It was hypothesised that, due to the large number of contaminant proteins, the milder 
detergents such as OG and LDAO were solubilising other, more easily accessible proteins 
and as such resulted in no solubilisation of MOMP under any of the conditions tried. As a 
result, the sarkosyl isolation step was reintroduced, instead with one batch prepared and 
then aliquoted in order to limit variability with pellet resuspension in individual samples. 
Firstly though, the sarkosyl concentration was tested in order to optimise MOMP isolation, 
with concentrations between 2-10% (v/v). This again was analysed using Western blotting, 
where it was determined that all concentrations were successful at isolating MOMP and 
therefore the lowest concentration of 2% (v/v) was used to prevent unnecessarily harsh 
treatment, as well as to limit residual sarkosyl, as visualised through smears in the samples 
with higher concentrations.  
A number of additional conditions were tested, following sarkosyl isolation, including; 
changes in pH to raise it above MOMP’s pI of 8.29, increase in temperature to 30 °C to 
increase membrane fluidity, increase in sarksoyl isolation to two hours at room temperature 
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to remove more contaminant proteins, and testing of an additional zwitterionic detergent, 
namely, SB3-12. However, again only FC-12 was capable of solubilising MOMP. Although 
reports suggested that proteins only solubilised by FC-12 were most likely misfolded 
(Thomas and Tate, 2014), the soluble band visible in Western blotting was extremely weak 
and did not account for the observed high ratio of MOMP in comparison to the band visible 
before centrifugation. This suggested that much of MOMP remained inaccessible to the 
detergents within the membrane and thus a higher throughput technique, allowing an 
analysis of a greater number of detergents, was required. 
3.5.5 Detergent screening using the novel P3NTA tag with FSEC 
For a higher throughput method of detergent screening, FSEC was adopted. As previously 
discussed, MOMP previously tagged with GFP was incorrectly folded and expressed as 
inclusion bodies. To overcome the requirement for a fluorescence tag, the novel P3NTA 
probe was used, which binds to the his-tag under the same principle as IMAC. Being just 3 
kDa and supplemented after solubilisation, it was unlikely that any adverse effects would be 
observed on MOMP’s structure or stability. As a high throughput technique, a number of 
additional detergents could be tested, which along with DDM, OG, LDAO, and SB3-12 as 
tested before with Western blotting, included SB3-14, Elugent, LMNG, OGNG, UDM, 
CYMAL5, and C12E8.  
Despite DDM being the detergent of choice for MOMP solubilisation which successfully led 
to crystals (Atanu, 2014), the FSEC trace for this detergent revealed an unusual initial peak, 
possibly due to a high number of aggregates, with no void volume and a small peak at 20ml 
for unbound probe. On the contrary, all other detergents examined exhibited a peak around 
9 ml, correlating to aggregated protein which was too large to infiltrate the pores of the 
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column and thus was eluted first, commonly referred to as the void volume. Notably, the 
void volume for low cost detergent Elugent was particularly large, possibly due to a 
combination of the higher concentration of 5% and the non-ionic detergent mix of octyl-
glucosides and Triton X-100, and thus lower purity. Elugent was used at a higher 
concentration due to successful reports of its use between 1-5% for membrane protein 
solubilisation (Noinaj et al., 2013; Norell et al., 2014; Zabara et al., 2018). 
Additionally, each trace displayed a large peak at 20 ml, correlating to the 3 kDa unbound 
P3NTA probe. Due to the novel nature of this probe, especially in use with membrane 
proteins, the optimal concentration was unknown, although it became clear from the size of 
the peak that the concentration could be comfortably reduced from 1.5 µm in future. 
Most importantly from the trace, it was evident that whilst the peaks between the void 
volume and the unbound probe were all small, there was a distinctive peak at 17.5 ml 
correlating to SB3-14, a detergent previously used in the successful solubilisation of C. jejuni 
MOMP, as well as both native C. trachomatis MOMP (Tifrea et al., 2011) and rMOMP 
expressed in E. coli (Findlay et al., 2005). MOMP of C. jejuni shares both a name and a β-
barrel structure with C. pneumoniae MOMP, although exists as a trimeric protein lacking 
any cysteine residues with no regions homologous with MOMP. Despite this, the use of SB3-
14 to solubilise this Campylobacter β-barrel in E. coli has also proven useful in the 
solubilisation of Chlamydial MOMP. SEC columns are typically calibrated with standard 
proteins and Stokes radii to help identify the location of an uncharacterised protein (Nozaki 
et al., 1976). However, these calibrations are based on soluble proteins which are typically 
globular in shape with similar partial specific volumes, and are therefore at best an estimate 
for membrane proteins due to the accompanying detergent micelle (Slotboom et al., 2008). 
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The peak at 17.5 ml was deemed to result from a 36 kDa protein from previously calibrated 
data using the P3NTA tag, however membrane proteins analysed with this specific system 
were reported to elute with a 10 kDa difference. Therefore, MOMP being a 40 kDa protein, 
raised to 43 kDa with the addition of the fluorescent tag is likely the cause of the peak at 36 
kDa, although confirmation was required through gel electrophoresis. 
There were also a number of additional peaks of very small sizes, possibly due to MOMP 
degradation products or contaminant histidine containing proteins, which would be in 
higher quantities due to the omission of the sarkosyl isolation step. The most common peak 
other than that observed at 17.5 ml was that at 15 ml, correlating to a protein of 95 kDa and 
therefore possibly trimeric MOMP, although at extremely low levels.  
Whilst SB3-14 clearly exhibited the strongest peak correlating to MOMP, just prior to this 
was a broad peak spanning 5 ml, likely due to a large aggregate of disulphide bonded 
MOMP. Whilst care would be required to eliminate this aggregate in such close proximity to 
the peak of interest in future, SB3-14 was undoubtedly the most promising detergent for 
MOMP solubilisation. As the P3NTA tag was a novel probe, a fluorescent SDS-PAGE gel was 
compared to a Western blot of the same samples in order to draw comparisons with the 
blotting method adopted during the early stages of solubility screening. From the P3NTA 
labelled gel, the most visible band was one at 63 kDa, which previously has been reported as 
the size of trimeric MOMP (Kari et al., 2009), although the reasoning behind this is unclear, 
especially due to MOMP’s monomeric MW of 40 kDa, although OMPs PhoE and OmpF of E. 
coli, both with monomeric MWs of 39 kDa, have also been shown to migrate to a similar 
MW as trimers (Sun et al., 2007). It was certainly possible that this 63 kDa band was a result 
of non-specific binding of P3NTA to a native E. coli protein, such as 66.8 kDa protein GlmS 
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(Bolanos-Garcia and Davies, 2006) which contains almost 4% histidine residues, which 
would likely become exposed upon denaturation with SDS-containing loading buffer. 
Despite the presence of this 63 kDa band within every sample in fluorescent SDS-PAGE 
analysis, such a peak common to all detergents was not visible within the FSEC traces. This 
suggested that the histidine residues binding to the P3NTA tag only became exposed upon 
denaturation for gel electrophoresis and thus were not detectable during the FSEC 
experiment. Interestingly, these 63 kDa bands were not visible with Western blotting, which 
suggested that the P3NTA probe, which only needs to bind to just two histidine residues, 
was far less specific than the anti-his6 antibody.  
Below the 63 kDa band were additional fainter bands within each sample correlating to 
MOMP at the correct MW size, which was only visible in one well with Western blotting, 
which correlated to SB3-14. This strongly indicates that the peak of interest identified at 
17.5 ml determined to be due to monomeric MOMP was in fact correct. Most importantly, 
no other bands corresponding to monomeric MOMP were visible within the Western blot, 
and therefore the solubilising effect of SB3-14 was clearly distinguishable from the 
remaining detergents, as opposed to in the fluorescent SDS-PAGE gel.  
As a result, whilst FSEC with the novel P3NTA tag proved extremely useful in screening a 
large number of detergents, validation of results through Western blotting was preferred 
over fluorescence gel electrophoresis. 
3.5.6 MOMP solubilisation with SB3-14 assessed with Western blotting 
After SB3-14 was established as the most promising detergent for rMOMP solubilisation, 
Western blotting was again used to determine the optimum concentration. In FSEC 
experiments, solubilisation with 1% (w/v) SB3-14 resulted in the most significant peak 
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relating to MOMP, which was later confirmed with Western blotting. Again, a 1% 
concentration was tested, in addition to 2%, along with two novel cysteine mutants C201A 
and C201/203A as well as native MOMP. The broad aggregation ‘peak’ demonstrated in the 
SB3-14 FSEC trace was hypothesised to result from intermolecular disulphide bonding 
within MOMP, which is discussed and investigated in greater depth in Chapter 5. Briefly, 
Chlamydia uses a network of cysteine rich proteins, connected through intermolecular 
disulphide bonds, to provide circulating EBs with structural stability, of which MOMP is a 
dominant protein. It was hypothesised that mutation of particular cysteine residues 
believed to play major roles in such interactions would prevent MOMP clusters from 
forming and thus improve MOMP solubility. However, supplementation with 1% SB3-14 had 
no effect on solubility in both mutants, as opposed to a concentration of 2% which resulted 
in an inexplicable shift in the size of the band corresponding to MOMP up to approximately 
50 kDa, in comparison to the expected 40 kDa observed in the remaining samples. As a 
result of this peculiar shift, the lack of soluble protein observed for any of the mutants, and 
the good solubility of native MOMP with 1% SB3-14, only the latter was taken forwards into 
large scale purification optimisation. Solubilisations were carried out at 4 °C for two hours, 
due to the increase in denaturation and aggregation observed at room temperature. 
3.5.7 Optimisation of MOMP purification 
After successful optimisation of MOMP solubilisation, a small scale purification following the 
his-trap affinity chromatography procedure was again followed. A lower concentration of 
0.1% (w/v) SB3-14 was used in the two buffers in order to reduce excess detergent not 
required for micelle formation, with the CMC of SB3-14 being 0.007%. However, an artefact 
of SB3-14 not previously realised was its eventual precipitation upon storage at 4 °C. Due to 
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the fragility of MOMP, previously observed during room temperature experiments, all 
buffers required for purification were chilled prior to use. However, after successful loading 
of the his-trap column using a peristaltic pump, the buffers containing SB3-14 began to 
precipitate within the thin tubing of the ÄKTA system, which was over three times narrower 
in diameter compared to that used in sample loading. Despite warming the buffer to 
decrease its viscosity, once drawn inside the tubing within the 4 °C cabinet, the viscosity 
returned, in turn increasing the pressure within the ÄKTA system. The buffers were 
exchanged for those containing just 0.01% SB3-14 in an attempt to alleviate this effect, but 
to no avail. Whilst the flow rate was reduced, the continued increase in viscosity resulted in 
an eventual run time of over 12 hours, by which time MOMP may have become degraded or 
pressure damage occurred to the ÄKTA system or column. Instead, the his-trap column was 
manually washed using the peristaltic pump and eluted in a single step with 250 mM 
imidazole. However, as this method was not optimised in terms of the imidazole wash steps 
and elution, a number of contaminant proteins and potential MOMP degradation products 
were observed upon analysis of the eluted fraction with an SDS-PAGE gel.  
Due to the negative effect of SB3-14 on pressure within the ÄKTA system, free nickel resin 
was used for future purifications, as opposed to a his-trap column. Whilst it is possible to 
purify MOMP, as before, using a his-trap column and peristaltic pump, as the pressure is not 
measured there is a high risk of damage to the column. This alternative method required 
optimisation at each step, starting with the ratio of resin to protein. Whilst a large quantity 
of resin may in the first instance appear beneficial for optimum isolation of the POI, this 
actually can increase the non-specific binding of contaminant proteins and decrease the 
overall purity. For MOMP, 1 ml of resin per 1 L of original culture was used, with the resin 
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capable of binding up to 50 mg/ml. Another vital step in prevention of contaminant binding 
was in the addition of a low concentration of imidazole during the resin binding step. As 
discussed previously, the imidazole rings found in both histidine and imidazole 
competitively bind to the Ni2+ ion, and therefore weakly interacting contaminant proteins 
can be replaced by low levels of imidazole. Concentrations of imidazole between 10 mM 
and 90 mM were tested and analysed with both Coomassie stained SDS-PAGE gels and 
Western blotting, whereby from the former it was evident that no imidazole 
supplementation resulted in retention of a multitude of contaminant proteins. Use of 10 
mM imidazole decreased the contaminant binding, visualised with Coomassie blue staining, 
although a number of faint bands remained visible. With Coomassie staining, the 30 mM 
imidazole supplementation appeared to result in no protein within the eluted fraction, 
however cross validation with the Western blot indicated a band corresponding to MOMP. 
Due to the presence of a small number of contaminant proteins still present with 10 mM 
imidazole on the SDS-PAGE gel, but the weaker band corresponding to MOMP with 30 mM 
imidazole on the Western blot, a concentration of 20 mM imidazole was used during nickel 
resin binding. Solubilised protein was incubated with nickel resin with gentle agitation for a 
duration of one hour at 4 °C.  
A small scale purification following this protocol analysed with Western blotting revealed 
the absence of a band corresponding to MOMP within the nickel resin flow through fraction. 
This suggested that all available MOMP was successfully isolated on the resin and that both 
the duration of binding was sufficient and that the supplementation of 20 mM imidazole did 
not compete with MOMP-nickel interactions. Two wash steps were also introduced in order 
to remove any contaminant proteins prior to elution. Concentrations of 40 mM and 60 mM 
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imidazole were used, whereby it was evident from the Western blot that MOMP was also 
removed but most noticeably with the higher concentration. The 40 mM wash also 
appeared to remove the majority if not all of the contaminant proteins, as visualised with 
Coomassie blue staining, which suggested that only a low concentration of imidazole was 
required to observe the desired effect. Due to the detrimental effect of contaminant 
proteins in crystallisation, a trade-off between loss of MOMP and removal of contaminants 
was essential. In an additional purification, wash steps of 30 mM and 50 mM imidazole were 
also tested, whereby only a very faint band corresponding to MOMP was visible with 
Western blotting of the higher concentration fraction and thus as a result, these two wash 
steps were included in future large scale purifications. In initial purification attempts, three 
elution steps of 100 mM, 200 mM and 300 mM imidazole were assessed with three 
fractions taken of each, whereby it was apparent that the majority of MOMP was eluted 
within the 100 mM fractions, and the first two fractions of the 200 mM step. At this stage, 
an additional band was visible at a higher MW of approximately 80 kDa, corresponding to 
dimeric MOMP. It was likely that dimeric MOMP was present during the earlier stages of the 
purification, however due to its low proportion to monomeric MOMP, only became visible 
at higher concentrations during the elution steps. As much of MOMP was eluted at the 
lower concentration of 100 mM, confirmed through an additional small scale purification, a 
single step elution of 200 mM was used, whereby the higher concentration would permit 
elution in a smaller volume and thus decrease both the volume of dialysis buffer required 
and the volume of protein to be concentrated. It was important to remove imidazole 
through either dialysis or SEC due to its detrimental effect on crystallisation, although in 
some cases imidazole can act to stabilise particular proteins. Additionally, due to the 
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aromatic ring, the presence of imidazole is capable of distorting the true protein 
concentration measured using spectroscopy at 280 nm.  
From the Western blot of all steps, including the sarkosyl isolation and SB3-14 solubilisation, 
it was evident that only a small quantity of MOMP was lost to the sarkosyl soluble fraction, 
which was likely to be inclusion bodies and thus undesirable for crystallisation. SB3-14 
exhibited good solubility, with much of MOMP retained although as a large smear between 
40-60 kDa, a likely artefact of the detergent. Samples taken for Western blotting were also 
stored at -20 °C and not flash frozen, and therefore were subjected to freeze-thaw 
degradation and aggregation. The additional lower MW bands were most probably 
degradation products, again emphasising the requirement to both limit the duration of the 
purification procedure and to conduct all steps at a low temperature. No MOMP was 
detectable in the resin flow through, again signifying efficient binding, or in the first 30 mM 
imidazole wash step, with trace amounts lost during the higher concentration wash. As 
discussed, a single step elution containing 200 mM imidazole was used for future 
purifications.  
Due to MOMP’s low expression and toxicity, it was essential to optimise each stage of the 
purification procedure in order to limit protein loss and increase overall yield. In this case, 
due to the low expression, Western blotting proved invaluable in assessing each stage of the 
procedure, although Coomassie blue staining was also essential in determining the presence 
and quantity of contaminant proteins. 
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3.5.8 Buffer exchange of SB3-14 solubilised MOMP into a crystallisation suitable 
detergent 
SB3-14, whilst the most useful detergent for extraction and solubilisation of MOMP, has not 
demonstrated previous success in crystallisation with many researchers instead opting to 
buffer exchange into more amenable detergents such as DDM and OG (Beis et al., 2006). 
This is typically undergone using SEC, whereby not only can detergent exchange occur, but 
the salt concentration can be reduced and the sample assessed for its monodispersity. 
Following elution from the nickel resin, fractions were dialysed in order to both remove 
imidazole, which may have detrimental effects upon MOMP’s stability, and to decrease the 
SB3-14 concentration down to 1.5 times CMC (0.01%) in order to limit the presence of 
excess detergent micelles whilst also maintaining MOMP’s solubility. In selecting a suitable 
concentrator, the micellar size of the detergent was an important consideration as it 
envelopes the POI thus contributing to the overall MW. SB3-14 has a micellar size of 30 kDa, 
which combined with MOMP was a total size of 70 kDa and as a result a centrifugal 
concentrator of 50 kDa was selected, whereby it was intended that concentrated MOMP 
would then be buffer exchanged into a crystallisation suitable detergent such as OG using 
SEC. However, unexpectedly, excess detergent micelles were concentrated alongside 
purified protein, the increase in concentration of which resulted in denaturation of MOMP. 
Despite the presence of the 50 kDa filter, it was likely that gradual build up detergent 
blocked the filter and permitted concentration of excess detergent alongside MOMP. In 
order to overcome this, the SB3-14 concentration required reducing but was already at a 
very low CMC of just 1.5 times, whereas it is more typical to use three times CMC to ensure 
protein stability. An alternative method was adopted, whereby MOMP was detergent 
exchanged into OG during the IMAC purification procedure. The OG concentration was 
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gradually increased to a two times CMC of 1.17% (w/v), in 0.6% and 0.9% steps, whilst 
concurrently reducing the SB3-14 concentration. However, with a micellar size of 25kDa, a 
smaller MW cut off concentrator of 30 kDa was required for concentration of MOMP buffer 
exchanged into OG, as much of MOMP became trapped within the filter of a 50 kDa MW cut 
off concentrator used in a small scale test run. However, again precipitation occurred after 
the protein concentration reached 1 mg/ml, which initially was believed to be due to rapid 
concentration. The centrifugation duration was reduced by half, to just five minutes, in 
order to permit regular resuspension and prevent localised increases in protein 
concentration. However, it was then hypothesised that due to the size of the concentrator, 
it was likely that both OG and excess SB3-14 were also becoming concentrated. Despite 
buffer exchange into OG, it was highly likely that some SB3-14 still remained, and potentially 
also traces of sarkosyl used during membrane isolation, all contributing to an 
uncharacterised detergent ‘soup’. To limit the concentration of detergent and the loss of 
protein within the higher MW membrane, a two-step concentration procedure was devised 
whereby a 30 kDa cut off was used before switching to a filter of 50 kDa. This was in 
attempt to prevent protein loss in the first instance, with exchange into the higher MW cut 
off to remove concentrated detergent. However, whilst the protein stability was improved, 
the total yield was poorer than anticipated so again an alternative method was adopted. 
MOMP was again buffer exchanged during gravity flow IMAC but instead with DDM, a 
detergent with a higher MW of 70 kDa, resulting in a total MW of 110 kDa. This then 
permitted the use of a 100 kDa centrifugal filter, which would remove excess DDM as well 
as low MW SB3-14 and any residual sarkosyl. Due to the lower cost of DDM compared with 
other high purity detergents, a concentration of three times CMC was used in the final 
elution with concentration resulting in a theoretical increase in yield by 35%, compared to 
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that obtained from detergent exchange with OG with two-step concentration. From a scaled 
up 18 L membrane preparation, 7.6 mg/ml of protein was obtained following this 
procedure, equating to ~460 µg which was enough for two crystallisation trials in MemGold 
I and II. Whilst successes have been observed in crystallisation with DDM, previous attempts 
by Atanu in 2014 produced small and poorly diffracting crystals. Additionally, due to the 
difficulty in producing stable, purified MOMP, the sample was not analysed with SEC for 
monodispersity at the risk of losing sample. Instead, the procedure was again repeated with 
a 24 L membrane preparation, whereby protein buffer exchanged into DDM was 
concentrated to a volume of 500 µl for injection onto a SEC column. Given the volume, the 
yield of protein (365 µg) was as expected, however disappointingly only a small 
monodisperse peak was observed, which upon collection and concentration resulted in 
minimal protein. It was uncertain as to where such drastic protein loss occurred, as no other 
peaks corresponding to aggregated protein were observed. In order to obtain enough 
protein for crystallisation trials following this method, a culture volume of over 700 ml was 
required, which was simply unfeasible.  
As a result, an alternative method was sought, whereby a HiPrep desalting column was used 
to both remove excess imidazole in place of dialysis, whilst also buffer exchanging MOMP 
into OG from SB3-14, in addition to reducing the salt content. Not only would this method 
limit the time MOMP spent at 4 °C, but would also remove excess SB3-14 and OG, 
preventing denaturation during the concentration procedure. Initially, the system required 
optimisation, whereby a multitude of fractions were collected in order to determine the 
location of MOMP within the trace. What appeared to be a baseline, soon dropped away to 
form a large broad flat topped ‘peak’, which was later discovered to contain MOMP. As 15 
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ml of eluted sample from the IMAC procedure could be applied, in the absence of a large 
enough loop, sample was injected directly onto the column using a syringe. Due to the 
pressure within the ÄKTA system, the tubing connected to the UV reader was disconnected 
whilst sample was applied. With a void volume of 15 ml, the sample was eluted almost 
immediately after reconnection of the tubes and commencement of flow. After 
determination of MOMP’s location with Coomassie blue staining and Western blotting, and 
successful concentration to 0.1 mg/ml in 1 ml from a 6 L prep, the procedure was repeated 
to a larger scale which involved multiple sample applications of 10-15 ml from the 50 ml (2 
CV) elution step. By increasing the culture volume four fold from 6 L to 24 L, it was 
anticipated that a concentration of 0.4 mg/ml in 1 ml would be achieved, which could then 
be concentrated down to 10 mg/ml for a number of crystallisation trials, which require 12 µl 
of sample per screen. Due to the fast flow rate of the HiPrep column, the eluted fractions 
were pooled and concentrated immediately in order to limit the duration at which the 
protein was left at 4 °C. Promisingly, concentration to a 1 ml volume revealed a 
concentration of 0.3 mg/ml, which whilst lower than calculated theoretically, was a marked 
improvement from previous attempts. However, the large volume eluted, approximately 50 
ml, hugely increased the time taken to concentrate and at 1.37 mg/ml (~250 µg) MOMP was 
stored at 4 °C for eight hours before re-commencement of concentration. Due to the high 
concentration, precipitation occurred overnight as indicated by the lack of increase in 
concentration and the presence of precipitant upon washing of the membrane. Not only 
this, but it was also observed that the concentration of protein was not increasing as 
expected, with a higher total quantity of 300 µg measured at 1 ml compared to 250 µg 
measured following concentration down to ~200 µl. This suggested that loss of protein was 
not solely due to storage at 4 °C. The procedure was again repeated, instead with 
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concentration the following day after storage of the eluted product at 4 °C. The large 
volume of sample was split into three concentrators in order to limit both the time required 
to concentrate (from five hours in the previous preparation) and to prevent the potential 
aggregation from highly concentrated samples. However, despite these precautions, the 
final yield was too low for crystallisation screening and it was hypothesised that with the 
introduction of two extra concentrators, more protein was lost within the membrane. 
Additionally, the HiPrep column is marketed as being high throughput, with flow rates of 15 
ml/min achievable. In initial experimentation of this column with a 6 L prep, the flow rate 
was limited to 2 ml/min by the back pressure on that particular ÄKTA. However, two large 
scale experiments were able to be run at a flow rate of 8 ml/min, due to the use of a 
different ÄKTA system where back pressure was no longer an issue. Therefore, it was also 
hypothesised that the fast flow rate limited the success of detergent exchange into OG, 
resulting in unstable protein that did not concentrate as well as expected, and as a result 
the flow rate should be restricted to 2 ml/min in future.  
Despite the complications associated with concentration, this method offers a novel and 
higher throughput method for MOMP purification. Further optimisation is required in the 
vital concentration step, with the addition of extra TCEP following overnight incubation at 4 
°C likely to prevent aggregation arising through intermolecular disulphide bonding. This 
would permit lengthy concentration in a single concentrator as opposed to three, whereby 
it was likely that MOMP became trapped within the membrane. 
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3.5.9 Analysis of DDM purified MOMP crystal screens on microfocus beamline, 
I24 
MOMP buffer exchanged into DDM during IMAC purification resulted in a concentration of 
7.6 mg/ml. Due to the difficulties associated with obtaining stable and purified MOMP, this 
was put into two crystallisation screens, MemGold I and II, using the sitting drop vapour 
diffusion method and incubated at 20 °C. After incubation for six weeks, a number of 
crystalline structures were detected in both screens. In initial screening, it was imperative to 
consider the future analysis of any hits, and therefore plates compatible with the I24 
microfocus beamline at DLS were used. Following identification of a number of hits, crystals 
were analysed with in situ plate screening, whereby areas of interest were grid scanned. The 
purpose of this was to determine the presence of proteinaceous material, as it is certainly 
not uncommon for salt crystallisation to occur. Additionally, as this sample was not analysed 
with SEC, excess buffer was not removed except through concentration with a higher MW 
cut off and therefore the formation of detergent crystals was also possible. All spots present 
within the diffraction patterns were in the low resolution region, although no high 
resolution spots corresponding to ice rings or salt were detectable. Whilst a small subset of 
data was indicative of a regular crystalline lattice, the majority exhibited ‘smeared’ or 
double spots, likely arising due to detergent crystals.  
3.6 Conclusion 
Currently, there are no known structures for any Chlamydial OM proteins, with very little 
definitive information regarding their function, aside from the established proteins of the 
COMC (Liu et al., 2010), porin PorB (Kubo and Stephens, 2002), and adhesin, OmcB 
(Mölleken et al., 2008). Many of the Chlamydial OMPs have hypothetical roles, based on 
their homology to other Gram negative membrane proteins, with Omp85 suspected to 
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mediate porin translocation (Jacob-Dubuisson et al., 2009) and the many Pmps alleged to 
have various roles as autotransporters and invasins (Mölleken et al., 2013). While the 
majority of the Chlamydial OMPs contribute to the COMC, it is interesting to note that a 
number of these proteins are also suggested to have additional roles in Chlamydial biology. 
This, along with knowledge on Chlamydia’s small genome size, indicates that a number of 
OMPs have multiple functions, again supportive of both MOMP’s role within the COMC and 
as a potential transporter.  
MOMP was previously solubilised in DDM prior to buffer exchange into OG and LDAO, both 
of which produced diffraction quality crystals, with the former resulting in a low resolution 
(4 Å) structure solved by molecular replacement (Atanu, 2014). As a starting point for this 
work, the same protocol was followed in order to optimise the crystallisation process, with 
the main objective of obtaining a higher resolution crystal structure, which would provide 
novel insight into not only MOMP’s structure but also its potential function, whether that be 
solely in contributing to formation of the COMC or, additionally, in ligand transport.  
However, replication of the protocol revealed poor solubility with detergent DDM, with the 
majority of rMOMP lost to the insoluble fraction. Purification attempts at both small and 
large scale, surprisingly, did not result in any difference in yield, which was strongly 
suggestive of suboptimal solubilisation. As MOMP is a major contributor to the COMC, 
forming intermolecular disulphide bonds both with other MOMPs and other cysteine rich 
OMPs (Liu et al., 2010; Newhall et al., 1983), it was speculated that the improved expression 
of MOMP, achieved simply through increased aeration, resulted in increased clustering 
within the E. coli membrane. This, in turn, reduced the effect of the mild detergent DDM to 
efficiently extract MOMP from the membrane, despite the inclusion of reducing agents such 
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as DTT and TCEP. Cysteine mutants of MOMP designed to decrease this clustering 
behaviour, discussed in greater depth in Chapter 5, exhibited unusual migration with 
Western blotting and thus their solubilisation and purification was not pursued at this time.  
Instead, the solubilisation of native MOMP was optimised. Previous studies have utilised a 
range of different detergents including OG, LDAO, SB3-14, and CHAPs (Findlay et al., 2005; 
Pal et al., 2005; Tifrea et al., 2011) for MOMP solubilisation, and therefore a range of 
detergents were examined. In the first instance, due to low expression, MOMP solubility 
was analysed through a series of small scale screens using Western blotting. However, 
introduction of the novel P3NTA fluorescent probe, which was designed to bind to any his-
tagged proteins, permitted a higher throughput method known as FSEC, which also was able 
to readily identify monomeric MOMP. Whilst the P3NTA tag proved useful in FSEC 
experiments, identifying SB3-14 as the most promising detergent, its reliability in SDS-PAGE 
gels was somewhat debateable due to the non-specific binding of the 63 kDa protein that 
was not observed in Western blotting using the anti-his antibody. Fluorescent gels also did 
not identify a discernible difference between the detergents; all appeared to solubilise 
MOMP protein, although both FSEC and Western blotting clearly demonstrated SB3-14 to 
be the more promising lead for the solubilisation of monomeric MOMP, in support of 
previous studies which used SB3-14 during MOMP purification (Findlay et al., 2005; Tifrea et 
al., 2011). Therefore, it was still important to use Western blotting not only to correctly 
identify MOMP but also to distinguish the most effective detergent in solubilisation 
experiments. Nevertheless, FSEC with the P3NTA tag was an extremely useful combination 
for screening a large number of detergents in a high throughput manner.  
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The concentration of SB3-14 and the conditions under which solubilisation of MOMP was to 
occur were optimised, however, it was not possible to follow MOMP’s elution profile using 
an ÄKTA system, due to precipitation of SB3-14 at low temperatures. Instead, MOMP was 
purified with free Ni-NTA resin in a gravity flow column, in which each stage of the binding, 
washing, and elution steps were optimised for maximum yield. A number of complications 
arose upon concentration of MOMP, with increases in free detergent micelles denaturing 
MOMP and causing it to precipitate out of solution. Instead, MOMP was buffer exchanged 
into DDM during the IMAC procedure. In the presence of this detergent, MOMP was 
successfully concentrated to 7.6 mg/ml and used in sitting drop vapour diffusion 
crystallisation screens. Following a period of incubation, a number of crystalline structures 
were observed and scanned on the microfocus beamline on I24, DLS using in-plate 
screening. Many of the resulting diffraction patterns of low resolution were attributed to 
detergent crystals, although a small selection exhibited regular patterns of reflections 
suggestive of protein diffraction.  
Due to the difficulties in producing pure and stable MOMP, MOMP buffer exchanged and 
concentrated in DDM was not assessed for monodispersity with SEC for fear of losing the 
protein through aggregation. In order to buffer exchange MOMP into a more crystallisation 
suitable detergent, such as OG, the protein eluted from the nickel resin (still solubilised with 
SB3-14) was applied to a desalting column. Initially, in small scale trials, this new method 
appeared to hold significant promise, although it did not yield as much protein as expected 
once scaled up, again with difficulties observed during the concentration process.  
Presented here is a novel method for MOMP purification, in which each stage has been 
rigorously optimised in order to increase the total protein purity and yield. Due to MOMP’s 
toxic expression and high cysteine content, each unit expressed within the E. coli membrane 
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is precious. Comparable levels of protein are now obtainable with half the culture volume 
previously required (Atanu, 2014), following the protocols described in Chapter 2 Sections 
2.2.2.4 to 2.2.2.7, and final optimisation of the concentration procedure will certainly and 






















Investigating the functional role of MOMP as a 















4 Investigating the functional role of MOMP as a fatty acid transporter 
4.1 Introduction 
4.1.1 MOMP as a potential fatty acid transporter 
Due to the paucity of high quality structural data available for Chlamydial MOMPs, a 
functional role for this protein has been difficult to infer. Due to its high β-strand content of 
between 38-44% (Sun et al., 2007) and modelled amphipathic barrel shape, (as discussed in 
Chapter 1, Section 1.6.4), it has been suggested that MOMP exhibits classic porin activity, 
typical of this OMP bacterial class. This has been demonstrated through liposomal swelling 
assays, whereby rMOMP from C. trachomatis was able to transport all twenty of the amino 
acids (Jones et al., 2000), and nMOMP was able to transport the sugar L-arabinose, although 
at a considerably reduced rate in comparison to the well characterised porin OmpF of E. coli 
(Sun et al., 2007). However, porins (also known as non-specific channels) are not capable of 
transporting large solutes over 600 Da, and therefore transporter proteins are required in 
order to supply the bacterial cell with additional nutrients and carbon sources. Additionally, 
organisation of the residues within the E. coli OmpF pore, detailed in the crystallographic 
structure (PDBid: 2ZFG), creates a highly ordered water filled area, which makes passage of 
hydrophobic molecules, such as fatty acids, energetically unfavourable (Schulz, 2002; van 
den Berg, 2010). As fatty acids are principle sources of metabolic energy, as well as being 
vital components of the cellular membrane, their transport into the cell is essential and 
occurs via OM transporter proteins, such as FadL in E. coli, TodX in Pseudomonas putida, 
and TbuX in Ralstonia pickettii (Black et al., 1987; Hearn et al., 2008).  
Since Chlamydia have a small genome (1 million bp), it is imperative that they scavenge the 
host cell for essential nutrients that cannot be synthesised independently. Chlamydia 
possesses a de novo biosynthetic pathway for the synthesis of its membrane phospholipids, 
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which involves the uptake of the host building blocks serine, glucose, and isoleucine (Yao, 
Dodson et al., 2015). However, lipidomic analysis of C. trachomatis cells indicated that 8% of 
the OM phosphatidylethanolamine consisted of fatty acids 18:1/15:0. Furthermore, C. 
trachomatis is unable to synthesise unsaturated fatty acids (Yao, Cherian et al., 2015), unlike 
E. coli which possesses a gene encoding an acyl-carrier protein dehydratase/isomerase 
(fabA) used for the insertion of a double bond (Feng and Cronan, 2009). Therefore, it is 
hypothesised that oleic acid (18:1) was derived from the host HeLa cells (Yao, Cherian et al., 
2015). Furthermore, mass tracing of isotopically labelled fatty acids identified incorporation 
of lauric, palmitic, and myristic acid into the C. trachomatis phospholipids (Yao, Dodson et 
al., 2015). As fatty acid biosynthesis is an energy intensive process, it is not unexpected that 
Chlamydia may instead scavenge these fatty acids from the host, which are then modified 
for use in the Chlamydial membrane. The mechanism by which host fatty acids are 
transferred to the Chlamydial inclusion remains unknown, and therefore in this research 
MOMP was investigated as a potential fatty acid transporter due to its homology with FadL, 
which formed the basis for structural homology modelling. 
4.1.2 MOMP’s homology to E. coli fatty acid transporter, FadL 
Homology modelling of MOMP by Atanu et al in 2013 revealed a 14-stranded b-barrel 
structure, described in greater depth in Chapter 1 Section 1.6.4, which was based on the 
fatty acid transporter of E. coli, FadL, shown in Figure 4.1A. FadL permits cell growth with 
long chain fatty acids (LCFAs), fatty acids with over 14 carbons, which can act as substrates 
for the fatty acid degradation (Fad) enzymes, unlike fatty acids with a carbon chain length of 
less than eleven (Nunn and Simons, 1978). Specifically, FadL has the highest binding affinity 
to oleic acid (18:1) and palmitic acid (16:0), it binds myristic acid (14:0) with a lower affinity, 
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and with no affinity for decanoic acid (10:0) (Black, 1990). In E. coli, LCFAs are transported 
across the OM in an energy independent manner by FadL. A specific transporter is required 
due to the restrictions placed on spontaneous diffusion across the lipid bilayer by the LPS 
permeability barrier, which can extend to up to 30 Å in thickness (van den Berg, 2010). FadL 
has an internal N-terminal plug domain within its 14-stranded β-barrel, as shown in Figure 
4.1B, which would require a spontaneous conformational change in order to allow classical 
transport of solutes. Instead, structural and functional growth studies have provided 
substantial evidence that FadL exhibits a lateral opening within the barrel due to a kink in 
the S3 strand (Figure 4.1C) (Hearn et al., 2009), which interacts with the plug domain and 
creates a hole of approximately 8 x 10 Å, which is large enough for the passage of LCFAs. 
The detergent LDAO, used in the solubilisation process, was found to be positioned at the 
lateral opening indicative of a high affinity site for LCFAs, with many of the proximal 
residues hydrophobic in nature (Hearn et al., 2009). The hydrophobic core of the barrel, in 
addition to the lateral opening, would then permit transport of LCFAs into the OM region, 
where these then could diffuse into the periplasmic space (Hamilton, 2007; van den Berg, 
2010). The LCFAs are then transferred to the IM associated protein FadD (acyl-CoA 
synthase). Once transported into the cystosol by FadD the LCFAs then enter into the β-
oxidation cycle, where a number of enzymes are involved in FA catabolism, such as FadE, 
FadB and FadA (Fujita et al., 2007). Expression of these β-oxidation proteins, along with 
FadL and FadD, are repressed by FadR, which binds to promoter sites in the operon; this 
interaction is reversed by accumulation of long chain acyl-CoA esters, resulting from fatty 
acid uptake (Janßen and Steinbüchel, 2014). As FadL and FadD are required for fatty acid 
uptake, these proteins are only partially repressed by FadR (Feng and Cronan, 2012). In 
mutant strains, lacking a functional FadR, E. coli can grow on medium chain length fatty 
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acids, as well as LCFAs, since all Fad genes are no longer repressed (Janßen and Steinbüchel, 
2014). Experiments with a fadL knockout had no effect on medium chain fatty acid uptake 
(6-13 carbons), which are typically more polar than LCFAs, indicating an alternative 




















Figure 4.1. FadL crystal structure showing the occluded barrel and lateral opening. A, 14-
stranded β-barrel structure; B, view up into the barrel of the N-terminal plug domain; C, 
the lateral opening at the S3 kink. 2.6 Å crystal structure of FadL of E. coli (PDBid: 1T16), 
coloured according to secondary structure (yellow, beta sheet; red, alpha helix; green, 
random loop) with the lateral opening highlighted in violet. Imaged using PyMOL (van den 
Berg et al., 2004) 
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4.1.3 Increased thermal stability of MOMP in the presence of fatty acids 
Circular dichroism (CD) spectroscopy records the unequal absorption of right and left-
handed circularly polarised light from a chromophore, a light absorbing group such as the 
Ca carbons of the polypeptide backbone. SRCD spectroscopy extends the applications of CD 
spectroscopy as the elevated flux of a synchrotron permits the collection of data at 
considerably lower wavelengths and in much more dilute samples in smaller volumes 
(Wallace and Janes, 2010); a distinct advantage for membrane proteins, which are 
notoriously difficult to obtain in high quantities and at high concentrations. Due to the 
sensitivity of protein secondary structures, SRCD also permits data collection in the 
presence of small additives, such as ligands, or under environmental changes such as pH or 
temperature. The secondary structure of solubilised and purified rMOMP was analysed with 
SRCD in the far-UV, 190-260 nm, along with a number of potential ligands including the fatty 
acids palmitate and oleate. The midpoint of denaturation, also known as the Tm, is often 
taken as a measure of stability, which for native MOMP was 57.7 °C following temperature 
ramping between 10 °C and 80 °C (Figure 4.2A). Fatty acids palmitate and oleate increased 
the Tm of native MOMP to 59.3 °C and 72 °C (Figure 4.2B), respectively (Atanu, 2014). It is 
hypothesised that these two fatty acids contribute to MOMP’s thermal stability, through 
binding of a hydrophobic hatch region at the externally exposed surface of MOMP, the site 







Figure 4.2. SRCD spectroscopic traces of A, native MOMP and B, MOMP supplemented 
with oleate. rMOMP solubilised in FC-12 and buffer exchanged into 0.026% (w/v) DDM was 
used at a concentration of 12 µm, in 20 mM Tris, 150 mM NaCl, 5 mM EDTA at pH 8.0. CD 
spectroscopic changes observed in the far-UV (at 218 nm) showing the increased Tm of 
71.98 °C in the presence of five molar excess of oleate, the chemical structure of which is 
displayed (inset). (Atanu, 2014) 
 
4.1.4 E. coli as a model system 
E. coli is an excellent model organism for a fatty acid functional assay, as the transport 
proteins, mechanism, and degradation enzymes required for the use of LCFAs as a sole 
carbon source are all extremely well characterised, as described above. This enables 
knockout mutants of fadL to be used, in complementation with the POI, to determine if the 
POI can transport fatty acids and reinstate E. coli growth. Additionally, unlike liposomal 
swelling assays, pure protein is not required; the production of which is a costly and time 
consuming process, especially for membrane proteins. Instead, the protein can be 
expressed recombinantly from the pBADrha vector through induction with rhamnose 
(plasmid maps are shown in Appendix A2). Rhamnose, a naturally occurring sugar, is taken 
up by the RhaT transport system and is under the control of two activator proteins, RhaR 
and RhaS. In the presence of rhamnose, RhaR binds to the rhaPBAD promoter in order to 
activate transcription of both RhaR and RhaS, to which rhamnose and RhaS then together 
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initiate transcription of the downstream genes, resulting in a regulatory cascade responsive 
to differing rhamnose concentrations (Wegerer et al., 2008). This makes rhamnose an 
especially useful inducer as protein expression is tuneable, a feature particularly important 
for toxic proteins, whereby a lower level of correctly folded and active protein is more 
desirable than higher yields of potentially misfolded protein trapped within inclusion bodies. 
The promoter is also controlled by catabolite repression (as described in Chapter 3 Section 
3.5.1) and is therefore inactive in the presence of glucose, again in order to limit toxic basal 
expression. Additionally, unlike the pET101/D-TOPO vector, the bacterial strain is not 
required to contain the DE3 lysogen, improving the flexibility in mutant strain selection and 
removing the time-consumptive process of introducing the prophage.  
 An important consideration for all growth assays is the media to which the bacteria are 
exposed. In this instance, the functional assay exploits E. coli’s ability to grow on a sole 
carbon source of LCFAs and, therefore, it was imperative that all other potential carbon 
sources were omitted from the growth media. For this reason, minimal media (MM) is 
utilised because, as the name suggests, it only contains the minimal ingredients required to 
sustain culture; inorganic salts and water, supplemented with a carbon source of choice. 
Additionally, the agar used in the MM growth plates must be free of any carbon sources. 
Initially, sodium palmitate was used in the set-up of the functional assay, as it had been 
previously confirmed that FadL was the designated transporter of this fatty acid (Hearn et 
al., 2009), whilst it also has been demonstrated that Chlamydia scavenge this fatty acid with 
high affinity from the host cells (Yao, Dodson et al., 2015). Experiments assessing the 
binding affinity of FadL also indicate that LCFAs, oleate and myristate, which are scavenged 
by Chlamydia, are FadL substrates and therefore can be tested. Previous experimental data 
concluded that host-derived lauric acid also was scavenged by C. trachomatis cells, 
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however, as a medium chain fatty acid of twelve carbons it was not possible to include 
laurate as a fatty acid carbon source in this functional assay, as it is transported through the 
E. coli OM via an alternative mechanism to the FadL system, most likely through a porin due 
to its increased water solubility (Hearn et al., 2009). 
4.2 Aims and Objectives 
MOMP’s similarity to the E. coli fatty acid transporter FadL, together with the increased 
thermal stability of native MOMP observed in the presence of fatty acids, and the presence 
of host fatty acids in the Chlamydial outer membrane provides rationale for a functional 
growth assay in E. coli. From the low resolution 4 Å structure shown in Chapter 1 Section 
1.6.5, MOMP does not seem to possess a lateral hole in the barrel wall, like FadL, and 
therefore remodelling of the N-terminal plug domain may be required for fatty acid 
transport. If MOMP is shown to act as a fatty acid transporter, then efforts can be focussed 
on designing an inhibitor of MOMP as an alternative to a vaccine, for which the former 
would result in decreased fatty acid uptake from the host, with the potential to both 
decrease Chlamydia’s infectivity and its ability to survive and proliferate within the host 
cells, since a stable membrane is essential for bacterial survival. Thus, based on previous 
research of E. coli FadL and on Chlamydia’s scavenging behaviour, uptake of LCFAs such as 









4.3 Materials and Methods 
4.3.1 Materials 
4.3.1.1 Minimal media (MM) 
Liquid MM, pH 7.4 contained; 42 mM Na2HPO4, 22 mM KH2PO4, 8.5 mM NaCl, 19 mM NH4Cl, 
2 mM MgSO4, 0.1 mM CaCl2. The media was supplemented with either 0.4% carbon source 
such as glucose (w/v) or glycerol (v/v), or 5 mM fatty acid and 0.25% (w/v) Brij-58, plus 
appropriate antibiotics.  
Fatty acids were prepared from their sodium salts, e.g. sodium oleate for oleic acid, in order 
to improve solubility. Autoclaved nH2O was used to create a 20 mM fatty acid solution 
containing 1% (w/v) Brij-58, heated to 70 °C in a water bath with frequent stirring to 
promote solubility. MM plates containing fatty acids were then prepared immediately with 
liquid MM supplemented with 1.5% (w/v) Oxoid no. 1 Agar. 
4.3.1.2 Oligomers 
Oligomers for all DNA work are given in Chapter 2 Table 2.6.  
4.3.1.3 Bacterial strains 
A list of bacterial strains used can be seen in Chapter 2 Table 2.1.  
4.3.2 Methods 
The following methods described herein relate specifically to the functional assay set up and 
optimisation. The standard and finalised protocol is detailed in Chapter 2 Section 2.2.4.  
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4.3.2.1 pBADMOMPH6 expression vector design 
For construction of a rhamnose inducible expression system, hexahistidine tagged MOMP 
from the pETMOMPH6 vector (R1185) was amplified using the CloneAmp HiFi PCR premix, as 
described in Chapter 2 Section 2.2.1.3. The pBADrha vector was linearised using restriction 
enzyme digestion at a single NdeI site, four bases downstream of the Shine-Dalgarno 
sequence. 0.5 µl of FastDigest NdeI (ThermoFisher Scientific) was incubated with 2 µl of 
pBADrha DNA (~100 ng) along with 1X FastDigest buffer (ThermoFisher Scientific) in a total 
volume of 10 µl for 1h at 37 °C. The enzyme was inactivated by heat treatment at 65 °C for 
5 minutes and the linearised vector size checked with agarose gel electrophoresis. Both the 
linearised vector and the amplified insert were DpnI treated and purified before the In-
Fusion reaction. The resulting vector was sequenced in both directions at the In-Fusion sites 
using sequencing primers rhaB and pBAD (Chapter 2 Table 2.6) and named pBADMOMPH6 
(R1407). 
4.3.2.2 Addition of ampicillin resistance to the pBADrha vector 
Due to the use of additional E. coli knockout mutants that contained the same antibiotic 
resistance as the pBADrha expression vector (chloramphenicol), an ampicillin resistance 
gene was added to the vector. The ampicillin resistance gene was amplified from the 
pETMOMPH6 (R1185) vector, which was then inserted by In-Fusion into empty vector 
pBADrha as well as the pBADMOMPH6 vector, both of which had been linearised by inverse 
PCR (Chapter 2 Section 2.2.1.5). The two new vectors were checked for resistance by 
growth on LB ampicillin plates and named pBADa and pBADaMOMPH6 (R1411), respectively 
(Appendix A2.4).  
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4.3.2.3 Complementation vector design 
For complementation of the functional assay, fadL, the knockout gene, was inserted into the 
pBADa vector. Genomic DNA was extracted from wild type BW25113 E. coli cells using a 
QuickDNA kit (ZymoResearch), and used as a template for fadL amplification with primers 
pBADa FadL for and rev displayed in Chapter 2 Table 2.6. The pBADa vector was linearised 
as before, with restriction enzyme NdeI, and the purified PCR product with fadL gene 
inserted by an In-Fusion reaction. The plasmid, designated pBADaFadL (R1414, Appendix 
A2.3), was isolated from an E. coli Top10 transformant and sequenced in both directions 
using sequencing primers rhaB and pBAD (Chapter 2 Table 2.6).    
4.3.2.4 Initial rhamnose concentration testing 
A small-scale growth experiment of BW25113 E. coli cells transformed with either 
pBADMOMPH6 or empty vector, pBADrha, was conducted to identify the optimum 
rhamnose concentration for limiting cell toxicity. Transformed cells from LB plates were 
inoculated in triplicate into 10 ml LB with 34 µg/ml chloramphenicol where appropriate and 
0.6% (w/v) glucose and incubated overnight at 37 °C with shaking at 225 rpm. Overnight 
cultures were diluted 100-fold into fresh LB and incubated at 37 °C with shaking until an 
OD600 of ~0.5. At this point, cultures were induced with either 0.2%, 0.02%, or 0.002% (w/v) 
rhamnose and grown for a further 7h at a lower temperature of 25 °C. At 5h and 7h post 
induction, OD600 measurements were taken. This was later repeated in triplicate for 
knockout strain LS6164 transformed with pBADaMOMPH6 testing the following rhamnose 
concentrations; 0%, 0.005%, 0.01%, and 0.02% (w/v), with OD600 measurements taken every 
hour following induction for a total of 6h.  
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4.3.2.5 Medium-scale expression test to determine optimal rhamnose 
concentration 
A medium-scale expression test of BW25113 E. coli cells transformed with both 
pBADMOMPH6 and empty vector pBADrha was conducted in order to identify the optimum 
rhamnose concentration for both protein expression and toxicity limitation. Membranes 
were prepared following the medium-scale expression testing protocol described in Chapter 
2 Section 2.2.2.3, with the following amendments; use of 34 µg/ml chloramphenicol in 
place of ampicillin and, based on the results described in the experiment conducted in 
Section 4.4.1, cultures were induced with either 0.1% or 0.02% (w/v) rhamnose as opposed 
to IPTG and grown for a further 3h at 25 °C. Harvested membranes were analysed by SDS-
PAGE and Western blotting.  
4.3.2.6 Brij-58 toxicity assay 
A Brij-58 toxicity assay was conducted to determine the level of Brij-58 at which cell growth 
begins to be adversely affected. BW25113 cells grown from MM plates were inoculated into 
liquid MM supplemented with 0.4% (w/v) glucose and incubated for 16h at 37 °C with 
shaking at 225 rpm. This culture was then diluted 100-fold into fresh MM containing 0.4% 
(w/v) glucose with varying concentrations of Brij-58 (0 to 1% w/v) and incubated with 
shaking for 20h at 37 °C. An OD600 measurement was taken every hour for 8h with a final 
measurement taken at 20h. 
4.3.2.7 Super-resolution microscopy 
E. coli knockout strain LS6164 cells transformed with pBADaMOMPH6 were grown overnight 
in MM with 0.4% (w/v) glucose at 37 °C in a shaking incubator. Overnight cultures were 
diluted 1/10 into fresh MM containing 0.4% (v/v) glycerol and grown at 37 °C in a shaking 
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incubator until an OD600 of ~0.5. Cells were induced with 0.02% (w/v) rhamnose for 3h, 
before harvesting and resuspension to an OD600 value of 0.5 in PBS. Cells were then 
prepared following the Ibidi slide method developed in this research (Chapter 2 Section 
2.2.5.4) and labelled with 1/100 Anti-his Alexa 647 fluorophore. LS6164 control cells were 
also prepared in MM, with OmpA labelled with 1/500 anti-E. coli OmpA polyclonal rabbit 
primary antibody and 1/500 Alexa-488 anti-rabbit secondary antibody. All cells were 
imaging following the standard STORM imaging conditions described in Chapter 2 Section 
2.2.5.6.  
4.4 Results 
4.4.1 Induction with 0.02% (w/v) rhamnose is optimal for MOMP expression from 
pBADrha vector  
For tuneable expression, the pBADrha vector was utilised in the functional growth assay in 
order to finely control protein expression with titratable inducer rhamnose. Additionally, 
this vector does not require the DE3 lysogen, unlike the pET101/D-TOPO vector, and 
therefore permitted the use of a wider variety of strains. A small-scale expression test was 
conducted in BW25113 E. coli cells transformed with empty pBADrha vector or 
pBADMOMPH6 (details on plasmid construction in Section 4.3.2.1 and plasmid map in 
Appendix A2.4) in order to determine the rhamnose concentration at which cell toxicity 
begins to occur due to expression of MOMP. Toxicity was measured by OD600, a monitor of 
cell density. Typically, between 0.002% and 0.2% (w/v) final concentration of rhamnose is 
used with this expression system (Cardona and Valvano, 2005; Ford et al., 2014; Wegerer et 
al., 2008) and, therefore, a broad range of concentrations of 0.002%, 0.02% and 0.2% were 
initially tested in this study. Cell cultures grown in LB were supplemented with rhamnose, 




















As indicated in Table 4.1, in contrast to cultures with the pBADrha vector control, MOMP 
expressing cells appeared to have stopped growing between the two timepoints, and had 
either grown more slowly or begun to die at rhamnose concentrations of 0.02% and 0.2%.  
Additionally, in conditions containing 0.02% and 0.2% rhamnose, cell density was 
considerably lower than that of the lowest rhamnose concentration (0.002%), at below 
OD600 0.9 compared to over OD600 1.3, respectively. Furthermore, in all instances, cell 
density in MOMP expressing cells was lower than the corresponding control cells 
transformed with only the empty vector, with the control cells also impacted by increasing 
rhamnose concentrations. 
In order to compare protein expression, a larger scale expression test was conducted, 
whereby membranes were isolated from induced cells and analysed by SDS-PAGE. The low 
impact of cultures induced with 0.002% rhamnose likely corresponded to low MOMP 
expression, and therefore the two higher rhamnose concentrations (0.02% and 0.1%) were 
selected for protein expression studies. The duration of protein expression also was limited 
to just three hours, due to the cessation of growth observed between five and seven hours 
in the initial trial. At the time of harvesting, both cultures transformed with pBADMOMPH6 
Table 4.1. The effect of rhamnose concentration on cell density. BW25113 E. coli cultures 
transformed with either empty vector pBADrha or pBADMOMPH6 were prepared in 
duplicate, grown in LB supplemented with 34 µg/ml chloramphenicol, and induced with 
rhamnose at an OD600 of ~0.5. Measurements were taken at 5h and 7h post induction and 
averaged. Rhamnose concentration is shown as w/v.  
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had reached an OD600 of 1.2, which suggests that both rhamnose concentrations had a 
similar effect upon cell growth, although the cells transformed with the empty vector 
reached a higher OD600 of 2.00.  
Membranes were isolated as described in Chapter 2 Section 2.2.2.3 and were analysed by 
SDS-PAGE, with both Coomassie blue staining and Western blotting, in order to compare 
MOMP expression. MOMP (40 kDa) was rarely discernible using Coomassie blue, due to the 
presence of an E. coli protein (likely OmpF) at the same MW and, therefore Western 
blotting was typically required for visualisation of MOMP, however, Coomassie blue staining 
was useful for comparing total protein levels. This ensured that the normal physiological 
protein expression of the cell was as expected and that samples were appropriately 
standardised for comparison and, therefore, any differences in levels of MOMP could be 
attributed to the recombinant expression conditions. In Figure 4.3A, a faint band for MOMP, 
identified through its absence in the pBADrha control samples, is indicated by the arrow just 
above the 40 kDa MW marker. The Western blot in Figure 4.3B confirmed MOMP 
expression in these samples and it was evident that actually the lower concentration of 
rhamnose (0.02%, well 5) produced more protein than the higher concentration (0.1%, well 
6), which also corresponds to a faint band with Coomassie blue staining. Consequently, 























































Figure 4.3. SDS-PAGE analysis of pBADMOMPH6 expression induced with 0.1% or 0.02% 
rhamnose. Membranes were isolated from BW25113 E. coli cells expressing either empty 
vector pBADrha or pBADMOMPH6 following the protocol described in Chapter 2 Section 
2.2.2.3 under the same conditions as per Table 4.1, for 3 hours. A) Coomassie blue stained 
gel. The suspected location of MOMP is indicated by the arrow. B) Western blot. For both 
samples, percentages refer to rhamnose concentration (w/v). 1, MW protein standard; 2, 
0.02% pBADrha; 3, 0.1% pBADrha; 4, Blank; 5, 0.02% pBADMOMPH6; 6, 0.1% 
pBADMOMPH6. MOMP was detected with 1/10,000 anti-his HRP conjugated antibody. 
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4.4.2 Brij-58 toxicity is reduced with concentrations below 0.5% (w/v) 
In order to establish the functional assay for fatty acid transport in E. coli (Hearn et al., 
2009), BW25113 wild type and the two isogenic DfadL mutants, named JW2341 7-3 and 8-3, 
were grown with a sole carbon source of sodium palmitate. As fatty acids are insoluble in 
water, due to their hydrophobic carbon chains, supplementation with a detergent such as 
Brij-58 was required. Following the protocol described by Hearn et al in 2009, the strains 
were spotted onto MM plates, containing 5 mM sodium palmitate and 0.5% (w/v) Brij-58. 
Whereas the control cells grown on MM supplemented with 0.4% (w/v) glucose showed 
confluent colony formation, the sodium palmitate plates had spots of translucent agar, as 
shown in Figure 4.4.  
 
Figure 4.4. Initial spot plate assay to assess growth of wild type and fadL knockout E. coli 
strains on MM. A dilution series of wild type BW25113 and JW2341 DfadL cultures (7-3 
and 8-3) were grown overnight in MM with 0.4% (w/v) glucose before being washed and 
plated onto MM plates containing either 0.4% (w/v) glucose or 5 mM sodium palmitate + 
0.5% (w/v) Brij-58. Plates were incubated at 37 °C for 96h. Tenfold dilution factor is given 
along the horizontal axis.  
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As the knockout JW2341 cells, not expected to grow on sodium palmitate, exhibited the 
same spots of translucent agar as the wild type BW25113, it was first hypothesised that the 
Brij-58 (used to solubilise the fatty acid) was provoking a toxic effect on the cell, resulting in 
cell lysis and release of sodium palmitate metabolising enzymes. A quick investigation of this 
revealed that colonies plated onto glucose MM plates, with and without 0.5% (w/v) Brij-58 
grew significantly better without Brij-58 supplementation, suggesting that this detergent 
was indeed detrimental to E. coli growth. To quantify the extent of this effect, a toxicity 
assay was conducted to assess the effect of various concentrations of Brij-58 on BW25113 
growth, measured by optical density, in liquid MM over an eight hour period with a final 
measurement taken following overnight growth. The graph in Figure 4.5 shows the growth 
curve over this period of time. However, further investigation to a lower dilution revealed 
that the cleared region within the opaque sodium palmitate plates was in fact a result of E. 
coli growth and healthy utilisation of the fatty acid, as visualised with individual colony 
formation at lower dilutions. Growth here was unexpected, due to the knockout of 
transporter FadL in the JW2341 strain, hence further testing of Brij-58 toxicity was 























Figure 4.5. Growth curve of BW25113 cells to assess the toxicity of varying concentrations of Brij-58. Liquid MM cultures were 
supplemented with 0 to 1% (w/v) Brij-58 to assess toxicity. Measurements were taken hourly over an 8 hour period. Error bars represent 
standard deviation.   
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It was evident that by eight hours, the cultures containing the highest concentrations of Brij-
58, 0.5% and 1%, were of a much lower density than those of the lower concentrations, 
between 0% and 0.2%. After twenty hours of growth, the OD600 measurement of the 0% 
control was 3.4, the 0.1% and 0.2% samples were 3.1 and 3.00 respectively, with the 0.5% 
and 1% samples, 2.7 and 2.2, respectively. It was clear that inclusion of 0.5% to 1% Brij-58 in 
the culture media reduced growth of BW25113. As Brij-58 was vital for the solubilisation of 
the fatty acids required in this functional study, reduction of the Brij-58 concentration may 
have hindered this solubility. However, experimentation revealed good solubility of 20 mM 
sodium palmitate in a 1% concentration of Brij-58, which allowed continued use of MM 
plates with a final concentration of 5 mM sodium palmitate and just 0.25% (w/v) Brij-58. 
Decreasing the Brij-58 concentration below 0.2% would slightly improve bacterial growth 
and survival, but be detrimental to sodium palmitate solubility and was therefore not used.  
4.4.3 Confirmation of suitable knockout E. coli strains 
Prior to optimising the spot plate growth assay, it was first necessary to monitor the growth 
of wild type BW25113 and the two knockout JW2341 DfadL strains on different carbon 
sources, before complementation with MOMP and FadL, to confirm that the physiological 
behaviour of the cells was as expected. As described in Section 4.4.2 and shown in Figure 
4.4 the initial spot plate showed plaque-like areas of sodium palmitate metabolism, 
assumed to result from the toxic effect of Brij-58. An additional unconfirmed knockout 
mutant was sourced, also lacking the fadR fatty acid metabolism regulator protein gene in 
addition to fadL, which was called BW25113 DfadL DfadR (van den Berg, unpublished) for 
use in this assay. As this newly acquired knockout mutant was uncharacterised, it was 
important to confirm the expected mutations with preliminary spot plate testing.  
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After decreasing the Brij-58 concentration to a more tolerable level of 0.25%, cells were 
spotted to a lower dilution of 10-7 (equating to ~<4 cells per 5µl spot) in order to identify 
single colonies (Figure 4.6A), as the initial glucose control plates only demonstrated 
confluent growth in the spotted areas (Figure 4.4). As previously described in Section 4.4.2, 
it appeared that the plaque-like areas observed on the sodium palmitate plates in Figure 4.4 
were in fact due to confluent growth, due to the appearance of colonies at dilutions below 
10-5 for both wild type BW25113 and knockout mutant JW2341 in Figure 4.6B. As the 
BW25113 knockout mutant showed comparable growth to the wild type strain on glucose 
plates, and no growth on sodium palmitate, as expected, this strain was taken forward for 
complementation with MOMP and FadL. Additional spot plates on MM, MM + 0.25% Brij-
58, and MM + 0.02% rhamnose showed no growth for either strain, indicating that neither 
Brij-58, required for fatty acid solubilisation, or rhamnose, used for induction, were utilised 














Figure 4.6. The BW25113 knockout strain was not able to grow on palmitate plates, as 
expected. A dilution series, down to 10-7, was prepared for cells grown overnight in MM 
and spotted onto MM plates, containing either A, 0.4% (w/v) glucose or B, 5 mM sodium 
palmitate + 0.25% (w/v) Brij-58. Plates were incubated at 37 °C for 96h. Dilution is given 
in the centre. Individual colonies can be observed at the lower dilutions. 
 154 
4.4.4 FadL complementation as a positive control 
As the BW25113 knockout strain contained the same antibiotic resistance marker 
(chloramphenicol) as the pBADMOMPH6 plasmid, an ampicillin resistance marker was 
introduced into the pBADrha vector to permit selectivity of the knockout strain transformed 
with pBADMOMPH6. This new plasmid was called pBADaMOMPH6. Additionally, the fadL 
gene from BW25113 wild type E. coli was amplified from genomic DNA and also inserted 
into the new pBADa vector and named pBADaFadL. Complementation of the knockout 
BW25113 cells with the pBADaFadL plasmid was intended to serve as a positive control for 
this transport assay, by reintroducing the gene encoding the knocked-out transporter 
protein, FadL. As performed previously, spot plates were set up from transformed cells 
cultured in MM. Both uninduced overnight cultures and cultures induced for three hours 
were spot plated onto sodium palmitate plates with either +/- rhamnose (0.02% w/v), in 
addition to the control glycerol plates. Glycerol was used as a carbon source in control 
plates for strains transformed with FadL or MOMP in order to prevent catabolite repression. 
However, knockout BW25113 cells transformed with pBADaFadL failed to grow under any 
conditions, except with glycerol as a carbon source (data not shown). As the knockout genes 
of this strain were unconfirmed, it is possible that other detrimental effects were 
unintentionally introduced. Consequently, a new knockout strain was acquired, named 
LS6164, again with DfadL DfadR knockouts (Ginsburgh et al., 1984). As this was a newly 
acquired strain originating from K12, optimal rhamnose concentration testing was repeated 
to confirm the optimum rhamnose concentration for minimisation of toxicity and 
optimisation of expression. The growth curve in Figure 4.7 shows the results whereby only 
cultures without any rhamnose (dark blue, LS6164 control; orange, LS6164 pBADaMOMP) 
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Figure 4.7. Growth curve of LS6164 E. coli cells induced with increasing concentrations of rhamnose. Liquid LB cultures were induced, in triplicate, with 
0% to 0.02% (w/v) rhamnose upon reaching an OD600 of approximately 0.5 (red line). Cultures were then grown for an additional 6h, with OD600 

















Growth curve of pBADaMOMP in LS6164 E. coli cells after induction with rhamnose
LS6164 LS6164 pBADaMOMP 0% LS6164 pBADaMOMP 0.005% LS6164 pBADaMOMP 0.01% LS6164 pBADaMOMP 0.02%
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Samples of whole cells harvested during growth at one, three, and five hours post induction, 
were pelleted, solubilised in SDS-PAGE sample buffer, and analysed by Western blotting for 
protein expression (Figure 4.8, loading control Appendix 4 Figure A4.1). The strongest 
reaction for MOMPH6 was identified in well 13, corresponding to a rhamnose concentration 
of 0.02% at three hours expression. There was no detectable MOMPH6 with 0% or 0.005% 
(w/v) rhamnose. As decreasing the rhamnose concentration did not improve cell growth, as 
indicated in Figure 4.7, all future experiments using the LS6164 knockout strain were 
induced with a concentration of 0.02% rhamnose, where applicable.  
 
Following additional rhamnose testing for the new knockout strain, a number of conditions 
for the MM plates were assessed including non-induced, induced for three hours, and 
induced with spotting onto rhamnose supplemented plates for wildtype BW25133, 
knockout LS6164, and LS6164 complemented with pBADaFadL, the results of which are 
Figure 4.8. Western blot of whole LS6164 knockout cells expressing pBADaMOMPH6. 
Cultures were grown as described in Figure 4.7 and induced with a range of rhamnose 
concentrations (given as percentage w/v). Whole cells were harvested after 1h, 3h, and 5h. 
1, MW marker; 2, LS6164 control cells; 3, 0% 1h; 4, 0% 3h; 5, 0% 5h; 6, 0.005% 1h; 7, 
0.005% 3h; 8, 0.005% 5h; 9, 0.01% 1h; 10, 0.01% 3h; 11, 0.01% 5h; 12, 0.02% 1h; 13, 0.02% 
3h; 14, 0.02% 5h. Samples 3-14 were all transformed with the pBADaMOMPH6 construct. 
MOMP was detected with 1/10,000 anti-his HRP conjugated antibody. 
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shown in Figure 4.9. As the pBAD promoter is under catabolite repression, as previously 
mentioned, glucose was substituted with glycerol in order to permit induction of FadL 








Palmitate + rhamnose 
InducedNot induced
PalmitateGlycerol + rhamnose 
Not induced
A B C D
10-310-210-1101 10-310-210-1101 10-310-210-1101 10-310-210-1101
Figure 4.9. Spot plate assay demonstrating successful complementation with FadL in comparison to wildtype and LS6164 knockout cells. A, 
0.4% (v/v) glycerol plates containing rhamnose, B and C, 5 mM palmitate plates, and D, 5 mM palmitate plates containing rhamnose. Dilutions 
from 101 to 10-3 were spotted on a range of MM plates. Induced cells were sub-cultured from overnight cultures and grown to an OD600 of 0.5 
before induction with 0.02% (w/v) rhamnose for 3h at 25 °C. Uninduced cells were sub-cultured and grown at 37 °C for the same duration. 
Sodium palmitate was solubilised with 0.25% (w/v) Brij-58, as before.   
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From these results it is evident that the new LS6164 mutant cannot transport palmitate but 
is able to grow with glycerol (Figure 4.9A), as expected. Complementation of this knockout 
with pBADaFadL showed that the knockout strain was then able to resume transport of 
palmitate in both induced and non-induced cells, as indicated by translucent spots in Figure 
4.9B and 4.9C. However, it is apparent that rhamnose supplemented into the MM plates 
prevented growth of pBADaFadL transformed knockout cells, as indicated by the lack of 
colonies in Figure 4.9D. There appeared to be fewer colonies of these cells in the rhamnose 
containing glycerol plate (Figure 4.9A), at dilutions below 10-2, in comparison to the LS6164 
knockout cells. It was evident that plates supplemented with rhamnose were detrimental to 
the growth of cells transformed with pBADaFadL as well as wild type BW25113 cells and, 
therefore, in all future experiments rhamnose was omitted from MM plates.  
4.4.5 Complementation with MOMP did not demonstrate cell growth on palmitate 
or oleate 
After successful confirmation of the assay with the FadL positive control, pBADaMOMPH6 
was transformed into the knockout strain to determine if MOMP was capable of 
transporting sodium palmitate or sodium oleate. Cells expressing FadL grew under all 
conditions, as shown in Figure 4.10A, confirming the robustness of the assay. However, for 
cells expressing MOMP, colonies failed to form at any dilution (Figure 4.10B). As for the 
positive control, this experiment was repeated at two induction times of 1.5h and 3h, and 
with rhamnose induction at a lower concentration of 0.01% in an attempt to alleviate any 
potential over expression or toxicity. However, LS6164 cells expressing MOMP were still 











































Figure 4.10. Complementation with MOMP does not permit cell growth on palmitate or oleate. Dilutions from 101 to 10-3 were spotted on a 
range of MM plates; 0.4% (v/v) glycerol, 5 mM palmitate, or 5 mM oleate, with none containing rhamnose. Induced cells were sub-cultured 
from ON cultures and grown to an OD600 of 0.5 before induction with a lower concentration of 0.01% (w/v) rhamnose for 3h at 25 °C. Fatty 
acids were solubilised with 0.25% (w/v) Brij-58, as before.   
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4.4.6 MOMP was located at the outer membrane with fluorescence microscopy 
One hypothesis as to why complementation with MOMP did not permit growth of the 
knockout strain on a fatty acid carbon source was that MOMP was not assembled in the 
outer membrane. To determine the cellular location of MOMP, pBADaMOMPH6 transformed 
into LS6164 was grown in MM and induced for three hours with 0.02% (w/v) rhamnose to 
replicate the conditions used in the spot plate growth assay. Anti-his Alexa-647 was used to 
label his-tagged MOMP before imaging with epifluorescence and STORM, two techniques 
described in Chapter 5. OmpA, a major protein of the E. coli outer membrane, was also 
fluorescently labelled with secondary antibody Alexa-488, as prepared in Chapter 2 Section 
2.2.5.5 for TIRF microscopy. The results are shown in Figure 4.11. OmpA (Figure 4.11A) is 
visualised as a distinctive and characteristic ring around the perimeter of the cell with 
epifluorescence imaging, and shown in greater detail with STORM, which can achieve 
resolutions of up to 20 nm (Rust et al., 2006). Figure 4.11B shows the MOMP labelled cells. 
Again, the majority of the fluorescent signal was located at the perimeter of the cells, with 
both epifluorescence and STORM imaging. The fluorescent signal observed in the MOMP 
epifluorescence sample does not exhibit the same membrane continuity as OmpA and has 
some denser patches; Chapter 5 is dedicated to further investigation of this observation. 
The brightfield images serve to demonstrate the location and morphology of the cells, but 





















Figure 4.11. Brightfield, epifluorescence and STORM imaging of A, OmpA and B, MOMP 
labelled LS6164 cells. Cells transformed with pBADaMOMP were grown under the same 
conditions used in the spot plate assay and induced for 3h with 0.02% (w/v) rhamnose. 
OmpA was labelled with 1/500 anti-E. coli OmpA polyclonal rabbit primary antibody and 
1/500 Alexa-488 anti-rabbit secondary antibody. MOMP was labelled with 1/100 anti-his 
Alexa-647 conjugated antibody. Data was collected using Octopus at the Central Laser 
Facility, Harwell.  
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4.5 Discussion 
4.5.1 Determining the optimal rhamnose concentration 
The pBADrha expression system is controlled by the titratable inducer rhamnose, which is 
typically used at concentrations between 0.002% and 0.2% (Cardona and Valvano, 2005; 
Ford et al., 2014; Wegerer et al., 2008). Induction with rhamnose is highly dependent on the 
number of rhamnose permeases present in each cell (Rosano and Ceccarelli, 2014) and, 
therefore, a cell with a high number will over-produce the recombinant protein. As 
expression levels are dependent on the strain used, it is imperative that the optimum 
rhamnose concentration for expression of the POI be determined for each new expression 
system. BW25113 E. coli cells were induced during the log phase of growth, at an OD600 of 
approximately 0.5, using three concentrations of rhamnose. MOMP expressing cells had 
lower OD600 values, under all rhamnose concentrations, in comparison to similarly treated 
control cells and also exhibited a marked difference in OD600 at the lowest rhamnose 
concentration of 0.002% compared to both 0.02% and 0.2%. This decrease in growth, 
observed between MOMP expressing cells with higher rhamnose concentrations, was 
indicative of toxic recombinant MOMP expression. Additionally, whilst the control cells 
showed increased cell density, in comparison to those expressing MOMP, there were still 
observable differences between the OD600 readings for control cells induced with different 
rhamnose concentrations, most dramatically after seven hours, with the lowest 
concentration of rhamnose producing the greatest cell density. This suggested that it was 
not only the recombinant protein expression that was toxic to the cells, but also the 
concentration of rhamnose used and, therefore, a balance between the two is required for 
optimal cell growth and protein expression. 
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Based on the observed effects in OD, during medium-scale expression testing, two 
additional concentrations of rhamnose were assessed, 0.02% and 0.1%, selected to 
encourage rMOMP expression whilst limiting rhamnose associated toxicity. The duration of 
protein expression also was limited to just three hours, as opposed to five or seven hours, 
due to the limited increase in OD600 observed between these two time points. In this 
experiment, all four cultures reached an OD600 of ~0.5 at the same time, although the OD600 
values of the control cells at the time of harvesting were higher than those expressing 
MOMP, which again confirmed the toxicity of MOMP in this cell strain. Membranes from 
this medium-scale expression test were prepared and analysed with both Coomassie blue 
staining and Western blotting, where it was clear that the lower rhamnose concentration of 
0.02% produced a higher quantity of rMOMP. Solely based on the OD600 readings taken at 
the time of harvesting, which did not differ significantly, it appeared that the level of cell 
toxicity caused by MOMP expression was equal in both cultures. However, as OD is really a 
measure of turbidity, deceased cells no longer growing or expressing protein may still result 
in a similar OD value to those that expressed protein more slowly, as is likely with the lower 
rhamnose concentration in this case. Under the higher rhamnose concentration, it was likely 
that rapid over production of toxic MOMP resulted in premature cell death and, hence, 
lower overall expression levels. Some cells may only have a small number of the required 
permease and, therefore, produce considerably less protein whilst also maintaining healthy 
cell growth and subsequently more sustained expression. Therefore, it is imperative that for 
each recombinant protein expression system, the rhamnose concentration is tested in order 
to identify optimal conditions. As a result of these optimisation experiments, for this 
expression system, BW25113 cells containing the pBADMOMPH6 construct were induced 
with a rhamnose concentration of 0.02% (w/v) for optimum protein yield.  
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4.5.2 Brij-58 toxicity assay 
Prior to complementation with FadL and MOMP, it was imperative that both the wild type 
and knockout E. coli strains were exhibiting the expected growth; the ability to grow on 
glucose/glycerol and LCFA carbon sources, or solely glucose/glycerol, respectively. Sodium 
palmitate, solubilised with detergent Brij-58, was used to characterise growth behaviour 
due to previously confirmed reports of E. coli growth with this LCFA (Hearn et al., 2009). The 
sodium salt of each LCFA was used (as opposed to the free fatty acid form) in order to 
improve solubility; polarity is reduced by replacement of the hydrogen in the carboxyl tail 
with a sodium ion, although detergent Brij-58 also was still required to solubilise the LCFAs 
to the desired concentration.  
A dilution series for each strain was created and spotted onto MM plates containing either 
carbon source. As expected, both the wildtype BW25113 strain and the isogenic fadL 
knockouts JW2341 7-3 and 8-3 grew with glucose. However, each dilution of the strains 
spotted onto the palmitate plate showed a region of translucent agar. Upon solidification, 
palmitate supplemented plates were opaque, as opposed to translucent MM plates 
containing glucose, which suggested that the appearance of translucent spots in the 
palmitate test was due to palmitate utilisation. However, as the JW2341 knockout strain 
lacked fadL, the gene required to transcribe the fatty acid transporter FadL which has been 
shown to uptake palmitate, it could be hypothesised that the Brij-58 used to solubilise 
palmitate produced a toxic effect on the cell. This toxicity may have perturbed the cellular 
membrane, resulting in cell lysis and release of fatty acid metabolising enzymes, such as 
FadE, FadB, and FadA. Alternatively, being a detergent, it is possible that excess Brij-58 (not 
required for palmitate solubilisation) was permeabilising the membrane, permitting the 
LCFA direct access to the periplasm and FadD within the inner membrane. An investigation 
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into the potential toxicity of Brij-58 was conducted on MM glucose plates with and without 
0.5% (w/v) Brij-58, in which colonies grew significantly better (more numerous and larger) 
without the presence of Brij-58. To further examine this effect, a toxicity assay was 
employed to determine the effect of varying Brij-58 concentrations on cell growth. From 
growth of wild type cells over an eight hour period, it was evident that concentrations over 
0.5% (w/v) produced a detrimental effect on growth. It was only after five hours of growth 
that the effects of Brij-58 became apparent, likely due to the slow growth rate already 
associated with MM. Cultures containing Brij-58 at 0.1% and 0.2% experienced a lag in 
growth around seven hours, but recovered within the following hour to an OD600 value 
comparable to the control cells not supplemented with Brij-58. This suggested that, at low 
concentrations, cells were able to overcome the potentially toxic effect of Brij-58. As Brij-58 
was essential for fatty acid solubilisation, a trade-off between optimising solubility and 
limiting toxicity was required. It was established that a final concentration of 0.25% Brij-58 
still permitted suitable solubilisation of 5 mM palmitate required for the growth assay, 
whilst limiting the associated cell toxicity.  
4.5.3 Confirmation of E. coli knockout strains 
Following the appearance of plaque-like regions in the palmitate plates, assumed to arise 
from Brij-58 toxicity, an additional mutant strain was acquired. This new mutant strain also 
contained a knockout for the fadR gene, called BW25113 ΔfadL ΔfadR. The fadR gene 
encodes the fatty acid metabolism regulator protein, FadR, which partially represses FadL 
expression through binding of the operon, as previously discussed (Section 4.1.2). It was 
hypothesised that this fadR knockout also may be required in order to encourage growth on 
LCFAs as a carbon source by release of the repression on FadL expression. Following Brij-58 
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toxicity assays, this new mutant, in addition to the isogenic JW2341 mutants, were 
examined on glucose and palmitate plates to determine their growth behaviour. Cultures 
also were plated to a lower dilution of 10-7 in order to identify individual colonies. As 
expected, all strains grew with glucose as a carbon source, with no adverse effects observed 
with knockout mutants in comparison to the wild type, with individual colonies visible at a 
10-6 dilution. However, the spots of translucent agar were still present in both the BW25113 
and JW2341 strains, but not the new double knockout strain BW25113 ΔfadL ΔfadR. At the 
lower dilutions, namely 10-5 and 10-6, it appeared that the translucent regions present in 
BW25113 and JW2341 spots were in fact due to colony formation and palmitate utilisation, 
as opposed to cell lysis or membrane disruption, as previously hypothesised. It was not 
anticipated that the JW2341 knockout strain would be able to grow on palmitate, due to the 
lack of fatty acid transporter protein FadL, however, due to the lack of growth observed 
with the double mutant BW25113 DfadL DfadR under the same conditions, it was 
hypothesised that knockout of both the fadL and fadR genes was essential for the 
prevention of fatty acid uptake. However, as FadR is a repressor, and no other LCFA 
transporter has been identified in E. coli, it was more likely that the JW2341 knockout was 
not correctly characterised, and perhaps only possessed a partial fadL mutant as opposed to 
a knockout. Both the wildtype and mutant BW25113 cells also were spotted onto plain MM, 
Brij-58, and rhamnose plates to determine if either of the strains were able to utilise the 
additional components of the assay as carbon sources. Whilst the BW25113 knockout strain 
mutations had not been formally characterised, its growth behaviour in the screens 
indicated that it was unable to utilise LCFAs or any other component in the plates as a 
carbon source, an essential trait for this functional assay and, therefore, this strain was 
taken forward for complementation with FadL.  
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To confirm the sustained knockout of the two genes, the mutant BW25113 strain contained 
two antibiotic resistance markers; chloramphenicol and kanamycin. The pBADrha vector 
expressing MOMP, which was to be complemented with this knockout strain in later 
experiments, also contained a chloramphenicol resistance marker and, therefore, it would 
not have been possible to select for successfully transformed cells. Instead, an ampicillin 
gene was inserted into the pBADrha vector. Within this vector, a fragmented ampicillin 
resistance gene was discovered and, therefore, the terminal ends of this region were used 
to insert the whole gene. In doing so, no other components within the vector were 
disturbed and newly transformed In-Fusion products were able to grow in the presence of 
ampicillin, confirming the correct insertion.   
For the complementation control, the fadL gene was obtained from wildtype BW25113 
genomic DNA and inserted into the newly created ampicillin resistant pBADa vector. It was 
anticipated that complementation of the knockout strain with the pBADaFadL construct 
would reinstate LCFA transport and permit growth on palmitate plates. Cells were grown as 
before and induced for three hours before spotting onto palmitate plates with and without 
rhamnose supplementation, to encourage FadL expression in subsequent colonies. 
However, transformed cells only grew in the presence of glycerol, which was used instead of 
glucose to avoid catabolite repression. As FadL is a native E. coli protein, this was 
unexpected as the cells possessed all the necessary mechanisms required for folding and 
export of FadL to the OM. Thus, it was hypothesised that induction with rhamnose resulted 
in over expression of FadL, which then became toxic and prevented growth, and therefore 
uninduced cells were also plated, as it was expected that basal expression would likely 
produce enough protein to observe growth. However, again growth was not observed in 
palmitate plates. As the knockout genes of this strain were unconfirmed, it was possible that 
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an additional detrimental effect was introduced, and therefore a new knockout mutant was 
acquired.  
The new double knockout mutant named LS6164 had been characterised previously 
(Ginsburgh et al., 1984) and used in several studies investigating LCFA transport (Kumar and 
Black, 1993; van den Berg, 2004; Hearn et al., 2009), but again was plated on glycerol and 
palmitate plates to confirm the expected growth patterns. Originating from K12, it was 
necessary to repeat rhamnose concentration testing again, due to potentially different 
permease levels within the cytoplasm. This was first investigated using a growth curve, as 
before, (described in Section 4.4.4) whereby lower concentrations were tested due to the 
toxicity observed previously with concentrations over 0.1%. Transformed cells, not induced, 
grew at a slightly lower rate than control LS6164 cells, suggesting that some basal 
expression was occurring. Rhamnose concentrations of 0.05%, 0.01%, and 0.02% all grew in 
a similar manner, with no increase in OD600 observed after six hours, suggesting that MOMP 
expression was toxic to cell growth. As a quick measure of protein expression, whole cells 
were pelleted one, three, and five hours post induction for each rhamnose concentration, 
which were then analysed via Western blotting. As membranes were not extracted and only 
a small volume of cells were pelleted, only faint bands corresponding to MOMP were 
observed (see Figure 4.8). No detectable protein was expressed at below 0.005% rhamnose, 
with samples induced with 0.02% rhamnose harvested after three hours producing the 
strongest band, as before. Therefore, for this strain the same rhamnose concentration was 
used as before.  
Upon acquisition of the more robust double knockout mutant LS6164, pBADaFadL 
complementation again was evaluated with both non-induced cells and cells induced for 
three hours, with the latter also spotted onto rhamnose supplemented palmitate plates to 
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encourage FadL expression in second generation cells. Complementation with pBADaFadL 
reinstated the cells’ ability to transport LCFAs in all instances, except where rhamnose was 
included within the plate. In this case, even wild type cells struggled to grow, indicative of 
rhamnose associated toxicity, the effect of which was likely enhanced in cells that also were 
induced, indicating why no growth was observed in this plate for complemented cells. The 
success of pBADaFadL complementation with LS6164, along with the strain’s inability to 
grow with palmitate as a carbon source, provided a robust assay for assessing the ability of 
MOMP to transport LCFAs. 
4.5.4 MOMP complementation to assess LCFA transport  
Following successful development of the functional assay with the control protein, FadL, 
pBADaMOMPH6 was transformed into knockout LS6164 strain and examined for growth with 
fatty acids palmitate and oleate. In the first instance, transformed cells were not induced, 
instead permitting basal expression to occur to allow low levels of MOMP expression, 
unlikely to result in overloading of the OM. However, colonies did not form under these 
conditions, nor in cultures induced for varying durations, nor at a lower rhamnose 
concentration, again to limit expression levels and prevent toxicity.  
Previous SRCD experiments on purified MOMP indicated an increase in thermal stability in 
the presence of both LCFAs oleate and palmitate (Atanu, 2014). However, this functional 
growth assay suggested that MOMP was unable to transport these ligands to support E. coli 
growth. It is therefore possible that instead of binding to the hatch domain (the external 
loop predicted to guide substrate entry) in preparation for transport, these two ligands 
were solely attracted to and interacting with the hydrophobic regions of MOMP’s structure, 
resulting in the increase in stability, as seen in an increase in Tm.   
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One of the most important considerations for success of the growth assay was in the correct 
folding and export of rMOMP to the E. coli OM in order for fatty acids to be potentially 
transported and delivered to FadD at the inner membrane. Previously, C41 (DE3) E. coli cells 
transformed with pETMOMPH6 successfully expressed rMOMP in the membrane, as shown 
through both the purification procedure (Chapter 3), whereby a sarkosyl isolation step 
indicated that the majority of MOMP was found in the insoluble outer membrane fraction, 
and STORM imaging (Chapter 5), which revealed fluorescence localisation to the external 
perimeter of the cell. Therefore, this expression system also was analysed with super-
resolution STORM to visualise the cellular location of rMOMP. From comparison with the 
control E. coli protein OmpA, it was apparent that rMOMP was localised at the membrane 
region of the cell, as opposed to within the cytoplasm as inclusion bodies, which would 
present as fluorescence in the central region of the cell. Previous research using electron 
microscopy determined the width of the periplasmic space in Gram negative bacteria to be 
between 13-25 nm (Seltmann and Holst, 2002) and, as the maximum resolving power of 
STORM is 20 nm, it was not possible to resolve the difference between fluorescently 
labelled inner and outer membranes (data not published). However, MOMP does not 
possess the appropriate hydrophobic α-helices required for IM insertion (Schulz, 2002), with 
less than 5% of native MOMP’s secondary structure content attributed to helices, as 
analysed with CD (Sun et al., 2007). As a result, if MOMP was incorrectly folded and unable 
to complete export to the OM, it would be present within the cytoplasm as inclusion bodies 
and not identifiable at the membranous region of the cell. A low concentration of detergent 
Triton X-100 was used during sample preparation, in order to permeabilise the outer 
membrane and permit access of the fluorophore to the internally exposed his-tag. Due to 
such permeabilisation, any MOMP expressed within the cytoplasm would also be amenable 
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to labelling, although this was not observed. The absence of cytoplasmic inclusion bodies, in 
addition to the membrane localisation observed using STORM, strongly suggests that 
MOMP was located at the OM region of the LS6164 cells. Additionally, it must be noted that 
whilst expressed at the membrane, MOMP does not display homogeneous dispersion as 
seen in OmpA. It has been hypothesised that MOMP forms clusters within the E. coli 
membrane due to the large number of cysteine residues available for intermolecular 
disulphide bonding; this is investigated in greater detail in Chapter 5.  
Biotinylation, commonly used in protein purification, has been used to label surface 
exposed loops of OM proteins (Voss and Cover, 2015), along with trypsin digestion of 
insoluble membrane pellets for analysis with mass spectrometry (MS) (Mirza et al., 2007) 
and MAb binding assays (Baehr et al., 1988). The low specificity of trypsin and the high cost 
associated with the production of MAbs has highlighted biotinylation as an alternative 
method to STORM imaging for confirmation of MOMP’s insertion into the OM. Previously, 
biotin was deemed membrane permeable and required supplementation with 
oligosaccharides, such as stachyose, in order to limit the reaction to the bacterial membrane 
(Myers-Morales et al., 2007), which is explicitly required in this research to confirm MOMP’s 
external exposure. However, more recently, negatively charged and water soluble long-
chain reagents such as Sulfo-NHS-LC-LC-Biotin (ThermoFisher) have been developed for cell 
surface labelling. Due to the large number of cysteines in MOMP, it is possible that these 
residues could be used as biotinylation targets, namely towards C52, C56, and C226 located 
near the top of the barrel (based on the low resolution structure shown in Chapter 1 Figure 
1.8), which are the most likely residues to be externally exposed. Alternatively, biotinylation 
could be targeted towards free lysine residues, such as K161 located within the external 
loop region of MOMP. However, whilst residue specific, these interactions are not protein 
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specific and, therefore, any array of lysine or cysteine containing E. coli proteins would also 
become labelled with biotin. Extraction of membranes for Western blotting, as previously 
conducted in this research, would identify biotinylated proteins through labelling with 
streptavidin HRP conjugated antibody. However, it would be essential to include a 
biotinylated E. coli control sample, not containing MOMP, in order to identify any ~40 kDa 
proteins, such as OmpA (37 kDa), OmpN (39 Kda), OmpC (38 kDa) or HofQ (42 kDa) (Molloy 
et al., 2000), any of which also may become biotinylated and thus mask observation of 
MOMP. Should such a protein be detected within the control at this location, the band 
within the test sample would require excision and analysis with MS in order to identify 
MOMP. Whilst MOMP is cysteine rich, due to Chlamydia’s unique biology, it has been 
hypothesised that many of these residues form intermolecular disulphide bonds and, 
therefore, would not be freely available for biotinylation, particularly as the addition of 
reducing agents was not demonstrated to improve MOMP solubilisation (Chapter 3). As it is 
unknown which cysteine residues form these interactions and therefore which would be 
available for biotinylation, in addition to the high likelihood of E. coli protein contaminant 
detection through lysine targeted biotinylation, this method was not adopted, with STORM 
imaging favoured. A higher resolution structure characterising the residues situated within 
the external loop regions, not previously modelled into the 4 Å structural data due to poor 
density in this region (Chapter 1 Section 1.6.5), would facilitate the design of an antipeptide 




Since the super-resolution STORM images indicated that MOMP was likely correctly inserted 
into the OM, based on the functional assay it appeared that the recombinant MOMP 
expressed from the pBAD vector was unable to transport LCFAs palmitate and oleate, 
evidenced through lack of growth with these substrates as a sole carbon source. 
Alternatively, it is possible that MOMP either requires a partner protein in order to initiate 
the conformational change required within the plug domain (for binding and transport) in 
the absence of a lateral hole, or that MOMP is able to transport the LCFAs but is then 
unable to communicate with FadD, the E. coli protein required for inner membrane 
transport, leaving the carbon source trapped within the periplasmic space and inaccessible 
to the cytoplasmic β-oxidation proteins. It may be possible to test this hypothesis through 
fluorescent labelling of substrates, however, due to both the difficulties associated with 
distinguishing the inner and outer membranes with fluorescent microscopy, as well as the 
requirement for complex three-colour imaging, this method is likely to remain unfeasible 
until higher resolutions are achievable.  
It has been demonstrated that Chlamydia is able to scavenge host-derived fatty acids such 
as oleic acid and palmitic acid (Yao, Cherian et al., 2015), most likely in order to limit the 
energy expenditure in intensive pathways such as phospholipid synthesis. As Chlamydial 
LOS is a truncated form of LPS (Rund et al., 1999), it may be possible for the LCFAs to ‘flip-
flop’ across the outer membrane due to a reduced lipid barrier, however, it is also possible 
that a transport protein is involved in translocation of host derived fatty acids from the 
inclusion lumen to the OM and perhaps has a role in MOMP transport activation. MOMP’s 
role in LCFA uptake could be investigated in Chlamydia, in a similar fashion to previous 
studies used to investigate uptake of radiolabelled host-derived LCFAs in E. coli (Lepore et 
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al., 2011), whereby mutations introduced into the lumen of MOMP’s β-barrel to encourage 
a water-filled pore, as observed in E. coli’s OmpF, would restrict the potential transport of 
hydrophobic substrates such as LCFAs. 
Given the increase in expression of MOMP during the EB stage of the Chlamydial lifecycle 
(Roulis et al., 2013), in addition to the high number of cysteine residues, it is possible that 
MOMP’s sole role is in providing structural stability within the COMC, although some typical 
porin activity has previously been reported (Jones et al., 2000; Sun et al., 2007). However, 
whilst down regulated in RBs, MOMP is still expressed during this metabolically active stage 
which is suggestive of a transport role. Additionally, it has been hypothesised that a number 
of the COMC proteins exhibit additional functions, such as porin PorB and the Pmps as 
adhesins, which also suggests that MOMP may have a dual function. Based on our current 
low resolution structure of MOMP, suggesting the occluded region at the periplasmic side of 
the lumen (Chapter 1 Section 1.6.5), it is highly likely that any ligand transport will require 
conformation changes in the plug to permit passage.  Developing a greater understanding of 
both Chlamydial biology and MOMP’s structure will provide further insight into the role of 













































5 Analysis of MOMP’s clustering behaviour using fluorescence microscopy 
5.1 Introduction 
As discussed in Chapter 1 Section 1.4, all species of Chlamydia possess a COMC in order to 
compensate for the lack of PG between the inner and outer membranes in EBs. As MOMP is 
both cysteine rich and the most abundant of the 17 proteins recently identified in the COMC 
(Chapter 1 Table 1.1), it is likely to play a significant role in intermolecular disulphide bond 
formation. The lack of high resolution structural data for any of these OMPs makes mapping 
the potential interactions extremely difficult, and as a result there is currently a paucity of 
knowledge in this area. Whilst bioinformatics analysis of each of the 17 proteins could be 
pursued, homology modelling for each protein would not only be extremely time 
consuming, but also any slight variation from the true structure could adversely alter the 
position of vital cysteine residues, resulting in miscalculations with regard to the significance 
of any particular residues.  
Aside from the two published homology models for MOMP (Atanu et al., 2013; Feher et al., 
2013), only one other COMC protein homology model exists, which is for PorB 
(Pourhajibagher and Bahador, 2016), further highlighting the difficulty in producing reliable 
models for these proteins. Additionally, as mentioned previously, the two homology models 
for MOMP were produced in the same year and therefore both groups of researchers were 
likely to have access to the same or similar software. Despite this, the two models still 
demonstrate significant variability, with one suggesting a 14-stranded β-barrel (Atanu et al., 
2013) and the other a barrel of 16-strands (Feher et al., 2013), which in turn would predict 
entirely different locations for the nine cysteine residues. However, these two models are 
based on C. pneumoniae and C. trachomatis MOMP, respectively and this, therefore, may 
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account for the differences observed. However, until high resolution crystal structures 
emerge for each COMC protein, homology modelling using a variety of techniques is likely 
the most promising in silico method for the identification of cysteine rich regions within the 
barrel, which can then be rationally targeted in mutagenesis experiments.     
Some experimental research has been conducted for C. trachomatis MOMP, in an effort to 
identify the cysteine residues likely to be involved in disulphide bonding, however, these 
reports appear to be conflicting. One group has predicted that cysteine pairs C48-C55 
(corresponding to C49-C56 in C. pneumoniae MOMP, as analysed with BLAST) and C201-
C203 form intramolecular disulphide bonds, leaving the remaining cysteines free and 
available for intermolecular disulphide bonding (Yen et al., 2005). The following year, 
however, a different group also investigating C. trachomatis MOMP inferred that C26-C337 
and C116-C208 (corresponding to C49-C353 and C136-C226 in C. pneumoniae MOMP, 
respectively) were forming intramolecular disulphide bonds (Wang et al., 2006). It seems 
highly unlikely that residues C201-C203 would form an intramolecular disulphide bond due 
to their close proximity and likely positioning on the same β-strand, which would not serve 
to enhance the stability of the barrel and, therefore, form a redundant interaction. 
Additionally, intramolecular disulphide bonding between C136 and C226 also seems 
improbable due to their location on opposite sides of the β-barrel, according to our low-
resolution C. pneumoniae rMOMP crystal structure, although, a potential (albeit significant) 
frame shift of the β-strands could make this sterically feasible. The method employed in 
both studies involved trypsin digestion of MOMP and analysis of the fragments using mass 
spectrometry. Through the creation of fragments, it is feasible that cysteine residues 
previously not sterically available for intramolecular disulphide bonding (when localised in 
the β-barrel) then became exposed to one another. As a result of these apparent 
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discrepancies and as the method used for analysis of potential disulphide formation is 
questionable, and the research was not conducted on C. pneumoniae MOMP, these results 
did not heavily influence the choice of cysteine mutants selected in this study.  
A low-resolution crystal structure of 4 Å, found using molecular replacement with the 14-
stranded MOMP homology model (Atanu et al., 2013), which although incomplete (with the 
absence of the external loop region), contains all nine cysteine residues allowing more 
astute predictions to be made on the potential residues involved in intermolecular 
disulphide bonding between other MOMPs. Due to the high number of cysteine rich 
proteins contributing to the COMC, which between them contain 194 cysteine residues, it 
would be an extremely energy intensive process to locate the specific and desired cysteine 
residue for each protein amongst the milieu of proteins inside the periplasm that are 
awaiting oxidation and export to the OM. Additionally, the mechanism by which disulphide 
bonds are formed in Chlamydia has yet to be established and, so far, only one enzyme, the 
oxidoreductase DsbH, has been characterised (Mac et al., 2008). As the exact interactions 
between the proteins comprising the COMC (as shown in Chapter 1 Table 1.1) have not yet 
been established, predictions made, based on relative protein abundance, can be useful in 
deciphering the likely interacting proteins. Due to the lack of information regarding the 
COMC, a novel hypothesis is herein proposed whereby COMC proteins possess cysteine rich 
regions or ‘pockets’ that act as general target regions for intermolecular disulphide bond 
formation. As MOMP is the most abundant of the COMC proteins, it seems highly likely that 
much of MOMP’s intermolecular disulphide bonding will occur with other MOMPs, with 
some cross linking to additional COMC proteins likely in order to form a complete network 
within the protein mesh. Therefore, in this chapter the hypothesis that rMOMP expressed in 
E. coli will display different OM localisations, depending on the cysteine residues present, 
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will be investigated through fluorescence microscopy. In native MOMP, it is expected that 
clusters will form due to intermolecular disulphide bonding, as opposed to cysteine mutated 
MOMP which will disrupt disulphide bonding and result in a more homogenous dispersion. 
Molecular dynamics simulations in conjunction with the low resolution crystal structure will 
be used to guide cysteine mutant design.  
5.1.1 Molecular dynamics simulations 
Molecular dynamics (MD) is a computer simulation technique developed in the 1970s 
utilised to assess the behaviour of biological molecules under certain conditions (Hospital et 
al., 2015). Since then, due to the advancement of both computers and key algorithms, 
calculations have dramatically improved from simulations of just ~300 atoms to well over 
75,000 now, permitting the modelling of large macromolecular complexes and membrane 
proteins within a lipid environment. As only a low resolution 4 Å crystal structure is available 
for C. pneumoniae MOMP, it is possible that a higher resolution structure may reveal 
variations within the side chain orientations, which are most accurately characterised at 
resolutions above 2.5 Å. Due to this, atomistic modelling is inappropriate at this stage as this 
method employs a high level of accuracy, parameterising each atom within the molecule to 
detail the precise dynamic behaviour of the protein and, additionally, is extremely 
computationally expensive. Alternatively, coarse grained (CG) modelling offers a more 
simplistic representation, with 4-5 heavy atoms (excluding hydrogen atoms) grouped 
together as one particle, simplifying the system and greatly reducing the computational 
time and expense required to run a biologically significant (~10 µs) simulation (Bond et al., 
2007). In this instance, MARTINI force-field equations (Marrink et al., 2007), derived from 
thermodynamic data, will be used in order to calculate the particles’ potential energy and 
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group atoms together. As MARTINI has a special focus on lipid parameterisation, the 
behaviour of polar and non-polar environments has been well characterised and, therefore, 
this CG model system is particularly appropriate for simulating membrane proteins within a 
lipid bilayer. 
An asymmetric lipid bilayer consisting of dipalmitoyl phosphatidylethanolamine (DPPE) and 
dioleoylphosphatidylglycerol (DOPG), the chemical and CG structures of which are shown in 
Figure 5.1, will be used in order to mimic the Chlamydial membrane as closely as possible.  
As discussed previously in Chapter 4 Section 4.1.1, C. trachomatis was demonstrated to 
incorporate oleic acid (18:1) into the Chlamydial membrane, as well as lauric (C12:0), 
myristic (C14:0) and palmitic acids (C16:0) derived from the host (Yao, Dodson et al., 2015).  
As the MARTINI lipid database does not explicitly include Chlamydia’s unique, truncated LPS 
(LOS), the two lipids that were selected, based on their chain lengths, are C16:0 for DPPE 
and C18:1 for DOPG, corresponding to both palmitic and oleic acid and to the reported lipid 
chain lengths on LPS, which correspond to chains of C14-16, C18, and C20 (Kosma, 1999) in 




Figure 5.1. Chemical and MARTINI CG structures for A, DPPE and B, DOPG. Four heavy 
atoms, including their respective hydrogens, are incorporated into a CG particle. White 
particles, carbon backbone; black, carbon backbone with double bond; yellow, carboxylic 
acid; pink, phosphate; cyan, amine; and orange, hydroxyl.   
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To create the DPPE/DOPG lipid bilayer, the tool Insane (Wassenaar et al., 2015), an acronym 
for ‘insert membrane’, will be utilised. Insane implements CG lipid templates, such as those 
created by MARTINI, to create simple custom membranes in which membrane proteins can 
be embedded. Insane also allows the protein’s membrane orientation to be shifted based 
on their defined Z location, permitting simulation of partially embedded proteins. The 
default for this system assures that the centre of the protein at Z=0 reflects alignment with 
the membrane, which will be implemented for MOMP modelling. Additionally, Insane is 
used to generate the solvent content of the system, in this instance solely consisting of 
water and sodium ions. The final MD simulation will be run in Gromacs (Abraham et al., 
2015), a highly optimised software package used to simulate the Newton equations of 
motion for a defined system. 
 The aim of these MD simulations is, firstly, to determine if two MOMP crystal structures 
inserted within an asymmetric lipid bilayer at a suitable distance and with multiple 
orientations will associate together after a duration of 10 µs and, secondly, if any 
associations are identified, to characterise the interacting residues and to determine if any 
are due to intermolecular disulphide bonding. It is intended that this in silico analysis will 
provide insight into which cysteine residues are responsible for or are most significant in 
MOMP clustering, which will help guide the planned mutagenesis studies for experimental 
research into MOMP’s behaviour within the E. coli OM. 
5.1.2 Fluorescence Microscopy 
5.1.2.1 Epifluorescence and total internal reflection fluorescence (TIRF) microscopy  
Since its first use, microscopy has been an important tool for the visualisation of 
physiological and morphological changes within cells. With technological advancements 
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come increasingly higher spatial and temporal resolutions, with fluorescence microscopy 
allowing us to selectively follow specific targets, such as proteins (Huang et al., 2009). 
Fluorescence is a property typically associated with aromatic hydrocarbons, also known as 
fluorophores. Fluorescence occurs in a three-step process. Initially, a photon of energy is 
supplied to the fluorophore by a light source, such as a laser, the absorption of which results 
in an excited state. This excited state is short lived, during which the conformation of the 
fluorophore becomes altered and dissipates some energy, before the fluorophore emits a 
photon, returning itself to the ground state. Finally, as some of the energy has been 
dissipated, the emitted light has a longer wavelength, compared to the first stage of the 
absorption; this difference is referred to as the Stokes shift (Sanderson et al., 2014).    
Epifluorescence microscopy is typically perceived as the conventional method for visualising 
fluorophores and is often used to gather preliminary data on fluorophore labelling methods, 
prior to more technically advanced procedures such as confocal microscopy. In 
epifluorescence, the incident light illuminates the entire sample, as shown in Figure 5.2A, 
however, in doing so also captures the out of focus plane leading to a low signal-to-noise 
ratio. Given the high background signal, the limit of resolution is only approximately 200 nm 
and, therefore, two fluorophores within the same cell are extremely unlikely to be spatially 





















As MOMP is situated within the bacterial OM, total internal reflection fluorescence (TIRF) 
microscopy will be used in complement with epifluorescence, due to the high background 
signal associated with the latter. TIRF is a near-field method of illumination, used to visualise 
fluorescently labelled molecules on the outer surface of cells. When a sample is exposed to 
a laser at a critical angle (qC), the differing refractive properties of the glass coverslide and 
the sample in buffer results in complete reflection of this light, which in turn propagates an 
exponentially decaying evanescent wave perpendicular to the coverslide that only 
illuminates the fluorophores situated within 60-100 nm of the glass/sample interface (Yao 
and Carballido-López, 2014). Unlike in epifluorescence, only a portion of the available 
fluorophores are illuminated within one focus plane, as shown in Figure 5.2B. This reduction 
in background fluorescence means that a resolution of at least 100 nm can be achieved with 
A B 
Figure 5.2. A, Epifluorescence and B, TIRF microscopy. Blue region, area of illumination 
within bacterial cell; green circles, excited fluorophores; white circles, non-excited 
fluorophores; black arrows, incident laser angle (q); blue arrows, critical angle (qC). 
Bacteria shown are Bacillus subtilis labelled with green fluorescent protein (GFP). A. In 
epifluorescence mode, q is approximately 0° and the cell is excited equally throughout. B. 
In TIRF mode, where q > qC, the light is completely reflected creating an evanescent wave 
that illuminates molecules close to the cell surface. Adapted from Yao and Carballido-
López, 2014. 
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this method. Whilst TIRF is mainly performed on mammalian cells, it is also possible to 
visualise bacterial cells using this method, such as Bacillus subtilis (Domínguez-Escobar et 
al., 2011) and E. coli (Jovanovic et al., 2014), despite being over ten times smaller at just 2 
µm in length. Possibly due to their small size, methods for bacterial cell preparation for TIRF 
are underrepresented in the literature and, therefore, in this research a new method will be 
developed. TIRF microscopy will be used in this research to obtain preliminary experimental 
data on MOMP’s membrane distribution whilst also optimising the imaging conditions 
including cell number, cell treatments, and fluorescent probe labelling. This knowledge will 
help ensure optimal imaging conditions for a higher resolution technique (see below), with 
the aim to obtain quantitative data for the analysis of MOMP clustering within the E. coli 
OM.  
5.1.2.2 Stochastic optical reconstruction microscopy (STORM) 
In order to acquire not only higher resolution images but also to obtain quantitative data for 
clustering analysis, stochastic optical reconstruction microscopy (STORM) will be adopted. In 
conventional epifluorescence microscopy, it is difficult to localise a large number of 
fluorophores within close proximity, which results in low resolution images. STORM is a 
fluorescent microscopy method based upon single molecule localisation, whereby the use of 
photoswitchable organic fluorophores for labelling is essential (Godin et al., 2014). These 
fluorophores can be controlled with exposure to low intensity light and a reducing agent, 
creating an on/off cycling state, also known as ‘blinking’, whereby, at any given time, only a 
sparse subset of fluorophores are in the on state and, therefore, are not overlapping. 
Collection of a large number of frames, over 15,000, captures the localisation of each 
fluorophore within the sample for which the centroid positions can be calculated and the 
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positions reconstructed into a high-resolution image, as shown in Figure 5.3. As a result, the 
resolution of STORM is not limited by diffraction, but rather the measured localisation 
precision (Bates et al., 2013) and is reported to be as good as 20 nm (Rust et al., 2006). It is 
not uncommon in STORM imaging for the same fluorophore to be present in a number of 
frames due to the on/off cycling times. For example, previously calibrated data for Alexa-
647 shows that this fluorophore remains in the on state for five frames and the off state for 
ten frames (Willson et al., 2016). Therefore, in post imaging analysis such data, known as 
trails, can be grouped according to the fluorophore from calibrated on/off times and known 
capture radii. Concurrent with STORM’s development (Rust et al., 2006), additional research 
groups established photoactivated localisation microscopy (PALM) (Betzig et al., 2006) and 
fluorescence photoactivated localisation microscopy (FPALM) (Hess et al., 2006). All three 





It is anticipated that with super-resolution STORM, valuable quantitative data can be 
obtained for the clustering behaviour of both native and cysteine mutated MOMP within 
Figure 5.3. The principle of STORM. The use of photoactivatable fluorophores in STORM 
means that, at any one point, only a small subset of fluorophores are in the on state at one 
time. Collection of a large number of images of these blinks results in a single molecule 
image. The resolution can be further improved by identifying the centroid location of each 
fluorophore, resulting in a computer rendered super resolution image. (Thorley et al., 2014) 
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the E. coli OM. By determining the cysteine mutants that most significantly disrupt or alter 
MOMP’s membrane localisation, insight can be gained into how MOMP, a major component 
of the Chlamydial COMC, may form these associations, enhancing our knowledge on how 
Chlamydia maintains its structural stability.   
5.1.2.3 Fluorophore labelling methods 
Within MOMP, both the N and C termini are located at the periplasmic side of the outer 
membrane, with the N terminus likely concealed inside the plug region of the β-barrel. 
Therefore, MOMP is labelled with a C-terminal his-tag in the pET vector, which is exposed to 
the periplasm as opposed to the extracellular side and as a result, for fluorescence imaging 
in E. coli, the fluorophore requires access to the internal side of the outer membrane. The 
novel P3NTA tag, used previously for detergent screening with FSEC in Chapter 3 Section 
3.1.2, which binds to the his-tag will be tested as a one-step labelling method in initial 
epifluorescence and TIRF experiments. Additionally, Alexa-647 is currently one of the most 
widely used fluorophores for STORM due to its high photostability, strong fluorescent signal 
and good blinking activity (Dempsey et al., 2011). However, labelling of pETMOMPH6 with 
both the P3NTA tag and anti-his Alexa-647 will require permeabilisation of the outer 
membrane with a low concentration of detergent, such as Triton X-100, which may disturb 
the structural integrity of the membrane.  
In order to overcome this, a construct consisting of the pOPINe-3C-Halo vector containing 
the C. pneumoniae AR39 MOMP gene (Appendix A2.2) was created using the In-Fusion 
method (Chapter 2 Section 2.2.1.6). The Halo-tag is a 33 kDa protein derived from a 
bacterial haloalkane dehalogenase from the Rhodococcus species that covalently and 
irreversibly couples to Halo-tag ligands, such as HaloTag silicon rhodamine (SiR) or HaloTag 
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Alexa-488 (Promega) and permits fluorescent imaging (Los et al., 2008). The highly stable 
covalent bond is achieved through mutation of the His272 residue, located within the active 
site, to a phenylalanine, which prevents the hydrolysis and release of the intermediate ester 
(England et al., 2015). Figure 5.4 displays a simple representation of the HaloTag protein 
bound to the HaloTag ligand. In lieu of a fluorescent ligand, the Halo-tag ligand can also be 
linked to resins for isolation of the protein during purification. Similar to the position of the 
tag within the pETMOMPH6 vector, the HaloTag gene was inserted at the C-terminus of 
MOMP and, therefore, Halo-tagged near-infrared SiR is of particular interest as a 
fluorescent probe, in this case. This is due to SiR’s membrane permeability meaning that 
detergent treatment for permeabilisation of the cell is not required, therefore, preserving 






Figure 5.4. The HaloTag principle. The HaloTag is derived from a haloalkane dehalogenase, 
mutated at residue 272, within the binding region, in order to permit irreversible covalent 
bonding of the HaloTag ligand. The HaloTag ligand can be coupled with a number of 
functional groups for fluorescent imaging or protein immobilisation and purification. 
(England et al., 2015) 
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5.2 Aims and objectives 
E. coli, being a Gram negative bacterium that is easy to transform and grow, is an ideal 
model organism for this research. Not only is C. pneumoniae classed as a category two 
pathogen, but due to its unique biphasic lifecycle the EB cells containing the COMC require 
isolation from the RBs, which in addition to the difficulties acknowledged in mutagenesis 
studies in Chlamydia makes research into natively expressed MOMP extremely challenging. 
With the support of MD simulations to aid identification of the key cysteine residues 
involved in intermolecular disulphide bonding and MOMP clustering, cysteine mutants will 
be designed initially in the pETMOMPH6 construct for analysis with epifluorescence and TIRF. 
These two lower resolution fluorescence microscopy techniques will provide preliminary 
information regarding the sample preparation and imaging conditions and will aim to 
indicate any initial qualitative differences observed between native MOMP and the derived 
cysteine mutants. As the HaloTag-SiR fluorophore is not commercially available and requires 
a time consuming and costly synthesis, the pOPINHaloMOMP mutant constructs will be 
created following initial epifluorescence and TIRF experiments, once the viability of this 
method to explore the clustering hypothesis has been confirmed; that native MOMP forms 
clusters within the E. coli OM and that the cysteine residues likely to be involved in 
disulphide bond formation increase homogenous dispersion. Ultimately, STORM will be 
used to quantitatively compare native and cysteine mutated MOMP in order to determine if 
disruption of intermolecular disulphide bonding occurred. 
Very little is currently understood about the COMC and the interactions that occur between 
the cysteine rich proteins, or even the mechanism Chlamydia employs to form disulphide 
bonds. Therefore, this research aims to provide novel insight into the clustering behaviour 
of MOMP in bacterial cells.  
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5.3 Methods 
The following methods described herein relate specifically to the preparation of super-
resolution microscopy slides, which were not used in data collection. The standard and 
finalised protocols for MD simulations, TIRF, epifluorescence, and STORM microscopy are 
detailed in Chapter 2 Section 2.2.5. 
5.3.1 Fluorescence microscopy  
5.3.1.1 Superfrost microscope slide preparation and immunostaining 
Cells harvested at 1h and 3h, stored in 1.5 ml microcentrifuge tubes, were washed once 
with PBS with centrifugation at 8,000 rpm (3,500 x g) for 3 minutes before being fixed in 1% 
(v/v) formaldehyde-PBS for 30 minutes. Fixed cells were then washed three times with PBS 
and stored overnight at 4 ˚C. On the day of imaging, only the pET constructs were incubated 
with 0.1% (v/v) Triton X-100 for 5 minutes, before all cells were incubated with 100 µg/ml 
lysozyme in PBS for 45 minutes, with wash steps between each treatment. Cells were then 
incubated with either 50 ng/ml HaloTag-SiR fluorescent dye (kindly gifted by the Eggeling 
group at the Weatherall Institute of Molecular Medicine, Oxford) for pOPINHaloMOMP 
constructs or a 1/100 dilution of Alexa-647 anti-his antibody for pETMOMPH6 constructs for 
between 30 minutes to 1h in the dark, before washing three times with PBS. A control 
sample of C41 (DE3) cells were not stained, in order to check for autofluorescence. A 
precleaned 76x26 mm superfrost microscope slide (ThermoScientific) was incubated with 
0.01% (v/v) poly-L-lysine-PBS for 10 minutes before being washed with PBS and left to dry. 
Once dry, cells were attached to the slide for 1h before being washed once with PBS. Cells 
were then post fixed with 2% (v/v) formaldehyde-PBS for 10 minutes, before three washes 
with PBS. 10 ul of 0.1 M DTT was pipetted onto the slide and a 0.17 mm (± 0.005 mm) 
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coverslip (Zeiss) overlaid, which was then sealed with clear nail varnish to prevent 
evaporation.  
5.4 Results 
5.4.1 Molecular dynamics simulations 
5.4.1.1 Initial orientation of MOMP models 
A number of CG simulations were run in parallel to determine the clustering behaviour of 
two MOMP models within a lipid bilayer. Two 4 Å crystal structures were placed a protein 
distance apart, ~42 Å, to limit bias with one model rotated 90° about the Z axis to create 
four initial conformations. Figure 5.5 displays these orientations, with tryptophan 55 (Trp55) 
labelled in red for clarity of orientation, as the low-resolution crystal structure does not 
























5.4.1.2 MD simulation of MOMP in a DPPE/DOPG bilayer 
Following a simulation time of 10 µs, the two MOMP molecules in Figure 5.5B, herein 
referred to as orientation B, migrated to a distance that enabled intermolecular contacts to 
occur between the two molecules, while inserted in the lipid bilayer, as indicated in Figure 
5.6A. The Trp55 residue (red) was selected as a marker due to its proximity to the predicted 
location of the extracellular loop, and as shown in greater clarity in Figure 5.6B it is evident 




Figure 5.5. A-D, the four orientations of the two 4 Å MOMP crystal structure models. The 
MOMP model on the right-hand side remained stationary whilst the other MOMP model 
was rotated 90° about the Z axis to allow multiple faces of the β-barrel to interact. Trp55 is 














5.4.1.3 Analysis of intermolecular interactions between MOMPs from orientation B 
simulation 
An additional script was implemented, in order to characterise the intermolecular 
interactions formed in the MD simulation of orientation B, whereby two cut off values for 
interaction were set, at both 45 Å and 80 Å, in order to ensure that all possible interactions 
were considered. From this, 37 interactions were identified for both cut off values. Figure 
5.7 depicts a graphical representation of these interactions, whereby the most frequently 
interacting residues are indicated by dark red bars, and the most likely interacting pairs by 
dark green blocks. From this graph, the most dominant residues involved in intermolecular 
contacts were as follows; Met85, Asn127, Arg195, Trp199, Thr262, Lys305, Pro318, Ser319, 




Figure 5.6. MD simulation of two MOMP models in a DPPE/DOPG lipid bilayer. A, View of 
the top, extracellular face of the bilayer. The final conformation of orientation B following 
a 10 µs simulation. The distance of ~42 Å between the two MOMP molecules was closed 
and intermolecular interactions formed. Residue Trp55 is also positioned on the external 
face of the bilayer in both MOMP models. B, Cross sectional view of the bilayer. Insertion 
of the two MOMPs within the lipid bilayer, is made clearer with a cross sectional view. 
Yellow, MOMP; red, Trp55; green, water; blue, cyan and purple, DPPE/DOPG. Images were 




































































































































































































Figure 5.7. Graph identifying the interacting residues from the MD simulation of 
orientation B. The interactions between two MOMP crystal structures inserted into an 
asymmetrical bilayer were analysed. The red bars indicate the percentage of interactions 
accounted for by each residue, while the green squares indicate the percentage of 
interactions accounted for by each pair.  
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An additional output from the interaction assessment was a PDB model with residues 
coloured by B factor (a measure of relative vibrational motion), whereby blue reflects well-
ordered residues with low displacement, red indicates highly displaced residues, and white 
is intermediate. As all residues are coloured on one model, Figure 5.8A depicts the model 
duplicated and aligned based on both the interacting residues suggested in Figure 5.7 and 
the location of the blue coloured residues, which relates to the residues most likely to form 
an interaction. This figure indicates the likely alignment of the two MOMP molecules within 
the lipid bilayer, as simulated by MD. Figure 5.8B shows the outward orientation of the two 
interacting faces in order to obtain a clearer image of the interacting residues. From Figure 
5.8B, the most dominant intermolecular contacts aligned to the complete MOMP protein 
sequence, in blue, are as follows; Arg195-Asp365, Trp199-Ser319, Asn127-Lys305, and 



























As none of the most important residues involved in the interaction occurring between the 
two MOMP models were cysteines, as expected, Figure 5.9 shows the MOMP crystal 
structure with each well-ordered interaction residue highlighted, along with each of the 
nine cysteine residues. Interestingly, from this figure, it is evident that residues C136, C201, 
C203, and C342 on the opposing face are in close proximity to the interacting faces of the 
barrel as predicted by MD simulations.  
Figure 5.8. MOMP crystal structure coloured according to B factor, arising from the MD 
simulation. A, Duplicated model to demonstrate the potential interaction between two 
MOMPs and B, The models orientated to show the labelled residues at the interaction 
interface. Blue, well ordered; red, highly disordered; white, intermediate; yellow, Trp55. 
Images were produced in VMD software v1.9.2. 
 
 198 
5.4.1.4 Cysteine residue mutagenesis of MOMP 
Figure 5.10 shows the current low-resolution crystal structure for C. pneumoniae MOMP, 
with four cysteine residues of interest highlighted in magenta; C136, C201, C203 and C226. 
In line with the novel hypothesis that cysteine rich pockets exist within the COMC proteins, 
the first three residues were of particular interest due to their close proximity and external 
orientation within the β-barrel, making these cysteine residues amenable for intermolecular 
disulphide bonding. Additionally, data collected from MD simulations indicated that these 
three residues, in addition to the single C226 residue, are in close proximity to the primary 
Figure 5.9. Two MOMP crystal structures showing the interacting residues from MD 
simulations and their proximity to the cysteine residues. Models are displayed in the same 
orientation as in Figure 5.8B. Well-ordered interacting residues identified through MD 
simulations are shown as orange spheres and labelled while the nine cysteines residues are 
shown in cyan, with key residues labelled.  
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residues involved in the interaction between two 
MOMP models within the asymmetric lipid 
bilayer and, therefore, are potentially involved in 
intermolecular disulphide bond clustering. 
Residue C226 was also mutated for 
completeness, in order to characterise all the 
cysteines on this interacting face of the barrel.  
Initially, residues C201 and C203 were both 
mutated individually and together, as a double 
mutant, to alanines using SDM with the 
pETMOMPH6 construct in order to observe their 
potential effect on intermolecular disulphide 
bonding, as characterised by MOMP’s distribution 
in the E. coli outer membrane. As these residues 
may have been essential for correct folding and 
insertion of MOMP, a growth curve was 
conducted. As expected, and shown in Figure 
5.11, the control cultures containing C41 (DE3) cells grew to a higher OD more quickly, 
reaching an OD600 of 0.5 around 45 minutes earlier than transformed cells, as well as 
reaching an OD600 of 2.12 after six hours of growth. By comparison, cells expressing MOMP 
and its mutants all took longer to reach an inducible level (compared to the control) with no 
substantial difference between the native and mutant proteins. All cells transformed with a 
variant of MOMP grew at a similar rate, with growth plateauing at an OD600 of 
approximately 1.3.  
Figure 5.10. MOMP crystal structure 
with cysteine residues highlighted. 
The four cysteines of interest C136, 
C201, C203, and C226 are labelled and 
shown as magenta spheres, with the 





















Growth Curve of MOMP Cysteine Mutants after Induction with IPTG
C41 (DE3) C41 (DE3) pETMOMPH6 C41 (DE3) pETMOMPH6 C201A C41 (DE3) pETMOMPH6 C201A C203A
Figure 5.11. Growth curve of pETMOMPH6 cysteine mutants compared to C41 (DE3) control cells. All samples were transformed into C41 (DE3) 
E. coli cells. The standard growth curve procedure was followed, with measurements taken hourly post induction for a total of 6h. Dark blue, 
control C41 (DE3) cells; orange, native MOMP; yellow, MOMP C201A; grey, MOMP C203A; and light blue, MOMP C201/3A. Error bars represent 
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A medium scale growth test of 250 ml was conducted for each mutant in order to compare 
the expression levels of MOMP. As previously discussed, due to low expression in general, 
Western blotting was used to compare each mutant, as shown in Figure 5.12. From this 
figure, it is evident that MOMP expression is comparable (and roughly equal) between each 















Figure 5.12. Western blot comparing expression of MOMP cysteine mutants. 
pETMOMPH6 constructs were transformed into C41 (DE3) E. coli cells and membranes were 
prepared as per the standard medium-scale expression protocol (see Chapter 2 Section 
2.2.2.3). 1, His-tagged protein standard; 2, C41 (DE3) control; 3, native MOMP; 4, MOMP 
C201A; 5, MOMP C203A; and 6, MOMP C201/3A. Protein was detected using 6X his 
epitope tag monoclonal mouse IgG primary antibody and anti-mouse IgG (H+L)-HRP 
conjugated secondary antibody.  
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5.4.2 Fluorescence Microscopy 
5.4.2.1 Determining the optimal bacterial count 
Initial experiments were aimed at determining the optimal cell number for adherence to the 
poly-L-lysine coated glass microscope slides, taking into account the potential loss of cells 
during the multitude of wash steps. Attachment of varying dilutions of cells indicated that 
an OD600 value of 0.5, measured at the time of harvesting and equating to approximately 
4x108 cells, produced an even dispersion of bacteria with limited overlap.  
5.4.2.2 Accounting for bacterial autofluorescence 
To account for bacterial autofluorescence under excitation with the 488 laser, control cells 
of C41 (DE3) not expressing any pETMOMPH6 were imaged in the first instance and the 488 
nm laser settings adjusted so that autofluorescence was no longer visible. In order to limit 
false positive results, test samples were then imaged using these baseline settings so that 
any fluorescence observed was due to the fluorescent labelling and not bacterial 
autofluorescence.  
5.4.2.3 Addition of a lysozyme treatment step to improve fluorophore access 
A lysozyme treatment step was added to the labelling protocol, in order to improve access 
of the fluorophores to the C-terminal his-tag of MOMP, which is positioned in the periplasm 
between the inner and outer membranes. This step was introduced, following 
permeabilisation of the outer membrane with Triton X-100, in order to hydrolyse the linker 
bonds within the PG layer and improve accessibility around the his-tag. From Figure 5.13, it 
is evident that this additional treatment dramatically increased the efficiency of antibody 





fluorescence in the respective epifluorescence and TIRF images, as opposed to the weak and 
patchy fluorescence seen in -lysozyme non-treated cells.  
 
5.4.2.4 Alternative labelling approaches  
A C. pneumoniae anti-MOMP antibody was obtained from the Chlamydia Biobank (CT603) in 
an effort to directly label MOMP, without requiring membrane permeabilisation. A series of 
dilutions between 1/250 to 1/1000 were used in cohort with anti-mouse Alexa-647 
secondary antibody, however, fluorescent labelling was not observed. A Western blot was 
also conducted on rMOMP membranes using this antibody, whereby again no signal was 
detected (data not shown). Additionally, the novel P3NTA tag, as used in FSEC for detergent 
Figure 5.13. Brightfield, epifluorescence, and TIRF microscopy images showing treatment 
with -/+ lysozyme. C41 (DE3) cells expressing MOMP were stained using anti-his antibody 
conjugated to Alexa 488 secondary antibody and imaged at the University of Reading with 
the following conditions; 0.7% 488 laser, 200 ms exposure, 200 gain, and a 512 x 512 pixel 
ROI. Scale bar is 5 µm.    
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screening, was used to tag pETMOMPH6 in a single step process. Unfortunately, the strength 
of the attached fluorophore, fluorescein, was not sufficient enough to resist photobleaching 
and, therefore, it was not possible to capture both epifluorescence and TIRF images before 
this occurred.  
5.4.2.5 Clustering differences between native and mutant MOMP 
Following the development of a successful method for sample preparation and labelling, the 
cysteine mutants of MOMP were imaged, alongside native MOMP and the control protein 
OmpA, in order to determine if these residues had critical roles in the clustering of MOMP in 
the outer membrane. OmpA is a well characterised and abundant E. coli outer membrane 
protein and, therefore, was labelled with an anti-OmpA antibody in order to demonstrate 
the membrane localisation of an evenly distributed protein. Importantly, OmpA does not 
form intermolecular disulphide bonds, as expected with MOMP. From Figure 5.14A, it is 
clear that OmpA forms a distinct and solid ring with epifluorescence imaging, which 
presents as a solid block of fluorescence with TIRF, signifying a regular distribution 
throughout the membrane. Figure 5.14B, showing native MOMP, exhibits cells with a 
clustering pattern of fluorescence observed in both microscopy techniques, hypothesised to 
be due to intermolecular disulphide bond formation, which prevents even distribution of 
MOMP in the outer membrane. Figures 5.14C, 5.14D and 5.14E represent the single C201A, 
C203A, and double C201/3A mutants respectively. Figure 5.14C, relating to mutant C201A, 
appears to exhibit a more homogenous distribution, as opposed to the C203A mutant in 
Figure 5.14D which still shows a high degree of clustering. Interestingly, the TIRF microscopy 
image of the double mutant in Figure 5.14E indicates highly disperse fluorescence within 
the membrane, through the observable solid and less speckled fluorescence. 
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Figure 5.14. Brightfield, epifluorescence and TIRF microscopy images of MOMP cysteine 
mutants in C41 (DE3) E. coli cells. A, E. coli anti-OmpA; B, native MOMP; C, MOMP C201A; 
D, MOMP C203A; E, MOMP C201/3A. All cells were stained using anti-his antibody 
conjugated to Alexa-488 secondary antibody and imaged at the University of Reading with 
the following conditions; 0.7% 488 laser, 200 ms exposure, 200 gain, and a 256 x 256 pixel 
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5.4.2.6 Additional cysteine mutant design 
Since the preliminary TIRF experiments indicated a difference between the native MOMP 
and the cysteine mutants C201A and C201/3A, an additional four mutants were designed, 
one of which was residue C226 near the top of the barrel, in agreement with the MD 
simulation predicted interaction face. The others included a single mutant C136A, due to its 
close proximity to the initial two mutants, and two associated double mutants C136/201A 
and C136/203A. Medium scale expression tests were conducted, whereby resuspension 
buffer volumes were calculated in proportion to the OD600 measurement taken at the time 
of harvesting. Prepared membranes were analysed by Western blotting, as shown in Figure 
5.15 (loading control Figure A5.1B), which indicates that all mutants produce comparable 
quantities of MOMP. The smear present in lane 4, corresponding to mutant C201A is an 
artefact of the gel, as this effect was not observed in the previous Western blot in Figure 








Figure 5.15. Western blot comparing expression of additional MOMP cysteine mutants. 
pETMOMPH6 constructs were transformed into C41 (DE3) E. coli cells and membranes were 
prepared as stated in the standard medium-scale expression protocol (Chaper 2 Section 
2.2.2.3). 1, His-tagged protein standard; 2, C41 (DE3) control; 3, native MOMP; 4, MOMP 
C201A; 5, MOMP C203A; 6, MOMP C201/3A; 7 MOMP C136A; 8, MOMP C136/201A; 9, 
MOMP C136/203A; and 10, MOMP C226A. Protein was detected using 6X his epitope tag 
monoclonal mouse IgG primary antibody and anti-mouse IgG (H+L)-HRP conjugated 
secondary antibody.  
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5.4.2.7 Initial STORM strategy  
STORM was used to obtain both higher resolution images and, more importantly, 
quantitative data desired for an analysis of MOMP clustering. Initially, the superfrost 
microscope slide method developed in this research was adopted, being the established 
protocol for bacterial cell adhesion for STORM at the Central Laser Facility (CLF). However, 
this method required pelleting cells after each treatment and wash cycle. The cells plated 
during this method demonstrated poor labelling with the same antibodies used in TIRF 
microscopy. Alternatively, the ibidi slide method, as developed for and used in TIRF 
microscopy experiments, was adopted. Sample processing for this technique was 
considerably quicker and resulted in improved labelling. Additionally, as a coverslide was 
not required, the samples were viable for a longer period, as the DTT imaging buffer did not 
evaporate as quickly within the wells after exposure to the intense laser beam.  
5.4.2.8 HaloTag-SiR fluorophore with the pOPINHaloMOMP construct 
HaloTag-SiR was tested as a potential labelling method for MOMP expressed using the 
pOPINHalo vector due to its membrane permeability and negating the requirement of Triton 
X-100 for cell permeabilisation. The pOPINHaloMOMP construct was not amenable to SDM 
using the QuikChange II XL commercial kit (Chapter 2 Section 2.2.1.2), the previous method 
used to create cysteine mutants, as the PCR products presented as multiple bands as 
determined using agarose gel analysis. Instead, In-Fusion was used to extract the mutated 
sequences from pETMOMPH6 for insertion into the linearised pOPINHalo vector. Insertion of 
the correct sequence was confirmed through sequencing in both directions with the 
commercially available T7 forward primer and the custom pOPIN3CHalo reverse primer 
(designed in this research). After single step labelling with HaloTag-SiR and incubation in 
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fresh imaging buffer, STORM data of native MOMP and the initial cysteine mutants at 
residues 201 and 203 were captured. Interestingly, unlike in preliminary epifluorescence 
and TIRF microscopy, the fluorescent signals were not localised to the cell membrane and 
instead appeared to form an angular criss-cross pattern in all samples, as seen in Figure 
5.16A. From the brightfield image in Figure 5.16B, of the same region of interest, it is clear 
that there is only a single cell present, and not a number of cells, as might be expected.  
 
To further investigate this anomaly, 3D STORM imaging was utilised for this particular 
sample in order to obtain details on the axial fluorophore locations, in additional to the 
lateral locations, as in conventional STORM. The aim of this was to determine if the criss-
cross pattern of fluorescence observed in Figure 5.16A was in fact a helical arrangement 
around the outside of the cells, possibly as a result of poor expression or inefficient export 
of MOMP to the outer membrane. The results of the 3D STORM imaging are shown in 
A B
Figure 5.16. C41 (DE3) E. coli cell expressing pOPINHaloMOMP C201/3A double mutant 
labelled with HaloTag-SiR. A, STORM image and B, Brightfield image. The criss-cross 
pattern of fluorescence was visible in both native and mutant MOMP samples. Cells were 
prepared without permeabilisation and labelled with HaloTag-SiR. Images were captured 
using Octopus at the CLF, Harwell using a 647 nm laser, 20 ms exposure, 100 gain, and a 
128 x 128 pixel ROI.  
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Figure 5.17, whereby 5.17A indicates the cellular morphology with brightfield imaging. 
Figure 5.17B-D illustrates various perspectives of the cell using 3D STORM, whereby the Z-
axis is highlighted in blue, the X-axis in red, and the Y-axis in green. Figure 5.17C depicts the 
same perspective as in Figure 5.17A, with only the X and Y axis. In Figure 5.17B and 5.17D, 
the Z-axis view enables 3D visualisation of the fluorophore labelling, which shows the 
fluorescence as defined loops around the cell, as opposed to being more dispersed across 




Figure 5.17. 3D STORM to investigate the behaviour of HaloTag-SiR fluorophore. A, 
brightfield image and B, C, and D, 3D STORM images. C41 (DE3) E. coli cells expressing 
pOPINHaloMOMP C201/3A double mutant were prepared without permeabilisation and 
labelled with HaloTag-SiR. A and C both show the same perspective, with B a view along 
the Z plane, and D demonstrating the cell within all planes. X-axis, red; Y-axis, green; Z-
axis, blue. Images were captured using Octopus at the CLF, Harwell and visualised with 
Zen Black 2012 software. 
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5.4.2.9 Anti-his Alexa-647 one-step labelling method 
Due to the unusual results observed with the HaloTag-SiR fluorophore, a different labelling 
method was adopted. As in Western blotting detection, the C-terminal his-tag was targeted 
with a conjugated anti-his Alexa-647 dye. However, as this antibody is not membrane 
permeable, treatment with Triton X-100, as employed in the preliminary TIRF experiments, 
was reintroduced. Since Alexa-647 exhibits high photostability and a strong fluorescence 
signal, only a laser power of 2-3% was required for successful cell imaging, permitting the 
collection of 20,000 frames before photobleaching began to occur. For each sample, at least 
ten STORM data sets were collected. Figure 5.18 shows a selection of the super-resolution 
STORM images for control OmpA, native MOMP and all seven of the cysteine MOMP 
mutants. Although the images in Figure 5.18 showed significantly more detail, compared to 
the TIRF images in Figure 5.14, it remained that qualitative distinctions between the 











Figure 5.18. Super-resolution STORM images of C41 (DE3) E. coli cells. A, E. coli anti-
OmpA; B, native MOMP; C, MOMP C201A; D, MOMP C203A; E, MOMP C201/3A; F, MOMP 
C136A; G, MOMP C136/201A; H, MOMP C136/203A; and I, MOMP C226A. All cells were 
induced for a total of 3h, with MOMP expressing cells labelled with 1/100 anti-his Alexa-
647 antibody and OmpA first with anti-OmpA primary antibody coupled with anti-647 
secondary antibody. 20,000 frames were collected at the Octopus facility (CLF, Harwell) 
under the following conditions; 2-3% 647 laser, 20 ms exposure, 100 gain, and a 128 x 128 





Each STORM image (Figure 5.19A) is in fact comprised of a dataset of fluorophore 
localisations, which are first drift corrected to account for miniscule camera movements and 
grouped to normalise trails before quantitative analysis of clustering can be conducted, 
using ClusDoC software, which implements the density based spatial clustering of 
applications with noise (DBSCAN) algorithm (Ester et al., 1996). The localisation text file 
from each STORM dataset was uploaded into the ClusDoC GUI (Figure 5.19B), whereby 
regions of interest (ROI), in this case whole bacterial cells, were manually selected with the 
ROI drawing tool. In order to utilise the DBSCAN algorithm for clustering a number of 
parameters were required, the most important being the radius of the fluorophore and the 
minimum number of points required for clustering (Figure 5.19C). Following analysis, the 
software provides an image of the ROI showing the normalised cluster density (Figure 





For each control and mutant, the resulting analyses were combined and the mean and 
standard error (SE) calculated, the results of which are shown in Figure 5.20 and Table 5.1. 
From Figure 5.20, it is evident that native MOMP was the most clustered, with an average 
relative density of clusters of approximately 3.7 arbitrary units (AU), compared to the OmpA 
control, which had an average density of 2 AU. The mutants with the most significant 
decrease in clustering were the two double mutants C201/203A and C136/201A and the 
single mutant C226A with average densities between 1.9 AU and 2.1 AU (Table 5.1). In order 
to further analyse the statistical significance of this data, a one-way ANOVA was conducted 
(Table 5.2) against the null hypothesis that there is no statistically significant difference 
Figure 5.19. Workflow for ClusDoC software for the analysis of STORM data. A, Post-
processing STORM image; B, ClusDoC GUI displaying imported STORM localisation data; C, 
Parameters required for DBSCAN algorithm; and D, Example of clustering assignment image 
for one ROI, colour coded according to the normalised cluster density.  
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between groups. The results of this one-way ANOVA (F(8,630) = 35.8, P>0.0001) revealed 
that the null hypothesis can be rejected, with a P-value less than an alpha value of 0.05 as 
well as the F critical value of 1.96 being less than the value of F. In order to determine where 
these differences occurred, for groups with unequal sample sizes, a Tukey post-hoc test was 
conducted (Table 5.3). From this test, it was apparent that clustering differences between 
OmpA and native MOMP were statistically significant, as well as those between native 
MOMP and all seven of the cysteine mutants. This complements the graph in Figure 5.20, 
whereby SE error bars between these groups do not overlap.  
A statistically significant difference was observed between OmpA and the following 
mutants; C201A, C203A, C136A, C136/203A (Table 5.3). This suggests that whilst these 
mutants exhibited reduced clustering from native MOMP, they were not as homogenous as 
control group OmpA. On the contrary, no statistically significant difference was observed 
between OmpA and mutants C201/203A, C136/201A, and C226A, (Table 5.3, highlighted in 
grey) suggesting that clustering in these mutants had been reduced to exhibit a 
homogenous dispersion similar to that observed with the OmpA control.  
It is interesting that the single mutants C201A, C203A, and C136A did not exhibit a dramatic 
effect on clustering reduction, despite the effect observed in their double mutant 
counterparts, although their reduction in clustering compared to the native MOMP still 
revealed significant differences (Table 5.3). Additionally, the double mutant C136A/203A 
resulted in a decrease in average density, compared to the native protein, but not as 





Figure 5.20. Graph displaying the relative cluster densities of OmpA, native MOMP, and MOMP cysteine mutants. STORM localisation data 
was analysed with ClusDoC software before the mean and standard error were calculated for each sample (Table 5.1). All data were 
collected and processed under the same conditions. The relative density in clusters is provided as a standardised arbitrary unit and error 




















































Clustering of native MOMP and its derived cysteine mutants
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Construct Relative density 
 in clusters 
SE n 
OmpA 2.04 0.05 94 
Native 3.68 0.17 59 
C201A 2.97 0.13 51 
C203A 2.61 0.11 62 
C201/203A 1.88 0.07 71 
C136A 3.02 0.14 69 
C136/201A 2.01 0.08 78 
C136/203A 2.69 0.07 90 




SS df MS F P-value F crit 
Between Groups 191.86 8 23.98 35.80 <0.0001 1.95 
Within Groups 422.09 630 0.67       
Total 613.95 638         
Table 5.1. The relative cluster densities and associated standard errors of OmpA, native 
MOMP, and MOMP cysteine mutants. STORM localisation data was analysed with ClusDoC 
software before the mean and standard error were calculated for each sample. All data were 
collected and processed under the same conditions. SE, standard error; N, number of cells 
analysed. 
Table 5.2. One-way ANOVA statistical analysis of STORM localisation data. The null 
hypothesis, that there is no statistically significant difference between groups, can be 
rejected as both the P-value is <0.05 and the F critical value of 1.95 is less than F at 35.80. SS 
refers to sum-of-squares; df, degrees of freedom; and MS, mean squares. 
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Important pairs Mean difference N (group 1) N (group 2) SE q-crit Significant? 
OmpA Native 1.64 94 59 0.10 17.05 YES 
Native C201A 0.71 59 51 0.11 6.44 YES 
Native C203A 1.07 59 62 0.11 10.15 YES 
Native C201/203A 1.80 59 71 0.10 17.63 YES 
Native C136A 0.66 59 69 0.10 6.45 YES 
Native C136/201A 1.67 59 78 0.10 16.71 YES 
Native C136/203A 0.99 59 90 0.10 10.21 YES 
Native C226A 1.58 59 65 0.10 15.21 YES 
OmpA C201A 0.93 94 51 0.10 9.20 YES 
OmpA C203A 0.57 94 62 0.09 6.03 YES 
OmpA C201/203A 0.16 94 71 0.09 1.75 NO  
OmpA C136A 0.98 94 69 0.09 10.65 YES 
OmpA C136/201A 0.03 94 78 0.09 0.33 NO  
OmpA C136/203A 0.65 94 90 0.09 7.60 YES 








Table 5.3. Tukey post-hoc test to indicate where differences between groups arise. 
Following rejection of the null hypothesis with a one-way ANOVA, a Tukey post-hoc test for 
groups of different sizes was conducted. Clustering between OmpA and native MOMP was 
deemed to be significantly different, as well as clustering between native MOMP and every 
cysteine mutant, as assessed with q-crit values above 4.39, the q value derived from a 
studentised q table with alpha as 0.05. Mean difference refers to the difference in clustering 
values in AU; N to the number of cells analysed; SE, standard error. 
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5.5 Discussion 
5.5.1 Simulating MOMP interactions within a lipid bilayer using MD 
5.5.1.1 MD simulation initial set up 
Two MOMP crystal structures were inserted into a DPPE/DOPG asymmetric lipid bilayer at 
the equivalent of one protein distance away or more specifically 42 Å, the measurement of 
the widest point of the barrel, based on the low resolution MOMP crystal structure. The 
purpose of this was to allow the proteins to associate in their own manner, without bias. 
Placed too close together and bias may occur, whereby the proteins are already 
predisposed to forming a particular interaction at a preselected interface. A distance of 42 Å 
was deemed significant, as an overly expansive distance would likely have required a longer 
simulation time in order for interactions to form, increasing the computational expense.  
Four orientations of the barrel (about the Z axis) were simulated to allow multiple faces of 
the protein barrel to interact, again endeavouring to reduce bias and sample the barrel 
more or less equally. It was hypothesised that, if suboptimal faces of the barrel were in 
alignment, then reorientation of the two models into the correct conformation would be a 
considerably more energy intensive process and may not prove successful. From the results, 
only the models in orientation B were successful in forming interactions while remaining 
embedded within the lipid bilayer, as indicated by the external exposure of the (red 
labelled) reference Trp55 residue (Figure 5.6). 
5.5.1.2 MOMP insertion and association within the lipid bilayer 
 Interestingly, the initial alignment of the two MOMP models in orientation B was not the 
same orientation of the interacting pair after a 10 µs simulation, which showed a rotation of 
90° about the Z axis of the stationary MOMP model (right-hand side), resulting in alignment 
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of the Trp55 residues. This resulting orientation was not modelled in the four initial 
orientations and, therefore, indicates that the distance between the two models and the 
duration of the simulation permitted ample time and movement for the models to form this 
novel interaction. Surprisingly, orientation D did not result in the same association or even 
correct insertion into the lipid bilayer, despite also only requiring a 90° shift in one of the 
models to align the Trp55 residues in the same manner as the successful interaction 
simulation.  
Although only four orientations were modelled, due to the nature of proteins with their 
numerous sidechains, there are in fact countless minor orientations in alignment possible 
between these two protein models, however, it would be a huge undertaking to simulate 
every 1-5° degree shift in orientation/rotation around the barrel. For example, if we were to 
assume simple rectangular cuboid structures in place of the two β-barrel MOMP models, 
then the four faces of each structure would be able to align in sixteen different ways. 
However, due to the dynamic nature of MD simulations, as demonstrated here, proteins 
aligned in a particular manner are clearly able to move and align to form the most 
favourable interaction and, therefore, a small subset of initial orientations is suitable in this 
instance.  
Additionally, orientation B was the only orientation that resulted in insertion of both MOMP 
models within the lipid bilayer, with the reference Trp55 residue indicating the location of 
the loop region, externally exposed to the extracellular side, as expected. In the remaining 
orientations, some models were able to form interactions but none were correctly inserted 
into the membrane. In one instance, one of the models was located lengthways along the 
external surface of the lipid bilayer and in another instance the MOMP models associated 
but were both lying on top of the membrane (orientation D). Based on experimental 
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knowledge of the COMC (Liu et al., 2010) and the typical behaviour of β-barrel proteins 
(Fairman et al., 2011), which both suggest OM insertion, these orientations were not 
considered to be biologically relevant and were consequently disregarded.   
5.5.1.3 Interaction assessment of associating MOMP models 
The interactions formed between the two MOMP models (from orientation B) were 
classified using an additional script, which identified 37 interacting residues with both 45 Å 
and 80 Å cut off distances, indicating that all residues were accounted for in both instances. 
It was clear from the resulting graph (Figure 5.7) that none of the key interacting residues 
were cysteines, as might be expected. In fact, not even the weakly associated residues, 
coloured white according to B-factor (Figure 5.8), were cysteines.  
Further investigation of the initial MD simulation script revealed that intermolecular 
disulphide bonding as a potential interaction was not explicitly accounted for; only 
standardised van der Waals, hydrogen bonding, and salt bridges were fully parameterised. 
So even if two cysteines were aligned and disulphide bonding could feasibly occur between 
the two MOMP models, the algorithm wouldn’t recognise -S-S- as an interaction, since the 
algorithm cannot compute the associated force fields and transition barriers arising from a 
disulphide linkage. As some proteins possess intramolecular disulphide bonding for 
structural stability, it is possible to account for this type of interaction in the initial CG 
protein set up, however, as the predicted bonds between MOMPs are intermolecular 
(between other proteins), to create such interactions would require two MOMP models to 
be reclassified as a single protein, with the disulphide bonds predefined as intramolecular 
interactions. Significantly, this approach would require biased alignment of the two models 
based on explicitly defining the cysteine residue location and their predicted 
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orientation/interaction and, therefore, the simulation would only serve to confirm if the 
models were correctly inserted within the membrane or not, as disulphide interactions 
would already be predefined. There are nine cysteine residues in C. pneumoniae MOMP, 
which creates a huge subset of potential combinations. Due to the extensive time required 
to map and define all these interactions, in addition to the huge bias and lack of real 
information achieved from running such a simulation, this option was not pursued. 
However, based on the crystal structure sensible pairings can be made relating to their 
location within the barrel, their outward orientation, and whether these are likely to be 
situated within the membrane region. Thus, potential interacting residues were mapped in 
conjunction with the cysteine residues to determine any correlation. Interestingly, the three 
cysteine residues at positions 136, 201, and 203 together with 226 near the top of the barrel 
were all situated in close proximity to one of the interacting faces (Figure 5.9), with residues 
C342 and C56, and also likely C52 and C49, all on the opposing side. Based on these 
observations, it is possible that the residues in the cysteine rich region of 136, 201 and 203 
were interacting with the cysteine residue on the opposing face of the barrel at position 
C342 and, that C52 was interacting with C226 due to their complementary alignment, 

















Figure 5.21. Two MOMP crystal structures indicating the hypothesised intermolecular 
disulphide bonds between C342 and C201, and C52 and C226. The nine cysteines residues 
are shown in cyan, with key residues labelled. Hypothesised intermolecular disulphide 
bonding is indicated by red dashed lines.    
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5.5.2 Use of fluorescence microscopy to understand MOMP’s OM localisation 
5.5.2.1 Cysteine mutant design  
In order to determine which of the nine cysteine residues might play a significant role in 
intermolecular disulphide bonding between MOMP molecules, as a model of the COMC, 
mutants were carefully designed based on the low resolution crystal structure, the MD 
simulations, and the novel cysteine rich pocket hypothesis developed during the course of 
this work. Using the crystal structure, the putative location of all nine cysteine residues can 
be visualised. Interestingly, some of these residues appear to group together, for example, 
those residues at positions 136, 201, and 203, and those at positions 49, 52 and 56. This 
supports the novel hypothesis proposed in this work suggesting that, due to the large 
number of cysteine residues amongst the 17 proteins of the COMC, intermolecular 
disulphide bonds may be generated in cysteine rich regions within a pocket, rather than 
towards specific residues. With 194 documented cysteine residues and a large number of 
interacting proteins within the COMC, specific interactions appear to be not only unlikely, 
but also energetically unfavourable in terms of locating the correct protein and organising 
the correct orientation. Whilst MD simulations did not directly characterise the 
intermolecular disulphide bonds, it provided an indication of which faces of the β-barrel 
were interacting. From these regions, a number of cysteines were identified, namely C136, 
C201, and C203. Therefore, these residues were selected based on their location at the 
interface of the interacting region as well as the fact that these form a cysteine rich pocket 
on the outer face of the barrel. Additionally, C226 was also selected for mutation in order to 
characterise all the available residues within this potential interacting region.  
As the only experimental data characterising potential disulphide bonding in MOMP was 
conducted for C. trachomatis MOMP, were obtained from peptide fragments that could 
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have re-associated in a number of ways, and gave rise to conflicting results across two 
independent research groups (Yen et al., 2005; Wang et al., 2006), these data could not be 
considered reliable for use in the cysteine mutant design and subsequent analysis presented 
herein. Furthermore, there is currently no published data available regarding how 
Chlamydia may form disulphide bonds, which renders predictions based on this new 
hypothesis entirely plausible and contributes significantly new knowledge to the field. 
Once rationalised, all mutants were successfully created in the pETMOMPH6 construct using 
SDM, however, this technique did not yield results with the pOPINHaloMOMP construct, 
which instead required In-Fusion cloning of the mutated sequence into the linearised 
vector. This vector suite possesses the genes required for expression in multiple hosts such 
as E. coli, mammalian cell lines, and insect cells, for parallel screening. Due to this, a β-globin 
polyA signal sequence is included in the vector in order to increase mRNA stability during 
mammalian cell expression. This repeated sequence of adenines likely disrupted SDM 
attempts, through non-specific annealing with the designed primers, resulting in the 
multiple faint bands observed in agarose gel electrophoresis of the PCR products.  
All cysteines were mutated to alanine in order to neutralise the effect of the side chain, 
through truncation, whilst also maintaining the hydrophobicity of the region. Additionally, 
mutation to serine may have resulted in salt bridge or hydrogen bond formation, due to 
serine’s polarity.  
5.5.2.2 Growth and expression testing of initial pETMOMPH6 cysteine mutants 
Initially, only mutants C201A and C203A, plus their double mutant, were created in the 
pETMOMPH6 construct for preliminary fluorescence microscopy experiments. As expected, 
in a growth curve experiment the control C41 (DE3) E. coli cells not expressing MOMP grew 
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more quickly and to a higher OD600, with each mutant and the native MOMP growing at 
rates comparable to one another for the total 10h duration (Figure 5.11). This comparable 
rate of growth suggests that none of the mutants were more toxic on E. coli growth than the 
native MOMP protein itself, which would exhibit as lower OD600 measurements at equal 
time points. Additionally, the comparable growth rates suggested that each mutant MOMP 
was being over-expressed, as none grew more quickly or reached a higher OD600, which one 
might expect if the protein was not being synthesised. Following this simple experiment, a 
medium scale expression test was conducted on the same constructs, which confirmed 
equivalent MOMP expression through Western blotting (Figure 5.12). The additional bands 
present in the Western blot, at a lower molecular weight, were likely due to freeze-thaw 
associated degradation. At this stage, it was not possible to determine if MOMP was 
expressed in the inner or outer membrane. However, as the membrane fraction was 
isolated through centrifugation, it was unlikely that MOMP was being expressed as inclusion 
bodies, which are typically discarded along with unlysed cells during the first 12,000 rpm 
centrifugation after cell lysis. Nevertheless, fluorescence microscopy was used in 
subsequent experiments to confirm membrane localisation of rMOMP.  
5.5.2.3 Sample preparation for epifluorescence and TIRF microscopy 
During the course of this work, it was necessary to optimise a number of parameters to 
achieve the highest image quality for preliminary epifluorescence and TIRF microscopy. 
These are highlighted herein. Following poly-L-lysine treatment of the microscope slides, the 
bacteria were plated using a range of dilutions in order to obtain an equilibrium between 
undesirable confluence, which would make membrane regions hard to distinguish, and a 
sparse distribution, which would require capture of a larger number of images to reasonably 
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characterise the population. An OD600 value of 0.5, equating to approximately 4x108 cells, 
measured at the time of harvesting was consistently successful in this regard. Standardising 
the cell number for each sample also assisted in determining if a particular mutation was 
resulting in cell death and, therefore, resulting in increased particulate matter, which also 
scatters light at 600 nm and increases the OD600 value, whilst also evident by a decrease in 
cell number.  
When imaging at 488 nm, it was important to account for bacterial autofluorescence, which 
can prove problematic during the detection of specific but weak fluorescence with green-
labels, such as GFP or the novel his-tag binding P3NTA probe. LB and other rich media 
typically contain yeast extract and tryptophan, both of which contribute to 
autofluorescence through excitation of their aromatic groups under UV and blue light. 
Alternatively, cultures can be grown in MM, although it is important to be aware that cell 
morphology is evolutionarily affected by the decrease in nutrient availability and must be 
considered when analysing cell features, such as membranes. Due to the associated changes 
in cell morphology with growth in MM, cells were grown in LB but were washed three times 
in PBS at low speed centrifugation, before plating, in order to limit the aforementioned 
autofluorescence. Furthermore, it has been well established that naturally occurring 
metabolites produced in bacteria, such as flavins and nicotinamide adenine dinucleotide 
(NADH), contribute to autofluorescence at this wavelength. To account for these effects, 
unstained control C41 (DE3) E. coli cells were imaged with the 488-laser and settings were 
adjusted so that the autofluorescent signal was no longer perceivable. These baseline 
settings were then used in all epifluorescence and TIRF imaging of cells labelled with either 
the P3NTA probe or Alexa-488 antibody.  
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As discussed previously (Chapter 1 Section 1.6.5), due to the suspected inaccessibility of the 
N-terminus within the β-barrel, MOMP was C-terminally his-tagged. However, as the C-
terminus of MOMP likely lies at the periplasmic side of the OM, membrane permeabilisation 
was mandatory to permit access of the chosen fluorophore to the his-tag. Despite 
permeabilisation with 0.1% Triton X-100, staining with anti-his primary antibody conjugated 
to a secondary Alexa fluorophore appeared erratic and weak. It was hypothesised that the 
peptidoglycan layer that lies between the inner and outer membrane in E. coli was 
restricting access of the primary and/or secondary antibodies. In response to this, an 
additional treatment step involving incubation with 100 µg/ml lysozyme immediately 
succeeded cell permeabilization, in order to hydrolyse the linker bonds within the 
peptidoglycan and improve probe access. The improvement in fluorescent signal observed 
in lysozyme treated cells was dramatic, with cell morphology now clearly visible in the 
fluorescent images for every cell identified with brightfield imaging (Figure 5.13), as 
opposed to the weak and patchy fluorescence observed in the absence of lysozyme. 
Consequently, it is strongly recommended that a lysozyme treatment step be included when 
fluorescently labelling a tag exposed to the periplasmic region within a Gram negative 
bacterium, such as E. coli, in order to improve the fluorescent signal.  
5.5.2.4 Alternative labelling techniques for preliminary experiments 
An anti-MOMP antibody obtained from the Chlamydia biobank and produced from C. 
pneumoniae was not effective at labelling recombinant MOMP for fluorescence microscopy 
imaging in whole cells or Western blot analysis of membrane preparations. Being an OM 
protein in Chlamydia, it has been widely accepted that MOMP is externally exposed and, 
therefore, natively produced antibodies would not require membrane permeabilisation to 
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gain access to the desired MOMP epitope. Initially, in fluorescence microscopy analysis, it 
was expected that MOMP was not correctly inserted into the E. coli OM, as no fluorescence 
was observed using a range of dilutions of the Chlamydia derived antibody. However, this 
was investigated further, through Western blotting of a number of different membrane 
preparations including those from both pETMOMPH6 and pBADaMOMP (used for the 
functional growth assay, Chapter 4) constructs in addition to purified MOMP, none of which 
revealed any observable bands in a Western blot analysis. The method by which this 
antibody was produced in Chlamydia was unclear. However, purified MOMP is notoriously 
hard to obtain and as it is a major contributor to the Chlamydial COMC, it is possible that 
some additional residual COMC proteins were present and bound by intermolecular 
disulphide bonds. Therefore, when tested in Chlamydial samples antibody binding occurs, 
whereas in E. coli, without the presence of the additional epitope regions of other, possible 
contaminating COMC protein(s), antibody binding cannot occur. Alternatively, it is entirely 
possible that the antibody had degraded at some stage, dramatically reducing its efficacy, 
although both theories are difficult to investigate in the absence of native MOMP controls.  
Additionally, the novel P3NTA probe, as used in detergent screening with FSEC to 
fluorescently label the his-tag, was tested as a potential single step labelling method. 
However, photobleaching occurred extremely quickly and did not tolerate the capture of 
both epifluorescence and TIRF images and, therefore, use of this probe would certainly not 
be amenable to super-resolution imaging with an ultra-high power laser. Redesign of the 
probe with a more robust fluorophore such as Alexa-647 was considered, however, due to 
the excessive expense, the time required for synthesis, and the low binding strength of the 
NTA region to this his-tag, this option was ultimately disregarded. Consequently, primary 
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anti-his antibody was conjugated to secondary Alexa-488 fluorophore for preliminary 
epifluorescence and TIRF imaging.  
5.5.2.5 Clustering differences observed with epifluoresecence and TIRF between 
native and mutant MOMP 
Upon establishment of a robust and efficient protocol for fluorescence imaging of 
recombinant MOMP in E. coli, the three cysteine mutants, C201A, C203A, C201/203A were 
imaged along with OmpA, a natively expressed E. coli outer membrane protein control. 
From these images it was apparent that native MOMP exhibited a speckled (uneven) 
membrane distribution, in both epifluorescence and TIRF, hypothesised to result from 
intermolecular disulphide bonding, resulting in unevenly distributed protein clusters in the 
membrane. As MOMP is the most abundant COMC protein, it is likely to be forming these 
intermolecular disulphide bonds with other MOMPs and, from these images, it was 
apparent that MOMP displayed the same behaviour as hypothesised when recombinantly 
expressed in E. coli. OmpA served as an excellent control to demonstrate homogeneous 
membrane dispersion, which was indisputably distinct from that of native MOMP. It was 
hypothesised that mutation of particular cysteine residues considered to be important for 
intermolecular disulphide bonding would result in a more homogenous membrane 
localisation pattern, more akin to that of OmpA. From the epifluorescence images of both 
C201A and C201/3A it appeared that, whilst not as intense as OmpA (Figure 5.14A), these 
mutants had somewhat increased the homogeneous dispersion (Figures 5.14C and 5.14E, 
respectively). For the C201/203A sample, TIRF microscopy supported this observation 
(Figure 5.14E). However, for the single C201A mutant, the TIRF microscopy image still 
exhibited a reasonable level of clustering (Figure 5.14C). Additionally, the C203A single 
mutant appeared to have had a negligible effect upon MOMP clustering, observed in both 
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techniques (Figure 5.14D). As these data are solely qualitative, it was difficult to draw 
robust conclusions regarding the mutants’ effect on MOMP clustering, although this 
preliminary experiment was vital in indicating an observable difference that warranted 
additional investigation using a higher resolution technique that could provide quantitative 
data.  
5.5.2.6 Additional cysteine mutant design and expression 
As discussed (Section 5.5.2.5), preliminary fluorescence microscopy of recombinant MOMP 
in E. coli indicated a decrease in clustering for mutants C201A and C201/203A. To expand 
the breadth of this investigation, additional mutants were designed. As residues C201 and 
C203 exist in a hypothesised cysteine rich pocket, their accompanying residue C136 on the 
neighbouring β-strand was mutated singly and also coupled with C201 and C203 to create 
two new double mutants, namely C136/201 and C136/203. Residue C226 at the top of the 
barrel was also mutated to alanine, due to its alignment with this interacting face as also 
indicated by MD simulations of the two MOMP models within the lipid bilayer. Additional 
medium scale expression tests were conducted on each of the new mutants, with 
membranes prepared for analysis with Western blotting, as before. From this Western blot 
it was clear that all four of the novel MOMP mutants expressed protein at comparable levels 
to that of the native protein and the original three mutants (Figure 5.15), again suggesting 
that these mutations did not adversely affect protein folding and export to the membrane, 
as inclusion bodies, where misfolded proteins accumulate, and are largely eliminated at the 
first centrifugation step following cell lysis. 
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5.5.2.7 Advancement to super-resolution STORM 
In order to obtain both higher resolution images and quantitative data for an analysis of 
clustering, super-resolution STORM imaging was conducted. The established protocol at the 
CLF Harwell, where the STORM experiments were conducted, was to use inverted 
superfrost microscope slides with the sample immersed in buffer and sealed with a 0.17 mm 
coverslide. In contrast to the Ibidi slide method adopted in TIRF microscopy, the samples 
were treated and labelled in microcentrifuge tubes, as opposed to being plated first. In 
order to wash the cells after each treatment, cells were pelleted by low-speed 
centrifugation and resuspended three times. Accounting for the total number of steps 
involved in the preparation procedure, samples were subjected to centrifugation and 
resuspension around seventeen times and, whilst care was taken to gently resuspend each 
pellet, the cells prepared this way exhibited very poor labelling. It was concluded that the 
shearing forces involved in both pelleting and resuspension resulted in damage to the cell 
architecture, especially the exposed outer membrane, which led to suboptimal labelling. 
Fortunately, as Ibidi slides consist of a 0.17 mm glass bottom, their use was considered 
appropriate for STORM imaging and sample processing using this technique was 
considerably more efficient, as the cells were plated first prior to treatment and labelling. As 
each slide has eight separated wells, samples could be incubated with the same volume 
over identical areas, as opposed to traditional microscope slides where aqueous solutions 
are difficult to confine to one region and tend to spread across the slide. Additionally, with 
eight wells per slide, the efficiency of data collection was dramatically improved since, to 
exchange samples, the chamber location can simply be adjusted without complete removal 
of the slide, thus eliminating the need to relocate the plane of focus with each sample 
change. As the wells could accommodate a total volume of 300 µl, the risk of imaging buffer 
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evaporation also was eradicated, as opposed to the coverslide method whereby it was only 
feasible to add 10 µl of buffer and, therefore each sample had to be incubated directly with 
buffer prior to imaging to limit evaporation.  
5.5.2.8 Investigation of HaloTag-SiR as a labelling method 
A new construct known as pOPINHaloMOMP was created in order to tag the C-terminus of 
MOMP with the Halo-tag protein, to allow irreversible covalent labelling with the cell 
permeable fluorophore, HaloTag-SiR. Initially, only C201A, C203A and C201/3A mutant 
pOPINHalo constructs were created in order to test the robustness of this labelling method. 
As SiR is cell permeable, the Triton X-100 detergent treatment step was omitted during 
preparation of this construct with the Ibidi slide method. Upon imaging of labelled cells, an 
unusual ‘criss-cross’ pattern was observed for each of the constructs instead of a distinct 
fluorescent signal at the membrane region, as in epifluorescence and TIRF microscopy. 
Initially, it was suspected that this unfamiliar signal was a result of many cells clumping 
together and overlapping. The importance of brightfield imaging (used to observe cells with 
conventional light microscopy) was emphasised at this stage, which revealed that the 
fluorescent signal originated from a single cell. The pattern appeared to be angular, almost 
forming a helix around the outside of the cells, although it wasn’t clear if the fluorescence 
detected in the central region of the cells was from inclusion bodies or was connected in a 
link to the fluorescence spots nearer to the membrane region. Subsequently, 3D STORM 
was used to investigate this in two independent samples, both of which demonstrated a 
continuous band of fluorescence looping and twisting around the cell, as opposed to a shell-
like layer of fluorescence surrounding the outside of the membrane, as expected and 
previously observed. As 3D STORM was considerably more time consuming than standard 
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2D STORM, both in terms of data collection and calibration with predefined probes, only 
two pOPINHaloMOMP samples were tested before this method of labelling was ultimately 
retired.  
It is hypothesised that, due to the large size of the Halo-tag at 33 kDa, particularly in 
comparison to the size of MOMP (40 kDa), protein expression, folding, and/or export was 
disrupted. Previous attempts to tag MOMP with GFP, a protein of 27 kDa, were unsuccessful 
due to poor expression (Atanu, 2014) and, therefore, it is not entirely unexpected that this 
effect has also been exhibited here with the HaloTag. As a result, an anti-his Alexa-647 
conjugated antibody was used with the pETMOMPH6 construct for all future STORM 
experiments, with the re-addition of the permeabilisation treatment step. Since the native 
E. coli protein OmpA was, of course, not his-tagged, the primary anti-OmpA antibody was 
conjugated to a secondary Alexa-647 antibody so that the same grouping parameters, to 
account for trails, could be applied to both control and test samples.   
5.5.2.9 STORM imaging and results 
Alexa-647 is regarded as one of the best fluorophores for STORM, mainly due to its effective 
blinking and high photostability (Dempsey et al., 2011). These characteristics were observed 
in the STORM data collection experiments for the pETMOMPH6 mutants using the Ibidi slide 
method, where 20,000 frames were collected before any decrease in blinking efficiency or 
photobleaching occurred. In total, at least ten STORM data sets were collected for each 
sample, under the same conditions, in order to obtain at least fifty regions of interest and to 
provide substantial data for analysis. Additionally, C41 (DE3) control cells were imaged with 
and without labelling with Alexa-647 antibody, as before, so as to identify non-specific 
binding and autofluorescence, respectively. Non-specific binding was detected to a small 
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degree in control samples incubated with the standard 1/100 concentration of antibody in 
1% (w/v) BSA and, therefore, to completely eliminate this effect a higher concentration of 
3% (w/v) BSA was certified and used for all test samples to ensure that the fluorescent 
signals detected arose from specific binding.  
 In all cases, following collection, data were processed to account for camera drift and trails. 
In comparison to the images captured in the preliminary epifluorescence and TIRF 
experiments, the STORM images acquired were of considerably higher resolution, predicted 
between 20-30 nm from the localisation precision histogram. However, with over ten 
images for each sample, and a number of cells in each image, visual comparison of 
clustering behaviour again was complex and subjective, due to the qualitative nature of the 
images.  
5.5.2.10 Clustering analysis using ClusDoC software 
However, with STORM the user acquires more than just a high resolution image. Each 
fluorescent spot visible within the STORM images actually has localisation data associated 
with it, all of which can be extracted as a simple text file using the Zen Black software 
(Zeiss). This information can then be uploaded into the ClusDoC software (Pageon et al., 
2016), which reconstitutes the original image within the GUI. As bacteria are so small, this 
feature was particularly useful in that within each image there were varying numbers of 
cells present and, therefore it was more appropriate to analyse clustering within each cell as 
opposed to across all cells in combination within one image. In doing so, each cell was 
accounted for and individually contributed to the data set, which then could collectively be 
statistically processed in the same manner.  
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Following clustering analysis, a measure referred to as the ‘relative density in clusters’, an 
arbitrary value which accounts for the number of fluorophores and the size of the ROI, was 
used to compare clustering between samples. Due to the arbitrary nature of this 
measurement, it was imperative to include control OmpA data in the study, to act as a 
reference point for low clustered samples. Data from each ROI was collated and averaged, 
before the standard error was calculated to represent the accuracy of the data. A smaller SE 
reflects a more representative sample and mutants were deemed to be significantly 
different to the native MOMP if their SEs did not overlap. From the results (Figure 5.20 and 
Table 5.1), it is evident that native MOMP was the most clustered sample with OmpA 
(representing homogeneous dispersion and low clustering) demonstrating a considerably 
lower score, both of which supports the observations made in the preliminary 
epifluorescence and TIRF microscopy experiments. Statistical analysis with a one-way 
ANOVA revealed a p-value <0.0001, permitting rejection of the null hypothesis, thus 
indicating a statistically significant difference between groups. In order to determine where 
these differences arose, a Tukey post-hoc test was conducted.  
From comparison of the SEs in Figure 5.20, the mutants with the most significant decrease 
in clustering were the double mutants C201/203A and C136/201A, as well as the single 
mutant C226A, although all other mutants also displayed significant decreases compared to 
native MOMP. This was supported by the Tukey post-hoc test which indicated significant 
differences between all seven cysteine mutants in comparison to native MOMP, with the 
aforementioned mutants showing no significant difference to OmpA, suggestive of 
comparable membrane homogeneity (Table 5.3). With regard to the double mutants, 
notably, their respective single mutants did not exhibit the same decrease in clustering, 
indicating that two mutations in combination were required to produce a more dramatic 
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response. Contrary to this, double mutant C136/203A did not decrease clustering to the 
same extent as that observed for the other two double mutants. For the C136/203A double 
mutant, the data are suggestive of something paradoxical; it suggests that residue C201 has 
a more critical role in disulphide bond formation than C203, but contrarily, the effect of the 
single C201A mutant was less significant than that of the C203A single mutant. 
Analysis of the putative location of the cysteines in the low resolution MOMP crystal 
structure, together with the interaction assessment data from the MD simulations, suggests 
that residue C342, on the opposite side of the barrel, is most likely interacting with the 
cysteine rich pocket (C136, C201, and C203) investigated here (Figure 5.21). With regard to 
the novel hypothesis, that the COMC proteins target cysteine rich pockets during disulphide 
bond formation, as opposed to specific residues, these results suggest that when only one 
of the cysteine residues within the C136, C201, and C203 pocket is mutated, the two 
remaining cysteine residues can compensate and continue to form the disulphide bond. 
However, with reference to the paradox previously mentioned, it is hypothesised that 
residue C201 is much more effective at forming the disulphide bond alone when C136 and 
C203 are mutated, in comparison to either C136 or C203 when singularly available. This may 
be because residue C201 is situated higher within the β-barrel and more in alignment with 
C342 and, therefore, sterically is able to form a more favourable interaction, although the 
neighbouring residues are still available to form a compensatory disulphide bond if 
required. From these results, it is evident that some compensatory mechanism is occurring, 
otherwise it would be expected that mutation of one particular residue would cause a 
decrease in both single and double mutants in equal (or greater) measure.  
Residue C226A also had a significant effect on clustering, despite being a single mutation 
that is not arranged in a cluster. Again with respect to the MD simulation interaction data 
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and the cysteine residue locations within the β-barrel, it is hypothesised that this residue is 
key in forming disulphide bonds with an additional cysteine rich region at residues C49, C52 
and C56. Due to its alignment with C226, it is possible that residue C52 would form the most 
favourable interaction, with its flanking residues C49 and C56 available for compensation 
(Figure 5.21).  
5.6 Conclusions  
MD is a powerful computational technique that allows us to model the behaviour of 
proteins that may be difficult to characterise experimentally. In this research, CG MD 
simulations modelled the insertion and behaviour of two low resolution MOMP models 
within an asymmetric lipid bilayer. From four initial orientations, only one resulted in 
correct insertion within the bilayer, which also resulted in a plausible protein-protein 
interaction. The resulting simulation was considered biologically relevant, as published 
experimental data to date indicates that MOMP is expressed within the outer membrane 
(Liu et al., 2010; Sun et al., 2007; Wolf et al., 2001) and, therefore, any deviation from this is 
less likely to be biologically relevant. Subsequent assessment of the interacting residues 
revealed that none were explicitly a result of disulphide bonds. Investigation of the original 
script revealed that only predefined intramolecular disulphide bonds could be accounted for 
and, therefore, mapping of potential intermolecular disulphide bonds between two MOMP 
models would require the reclassification of the two models as one protein and manual 
assignment of the interacting cysteines. This process would, of course, not only be 
extremely time consuming but also result in a high degree of bias, the results of which 
would be difficult to assess. However, upon closer inspection, the interacting faces of the 
barrel were located in close proximity to a number of cysteine residues, indicating that 
 238 
these residues may have a role in assisting the alignment of MOMP into the correct 
orientation for disulphide bond formation.  
Thus a novel hypothesis emerged, during the course of this research, which suggests that, 
due to the high number of COMC proteins and consequently the numerous cysteine 
residues available for disulphide formation, the COMC proteins target cysteine rich pockets 
or regions as opposed to specific residues. Therefore, the cysteines in the region of C136, 
C201, and C203 of MOMP were mutated to alanine in order to neutralise their disulphide 
bonding ability, the effect of which was observed with fluorescence microscopy. During the 
preliminary stages, only C201 and C203 were mutated and analysed, along with native 
MOMP and control OmpA, with lower resolution epifluorescence and TIRF microscopy. 
From these images, it was apparent that MOMP, as hypothesised, was forming clusters 
within the E. coli membrane, characterised as speckled fluorescence using both techniques. 
Two of the mutants indicated more homogenous membrane dispersion with 
epifluorescence, although the single C201 mutant still appeared speckled with TIRF. Due to 
the qualitative nature of epifluorescence and TIRF microscopy imaging, a higher resolution 
technique was pursued to enable further detailed characterisation of these differences. 
For super-resolution STORM, the C136 residue was mutated both singularly and in pairing 
with its neighbouring residues C201 and C203. Additionally, residue C226 near the top of 
the barrel and at the interacting interface, as predicted by MD simulations, was also 
mutated. Initially, for this higher resolution technique, it was intended that the membrane 
permeable HaloTag-SiR fluorophore would be used for labelling of MOMP in order to 
preserve the membrane integrity. However, use of this fluorophore required expression of 
MOMP within the pOPINHalo construct, which upon imaging exhibited an unusual labelling 
pattern most likely resulting from disrupted folding and export of MOMP to the membrane. 
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Alternatively, conjugated anti-his Alexa-647 fluorophore was applied with the pETMOMPH6 
construct which was used in preliminary experiments and was also known to express MOMP 
within the E. coli membrane due to previously observed sarkosyl insolubility, as discussed in 
Chapter 3. The subsequent efficiency of the Alexa-647 fluorophore permitted superior 
STORM data collection, resulting in a series of high resolution images. The localisation data 
from each image was analysed using clustering software, which revealed MOMP to be 
highly clustered and OmpA as more homogeneous, as hypothesised. Double mutants 
C201/203A and C136/201A reduced the clustering of MOMP most significantly, suggesting 
that within cysteine rich regions a compensatory mechanism is occurring, whereby 
neighbouring cysteine residues can continue to form intermolecular disulphide bonds in the 
absence of the most important residue. Notably, the single mutant C226A produced a 
significant effect upon disulphide bonding. In relation to the interacting regions predicted by 
MD simulations, it is likely that this residue is interacting with an additional cysteine rich 
region, likely formed by residues C49, C52, and C56. These results support the hypothesis 
that during COMC formation a general cysteine rich region is targeted, as opposed to 
specific residues, although it is possible that some residues within these regions, such as 
C201, have more substantial roles, perhaps even depending on the specific target protein 
partner in the COMC. However, until high resolution structural data emerges detailing the 
location of the cysteine residues within these other partner proteins of the COMC, then 
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6 General discussion and recommendations for future research 
Chlamydia is a widespread bacterial pathogen most infamous for its sexually transmitted 
infection caused by C. trachomatis. C. pneumoniae, another less well-known strain of this 
genus, most often implicated in human respiratory diseases such as pneumonia, sinusitis, 
and bronchitis, also has a more controversial role in chronic inflammatory diseases such as 
atherosclerosis (Sorrentino et al., 2015), asthma (Webley and Hahn, 2017), and arthritis 
(Zeidler and Hudson, 2016), following infection during the early stages of life. Common to 
each strain of Chlamydia is the major outer membrane protein, an abundant surface 
exposed cysteine rich protein, which is highly conserved amongst the species with 
demonstrable immunodominance in both humans and mice (Wolf et al., 2001; Molina et al., 
2010). Despite the huge global economic and health impact arising from Chlamydia 
infections, there are currently no suitable preventative vaccines. Currently, infections are 
treated with antibiotics such as azithromycin and doxycycline, however the increasing threat 
of antimicrobial resistance has the potential to soon render these methods nonviable, 
increasing the drive towards novel vaccine therapeutics. Being surface exposed, conserved, 
and highly abundant, accounting for 60% of the outer membrane protein, MOMP has long 
been the focus of vaccine studies (Kari et al., 2009; Olsen et al., 2015; O’Meara et al., 2017; 
Xia et al., 2013). Despite this, there is currently no high resolution structural data for 
MOMP, which would provide vital information regarding both the surface exposed domains 
and epitopes, as well as provide valuable insight into MOMP’s function, which could then be 
targeted for novel antimicrobials. CD spectroscopy has been used by multiple researchers to 
confirm MOMP’s β-sheet content (Wyllie et al., 1998; Sun et al., 2007; Cai et al., 2009; Wen 
et al., 2016), with homology modelling used to make predictions on more specific features 
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and side chain orientations, although due to the paucity of highly homologous proteins with 
structural data, results are conflicting (Atanu et al., 2013; Feher et al., 2013).  
Within the past three years, low resolution structural data for MOMP was obtained to a 
resolution of 4 Å using molecular replacement, by this research group (Atanu, 2014). 
Although the barrel structure was evident, it was not possible to accurately determine 
individual side chain orientations or to trace the extracellular loop regions with convincing 
electron density. As a result, the initial focus of this research was toward producing stable, 
active, and correctly folded recombinant MOMP to be used in structural studies, namely in 
optimising crystallisation conditions for analysis with X-ray diffraction, in an effort to 
produce quality higher resolution structural data. Not only would this provide valuable 
insight into MOMP’s structure, but also its potential functional role, information which 
could be transferrable to the other Chlamydial strains due to MOMP’s highly conserved 
nature in this organism. Due to the presence of an occluded region within the barrel of the 
density map, as modelled by the 14-stranded homology model (Atanu et al., 2013), this 
homology model was primarily used in cohort with the low resolution structural model in 
this research.  
 
The protocol for rMOMP expression and purification that previously resulted in diffraction 
quality crystals was not replicable, despite extensive and multiple attempts. It was 
hypothesised that increased MOMP expression through improved aeration resulted in 
protein that was more difficult to extract with the mild detergent DDM, likely due to the 
increase in intermolecular disulphide bonding and, therefore, substantial efforts were 
placed on solubility screening in order to improve the yield. The two techniques adopted, 
Western blotting and FSEC, identified zwitterionic SB3-14, also used in the solubilisation of 
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C. jejuni major outer membrane porin (Ferrara et al., 2013) as well as native and 
recombinant Chlamydial MOMP (Findlay et al., 2005; Pal et al., 2005), as the most promising 
lead. Further comprehensive optimisation of the IMAC purification procedure successfully 
enhanced the MOMP yield, which was then thwarted by the concentration of excess 
detergent micelles and proved detrimental to rMOMP stability. Instead, during the 
purification procedure MOMP was buffer exchanged into DDM, as used in the initial 
protocol, which due to its larger micellar size permitted MOMP concentration without the 
excessive build-up of smaller detergents SB3-14, OG, and sarkosyl. Under these conditions, 
MOMP was concentrated and used in crystallisation trials with two commercial screening 
kits explicitly designed for membrane proteins. Following a period of incubation, small 
crystalline products were observed in a number of wells, which were then analysed with a 
microfocus beamline in situ. The diffraction patterns observed from the majority of these 
crystals were likely due to detergent, although a small subset of crystals produced a regular 
pattern of reflections, indicative of protein. Data collection with a microfocus beamline 
often requires thousands of crystals to obtain a complete dataset, and therefore in this 
research this method was solely used for screening. Whilst the regular pattern of reflections 
observed was of low resolution, it is recommended that future crystallisation screening 
include the optimisation of this condition (D11, MemGold II). As MOMP buffer exchanged 
into detergent OG produced diffraction quality crystals in previous research (Atanu, 2014), 
MOMP concentrated in DDM was then buffer exchanged, using a desalting column, in order 
to concurrently decrease the salt concentration whilst also buffer exchanging into OG, also 
ensuring the removal excess detergent micelles. Whilst success was observed following this 
procedure during small scale experiments, using a larger culture volume and thus 
purification of a greater quantity of protein likely resulted in aggregation during 
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concentration over 1 mg/ml. Therefore, it is recommended that following overnight storage 
at 4 °C, samples be supplemented with additional TCEP in order to limit intermolecular 
disulphide bonding. Additionally, the flow rate used in buffer exchange should be 
maintained at the slowest rate possible to ensure complete buffer exchange for soluble and 
stable protein. Whilst high resolution quality crystals were not obtained, the robust and 
rigorous optimisation of each stage of rMOMP purification has resulted in higher yields than 
previously reported, with half the culture volume previously required. It must be noted that 
membrane proteins are notoriously difficult to purify to quantities suitable for 
crystallography whilst also maintaining a stable and active state, due to the requirement to 
extract them from their native lipid environment, which then must be detergent exchanged 
into a more crystallisation amenable detergent. There are a huge range of detergents 
available with a multitude of different properties for membrane protein solubilisation, and 
thus a suitable amount of time must be invested in detergent screening and optimisation. 
Additionally, as the detergent envelopes the hydrophobic regions of the protein, much of 
the protein is masked thus reducing the number of contacts that are able to form during the 
crystallisation process, and therefore a range of different detergents must also be tested to 
optimise crystallisation.  
 
Not only is MOMP a membrane protein, but it is also cysteine rich, with one of its known 
functions being a major contributor to the COMC through the formation of intermolecular 
disulphide bonds. Therefore, it is to be expected that many if not all of the nine cysteine 
residues within MOMP are externally exposed and available for disulphide bonding, as 
opposed to the more common intramolecular disulphide bond used for protein secondary 
structure stability. As a result, many of the difficulties observed in solubility and stability 
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during the purification procedure were likely exacerbated by disulphide bonding. Even 
though reducing agents were utilised, the nature and potential number of disulphide bonds 
in MOMP suggests that these residues will unlikely be readily accessible to such agents, 
likely being protected by the inward barrel orientations. Despite the difficulties associated 
with membrane protein research, the method presented herein not only produces a greater 
yield but is more time efficient, removing the requirement to culture and process such large 
quantities, and is also more cost effective through reduction of the quantity of reagents 
required. The final adjustment and optimisation of MOMP concentration will no doubt lead 
to the production of sufficient protein for crystallisation trials, potentially leading to more 
robust crystals suitable for high quality data collection.   
 
In the absence of structural data, the MOMP homology model, based on the fatty acid 
transporter FadL of E. coli developed by this research group (Atanu et al., 2013), was used in 
research investigating MOMP’s functional role. This model indicated an external α-helical 
loop domain with an internal N-terminal plug occluding the β-barrel at the periplasmic side. 
The low resolution structure for C. pneumoniae MOMP recombinantly expressed in E. coli 
revealed density within the lumen of the barrel, concurrent with the FadL homology model 
plug domain. Typically, β-barrel proteins function as porins, which non-specifically transport 
small solutes (Fairman et al., 2011), with some reports also indicating porin function for 
MOMP (Bavoil et al., 1984; Jones et al., 2000; Sun et al., 2007). However, in this instance 
due to the occluded barrel it was hypothesised that MOMP may have a more specific and 
active role requiring remodelling of the tertiary structure to permit ligand passage, possibly 
mediated by the NPA and NPS motifs (Guan et al., 2010). Chlamydia also has an extremely 
small genome, and has been known to scavenge various components from the infected 
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host, such as long chain fatty acids palmitate and oleate for incorporation into the bacterial 
membrane (Yao, Dodson et al., 2015). MOMP’s thermal stability also increased in the 
presence of these two ligands during SRCD experiments (Atanu, 2014), which was 
suggestive of ligand binding. Taken together, homology with FadL, experimental evidence 
demonstrating host fatty acid uptake, and increased thermal stability upon fatty acid 
binding, provided the basis for a functional growth assay assessing the ability of MOMP to 
act as a transporter for fatty acids. Whilst MOMP exhibits high expression in the circulating 
and infectious EBs, within RBs expression is downregulated although not completed 
eliminated (Roulis et al., 2013), which is suggestive of an additional role for MOMP in the 
metabolically active stage of the Chlamydial lifecycle, similar to PorB, which also functions 
as both a porin and a contributor to the COMC (Kubo and Stephens, 2002; Liu et al., 2010). It 
is well known that E. coli is able to use LCFAs as a sole carbon source, with FadL the 
recognised fatty acid transporter (Kumar and Black, 1993; van den Berg, 2010) and, 
therefore, a number of E. coli fadL knockout strains were utilised in the growth assay 
development. In order to create a robust assay, it was essential that the knockout mutant 
be complemented with the pBAD construct containing the fadL gene, the same vector to be 
used for MOMP expression. It was also imperative that knockout strains grew as expected 
under various carbon sources, for example with no growth on LCFAs. Double knockout 
mutant, LS6164, was sourced from researchers who investigated FadL LCFA transport (van 
den Berg, 2004), which grew as expected. Rhamnose is a tuneable inducer that is able to 
control expression with the pBAD vector, which is largely dependent on the quantity of 
cellular permease for activity (Rosano and Ceccarelli, 2014). As FadL is a protein native to E. 
coli, over expression through rhamnose induction was in fact detrimental to growth, most 
likely due to overloading of the membrane. Instead, basal expression of FadL was sufficient 
 247 
to reinstate LCFA transport in the knockout strain. Being a Chlamydial protein, it was 
uncertain how the level of MOMP expression would affect transport, and therefore a range 
of conditions were examined whereby rhamnose was included in plates, in the liquid 
medium for a variety of durations, or not at all. Interestingly, rhamnose included within 
plates (but not in liquid cultures) was highly toxic to both FadL and MOMP expressing cells, 
completely arresting growth in palmitate plates. This effect was also observed in glycerol 
plates containing rhamnose (Figure 4.9A), whereby LS6164 transformed with pBADaFadL 
showed individual colonies at a dilution of 10-2, as opposed to confluent growth down to   
10-4 in plates containing just glycerol (Figure 4.10A). In fact, the optimum growth conditions 
for FadL were achieved with basal expression, without rhamnose induction in plates or 
liquid media. Despite the multitude of conditions to encourage differing levels of MOMP 
expression, no growth of MOMP expressing cells was observed on LCFA plates, although 
MOMP exhibited comparable growth to FadL expressing strains on glycerol plates (Figure 
4.10B), which suggested that MOMP expression was not toxic. Another hypothesis, as to 
why growth did not occur, was that MOMP was expressed as inclusion bodies, as opposed 
to within the outer membrane and thus not in the correct location for ligand transport. 
STORM, a super resolution microscopy technique, was used to identify MOMP’s cellular 
location through comparison with control membrane protein OmpA, whereby MOMP 
appeared to be localised to the membrane. Therefore, a number of hypotheses were 
suggested as to why growth did not occur on a LCFA carbon source. Primarily, it is of course 
possible that, despite the homology to FadL and the increased thermal stability with oleate 
and palmitate, MOMP is not the fatty acid transporter of Chlamydia. Instead, either another 
outer membrane protein could be responsible, which at this stage is difficult to predict due 
to the lack of structural data for any OMP of Chlamydia, or that due to the truncated form 
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of LPS (also known as LOS) LCFAs are able to flip-flop across the outer membrane via a 
diffusion gradient (Hamilton, 2007). Alternatively, it is possible that MOMP requires a co-
activator protein to assist in the active rearrangement of the tertiary structure to enable 
transport. Since the low resolution structure for MOMP does not indicate a lateral opening, 
similar to that observed with FadL (Hearn et al., 2009), it is not expected that MOMP 
transports fatty acids in the same manner, although higher resolution data will confirm this. 
Additionally, it is currently unknown how FadL communicates with the inner membrane 
transporter FadD and, therefore, it is possible that LCFAs are transported into the 
periplasmic space by MOMP, but then are not able to access FadD for transport to the 
oxidation enzymes. Again, higher resolution structural data for MOMP will provide greater 
insight into the potential function of MOMP and the mechanisms that may be employed in 
ligand transport, which can then be targeted in Chlamydia studies with radiolabelled 
substrates, such as in the study conducted in the characterisation of FadL (Lepore et al., 
2011).  
 
A more established role for MOMP is in the COMC, a network of cysteine rich outer 
membrane proteins linked via intermolecular disulphide bonding (Bavoil et al., 1984; Hatch, 
1996; Liu et al., 2010; Newhall et al., 1983). MOMP, being both cysteine rich and the most 
abundant outer membrane protein, naturally has an important role in this mechanism. The 
COMC proteins are upregulated during the EB stage of the Chlamydial lifecycle and act to 
provide structural stability to the circulating infectious cells in the absence of peptidoglycan, 
the sugar polymer found in virtually all bacteria. Despite playing such a vital role in EB 
stability, there is a paucity of data on the interactions formed between the seventeen 
contributing proteins, most likely due to the difficulties associated with the expression and 
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purification of cysteine rich outer membrane proteins. A number of studies have however 
been conducted on MOMP to analyse the disulphide bond interactions formed, although 
each report provides conflicting results whereby some cysteine pairs were purported to 
form intramolecular disulphide bonds whilst others suggested these residues were freely 
available to form intermolecular disulphide bonds (Wang et al., 2006; Yen et al., 2005). In an 
effort to help resolve these discrepancies and shed light on the role of specific cysteine 
residues, in this work, the low resolution crystal structure was used to rationally target 
specific cysteine residues for both site-directed mutagenesis studies and to perform 
preliminary CG molecular dynamics simulations. Whilst intermolecular disulphide bonding 
was not an interaction specifically accounted for during the MD simulation of two MOMP 
crystal structure models in an asymmetric bilayer, the resulting interaction interface aligned 
with many of the cysteine residues. It is possible that MOMP’s cysteine rich structure 
encourages alignment of specific residues, through the location of particular hydrophobic 
regions. A novel hypothesis is proposed, arising from this research, suggesting that 
intermolecular disulphide bonds are formed between cysteine rich regions, as opposed to 
specific residues, in order to increase the likelihood of interaction and decrease the energy 
required to obtain the correct orientation in the COMC. Such a cysteine rich pocket (C136, 
C201, C203) was located in MOMP, using the low-resolution structure and coincident with 
the interacting plane identified in the MD simulations, and a number of mutant 
combinations subsequently were created. In preliminary experiments, TIRF and 
epifluorescence microscopy were adopted to visualise the clustering behaviour of MOMP 
within the E. coli outer membrane. Whilst it was possible to visually discern differences 
between the control protein OmpA, which exhibited homogenous membrane dispersion, to 
native MOMP, which appeared more clustered, and a number of the mutants, which 
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appeared to decrease clustering, it was not possible to quantify these variations. As a result, 
STORM was implemented to obtain both higher resolution images as well as quantitative 
data for comprehensive comparison. Initially, MOMP was to be labelled with a membrane 
permeable fluorophore known as HaloTag-SiR in order to limit disruption to the membrane 
architecture during the staining process. In order to do so, MOMP was expressed within the 
pOPINHalo vector, which introduces the HaloTag to the C-terminus of the POI, which is then 
able to form an irreversible covalent bond with the fluorophore (England et al., 2015). 
However, the size of the tag (33 kDa) likely disrupted MOMP folding and insertion into the 
outer membrane, as STORM imaging revealed an unusual geometric pattern. To further 
investigate this, 3D STORM was implemented in order to clearly discern the fluorophore 
localisation, which appeared to be looping around the cell as opposed to within the 
membrane region. As a result of this, Alexa-647 conjugated to an anti-his antibody was used 
for all future STORM experiments, selected as only one labelling step was required, and 
more importantly because Alexa-647 is reportedly the strongest fluorophore, both in terms 
of blinking and high photostability (Dempsey et al., 2011). Data were collected for mutants 
in the cysteine rich area, in addition to C226A, a residue situated at the top of the barrel in 
the same plane of orientation as the cysteine pocket. Whilst the images collected were 
clearly of a higher resolution, it was still difficult to draw qualitative comparisons between 
samples, and as a result the quantitative data arising from the localisations captured in each 
frame were analysed with clustering analysis software ClusDoC (Pageon et al., 2016). 
Comparison of the relative density in clusters revealed that the mutants with the most 
significant impact upon MOMP clustering were double mutants C201/203A and C126/201A 
within the cysteine rich pocket, in addition to the single mutant C226A located at the top of 
the barrel. Interestingly, the respective single mutants C136A, C201A, and C203A did not 
 251 
decrease clustering to the same degree, suggesting that two mutants were required to 
observe an effect. Additionally, double mutant C136/203A did not exhibit the same effect, 
with its degree of clustering similar to that of the single mutants. This evidence strongly 
suggested that two mutants within the pocket were required to disrupt disulphide bonding, 
with residue C201 having a more important role than its neighbouring residues. In C201 
containing mutants, the remaining residue was less able to compensate for the 
neighbouring mutants, as opposed to C201 which was in a position to maintain the 
interaction alone. This research is highly supportive of the cysteine rich pocket hypothesis 
proposed herein, as it appears that cysteine residues are able to compensate for 
neighbouring mutants, with some residues such as C201 having a more vital role. It may 
seem that the similar decrease in clustering observed with mutant C226A contradicts this 
theory, however, on the opposing face of the barrel is an additional cysteine rich pocket 
(C49, C52, C56), which is likely interacting with C226 due to their orientations. Therefore, it 
is proposed that C226 is a vital residue in this interaction, but that similarly any of the 
cysteines in the C49-C56 pocket can form the disulphide bond, with residue C52 likely being 
favoured due to its location. Similarly with the C136, C201 and C203 pocket, it is likely that 
residue C342 on the opposing face of the barrel is also vital to this interaction. To 
investigate these hypotheses, mutants should be created of the C49-56 pocket together 
with residue C342, as well as an additional triple mutant of the cysteine rich pocket analysed 
in this research.  
 
Due to the difficulties associated with the extraction of rMOMP from the outer membrane, 
the cysteine mutants designed here, which exhibited the least clustering should be 
implemented in further purification and crystallisation studies. It is recommended that 
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mutants C201/203A, C136/201A, and C226A be detergent screened using FSEC, as previous 
solubilisation with SB3-14 revealed unusual migration patterns with Western blotting. As 
each mutant expressed comparable levels of MOMP to the wild type, it is anticipated that 
optimisation of mutant solubilisation will greatly assist in the purification procedure, namely 
during solubilisation and extraction but also in concentration, where it is expected that 
disulphide bonding is resulting in aggregation.  
 
Despite MOMP accounting for 60% of the Chlamydial outer membrane protein, as well as 
displaying immunodominant features, little is known regarding its true structure and 
function. As MOMP is downregulated in the RB (Roulis et al., 2013), but not completely 
eliminated, it is possible that MOMP has a role in metabolic functions, such as the transport 
of important substrates. The transport of host derived substrates is highly likely, due to the 
small size of Chlamydia’s genome and the truncated or absent metabolic systems (Käding et 
al., 2014). Despite MOMP’s homology to the fatty acid transporter FadL (Atanu et al., 2013), 
this research concluded MOMP’s inability to transport fatty acids, although an improved 
structural model would provide insight into the plug domain and the potential mechanism 
employed in its possible reorganisation. Previous studies have reported the diffusion of 
small solutes, such as arabinose (Sun et al., 2007) and all twenty amino acids (Jones et al., 
2000), through MOMP, albeit at a considerably slower rate compared to more well 
characterised porins, such as OmpF. It is therefore possible that small solutes are able to 
bypass the plug domain. Such a channel would be visualised more clearly with improved 
structural data. Although it has been established that MOMP contributes toward formation 
of the COMC (Liu et al., 2010), the exact interactions formed and with which of the other 
sixteen cysteine rich proteins, along with the paucity of knowledge on how disulphide 
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bonding is mediated within Chlamydia, has left many questions unanswered. As the COMC 
encompasses the whole of the EBs as these circulate the host searching for new cells to 
infect, it seems to be a vital target for antimicrobials and vaccines, not only due to its 
surface exposure but also due to its essential role in cell structural stability. Only by 
enhancing our understanding of both the interactions that stabilise this network and the 
structures of the contributing proteins, can therapeutics be rationally designed to disrupt 
this mechanism.  
 
This research details original data pertaining to disulphide bonding in MOMP, proposing a 
novel hypothesis whereby cysteine rich pockets within the Chlamydial cysteine rich outer 
membrane proteins are responsible for clustering in the outer membrane, thus stabilising 
the COMC and contributing to structural stability of Chlamydial cells during infection. 
Additionally, the novel cysteine mutants designed herein are likely to facilitate improved 
purification of MOMP for structural studies, through reduced aggregation and improved 
membrane extraction, which will reveal not only important structural details but may also 
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sp|P08780|MOMP_CT_C            TINKPKGYVGA--EFPLNITAGTEAATGTKDASIDYHEWQASLALSYRLNMFTPYIGVKW 295 
sp|P13467|MOMP_CT_H            TINKPKGYVGA--EFPLDITAGTEAATGTKDASIDYHEWQASLALSYRLNMFTPYIGVKW 295 
sp|P23114|MOMP_CT_L3           TINKPKGYVGA--EFPLDITAGTEAATGTKDASIDYHEWQASLALSYRLNMFTPYIGVKW 295 
sp|P16155|MOMP_CT_F            TINKPKGYVGK--EFPLDLTAGTDAATGTKDASIDYHEWQASLSLSYRLNMFTPYIGVKW 293 
sp|P23421|MOMP_CT_B            TINKPKGYVGK--ELPLDLTAGTDAATGTKDASIDYHEWQASLALSYRLNMFTPYIGVKW 293 
sp|P06597|MOMP_CT_L2           TINKPKGYVGQ--EFPLDLKAGTDGVTGTKDASIDYHEWQASLALSYRLNMFTPYIGVKW 293 
sp|Q46409|MOMP_CT_D            TINKPKGYVGK--EFPLDLTAGTDAATGTKDASIDYHEWQASLALSYRLNMFTPYIGVKW 292 
sp|P19542|MOMP_CT_L1           TINKPKGYVGK--EFPLDLTAGTDAATGTKDASIDYHEWQASLALSYRLNMFTPYIGVKW 292 
sp|P17451|MOMP_CT_E            TINKPKGYVGQ--EFPLALIAGTDAATGTKDASIDYHEWQASLALSYRLNMFTPYIGVKW 292 
sp|Q07430|MOMP_CP_IOL-207      SLNKPKGYKGV--AFPLPTDAGVVTAAGTKSATINYHEWQVGASLSYRLNSLVPYIGVQW 289 
sp|P27455|MOMP_CP_AR39         SVNKPKGYKGV--AFPLPTDAGVATATGTKSATINYHEWQVGASLSYRLNSLVPYIGVQW 289 
sp|Q9XBF4|MOMP_CP_TWAR         SVNKPKGYKGV--AFPLPTDAGVATATGTKSATINYHEWQVGASLSYRLNSLVPYIGVQW 289 
sp|Q00087|MOMP_CPS_F           MIHKPRGYKGTAANFPLPVAAGTATATDTKSATVKYHEWQVGLALSYRLNMLVPYIGVNW 292 
sp|Q46203|MOMP_CPS_VR-125      VIHKPRGYKGASSNFPLPITAGTTEATDTKSATIKYHEWQVGLALSYRLNMLVPYIGVNW 299 
sp|P10332|MOMP_CPS_A22/M       VIHKPRGYKGASSNFPLPITAGTTEATDTKSATIKYHEWQVGLALSYRLNMLVPYIGVNW 299 
                                ::**:** *    :**   **.  .:.**.*::.*****.. :****** :.*****:* 
 
sp|P23732|MOMP_CT_A            SRVSFDADTIRIAQPKLAKPVLDTTTLNPTIAGKGTVVS-S-AENELADTMQIVSLQLNK 353 
sp|P08780|MOMP_CT_C            SRVSFDADTIRIAQPKLAEAILDVTTLNRTTAGKGSVVS-AGTDNELADTMQIVSLQLNK 354 
sp|P13467|MOMP_CT_H            SRVSFDADTIRIAQPKLAEAILDVTTLNPTIAGKGTVVA-SGSDNDLADTMQIVSLQLNK 354 
sp|P23114|MOMP_CT_L3           SRVSFDADTIRIAQPKLAEAVLDVTTLNPTIAGKGSVVA-SGSENELADTMQIVSLQLNK 354 
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sp|P16155|MOMP_CT_F            SRASFDSDTIRIAQPRLVTPVVDITTLNPTIAGCGSVAG-ANTEGQISDTMQIVSLQLNK 352 
sp|P23421|MOMP_CT_B            SRASFDADTIRIAQPKSAETIFDVTTLNPTIAGAGDVKT--SAEGQLGDTMQIVSLQLNK 351 
sp|P06597|MOMP_CT_L2           SRASFDADTIRIAQPKSATTVFDVTTLNPTIAGAGDVKA--SAEGQLGDTMQIVSLQLNK 351 
sp|Q46409|MOMP_CT_D            SRASFDADTIRIAQPKSATAIFDTTTLNPTIAGAGDVKT--GAEGQLGDTMQIVSLQLNK 350 
sp|P19542|MOMP_CT_L1           SRASFDADTIRIAQPKLATAIFDTTTLNPTIAGAGEVKA--NAEGQLGDTMQIVSLQLNK 350 
sp|P17451|MOMP_CT_E            SRASFDADTIRIAQPKSATAIFDTTTLNPTIAGAGDVKA--SAEGQLGDTMQIVSLQLNK 350 
sp|Q07430|MOMP_CP_IOL-207      SRATFDADNIRIAQPKLPTAILNLTAWNPSLLGSATAVSSS---DQFSDFMQIVSCQINK 346 
sp|P27455|MOMP_CP_AR39         SRATFDADNIRIAQPKLPTAVLNLTAWNPSLLGNATALSTT---DSFSDFMQIVSCQINK 346 
sp|Q9XBF4|MOMP_CP_TWAR         SRATFDADNIRIAQPKLPTAVLNLTAWNPSLLGNTTTLATS---DSFSDFMQIVSCQINK 346 
sp|Q00087|MOMP_CPS_F           SRATFDADTIRIAQPKLASAILNLTTWNPTLLGVATTLDTS---NKYADFMQIVSMQINK 349 
sp|Q46203|MOMP_CPS_VR-125      SRATFDADTIRIAQPKLKSEILNITTWNPSLIGSTTALPNNSGKDVLSDVLQIASIQINK 359 
sp|P10332|MOMP_CPS_A22/M       SRATFDADTIRIAQPKLKSEILNITTWNPSLLGSTTTLPNNGGKDVLSDVLQIASIQINK 359 
                               **.:**:*.******:    :.: *: * :  *   .       .  .* :**.* *:** 
 
sp|P23732|MOMP_CT_A            MKSRKSCGIAVGTTIVDADKYAVTVETRLIDERAAHVNAQFRF 396 
sp|P08780|MOMP_CT_C            MKSRKSCGIAVGTTIVDADKYAVTVEARLIDERAAHVNAQFRF 397 
sp|P13467|MOMP_CT_H            MKSRKSCGIAVGTTIVDADKYAVTVETRLIDERAAHVNAQFRF 397 
sp|P23114|MOMP_CT_L3           MKSRKSCGIAVGTTIVDADKYAVTVETRLIDERAAHVNAQFRF 397 
sp|P16155|MOMP_CT_F            MKSRKSCGIAVGTTIVDADKYAVTVETRLIDERAAHVNAQFRF 395 
sp|P23421|MOMP_CT_B            MKSRKSCGIAVGTTIVDADKYAVTVETRLIDERAAHVNAQFRF 394 
sp|P06597|MOMP_CT_L2           MKSRKSCGIAVGTTIVDADKYAVTVETRLIDERAAHVNAQFRF 394 
sp|Q46409|MOMP_CT_D            MKSRKSCGIAVGTTIVDADKYAVTVETRLIDERAAHVNAQFRF 393 
sp|P19542|MOMP_CT_L1           MKSRKSCGIAVGTTIVDADKYAVTVETRLIDERAAHVNAQFRF 393 
sp|P17451|MOMP_CT_E            MKSRKSCGIAVGTTIVDADKYAVTVETRLIDERAAHVNAQFRF 393 
sp|Q07430|MOMP_CP_IOL-207      FKSRKACGVTVGATLVDADKWSLTAEARLINERAAHISGQFRF 389 
sp|P27455|MOMP_CP_AR39         FKSRKACGVTVGATLVDADKWSLTAEARLINERAAHVSGQFRF 389 
sp|Q9XBF4|MOMP_CP_TWAR         FKSRKACGVTVGATLVDADKWSLTAEARLINERAAHVSGQFRF 389 
sp|Q00087|MOMP_CPS_F           MKSRKACGIAVGATLIDADKWSITGEARLIDERAAHINAQFRF 392 
sp|Q46203|MOMP_CPS_VR-125      MKSRKACGVAVGATLIDADKWSITGEARLINERAAHMNAQFRF 402 
sp|P10332|MOMP_CPS_A22/M       MKSRKACGVAVGATLIDADKWSITGEARLINERAAHMNAQFRF 402 













Figure A1.1. Multiple sequence alignment of MOMP from C. pneumoniae, C. trachomatis 
and C. psittaci human pathogenic strains. Conducted in Clustal Omega. CP, C. pneumoniae; 
CT, C. trachomatis; CPS, C. psittaci.  
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sp|P27455|MOMP_CP_AR39      --MKKLLKSALLSAAFAGSVGSLQALPVGNPSDPSLLIDGTIWEGAAGDPCDPCATWCDA 58 
sp|P10384|FADL_EC_K12       MSQKTLFTKSALAV-------------------AVALISTQAWSAGFQLNE-----F-SS 35 
                               *.*:..: *:.                      **.   *...          : .: 
 
sp|P27455|MOMP_CP_AR39      ISLRAGFYGDYVF--DRILKVDAPKTFSMGAKPTGSAAANYTTA---VDR----PNPAYN 109 
sp|P10384|FADL_EC_K12       SGLGRAYSGEGAIADDAGNVSRNPALITMFDRPTFSAGAVYIDPDVNISGTSPSGRSLKA 95 
                             .*  .: *: .:  *       *  ::*  :** **.* *      :.      .     
 
sp|P27455|MOMP_CP_AR39      KHLHDAEWFTNAGFIALNIWDRFDVFCTLGA----------------SNGYIRGNSTAFN 153 
sp|P10384|FADL_EC_K12       DNIAPTAWVPNMHFVAP-INDQFGWGASITSNYGLATEFNDTYAGGSVGGTTDLETMNLN 154 
                            .::  : *. *  *:*  * *:*.  .:: :                 .*    ::  :* 
 
sp|P27455|MOMP_CP_AR39      LVGLFGVK-------------------------GTTVNANEL--PN---------VSLSN 177 
sp|P10384|FADL_EC_K12       LSGAYRLNNAWSFGLGFNAVYARAKIERFAGDLGQLVAGQIMQSPAGQTQQGQALAATAN 214 
                            * * : ::                         *  * .: :  *          .: :* 
 
sp|P27455|MOMP_CP_AR39      GVV---ELYTDTSFSWSVGARGALWECGCA-TLGAEFQYAQSKPKVEELNVICNVSQFSV 233 
sp|P10384|FADL_EC_K12       GIDSNTKIAHLNGNQWGFG-----WNAGILYELDKNNRYALTYRSEV---KIDFKGNYSS 266 
                            *:    ::   .. .*..*     *:.*    *. : :** :  .      *   .::*  
 
sp|P27455|MOMP_CP_AR39      NKPKGYKGVAFPLPTDAGVATATGTKSATINYHEWQVGASLSYRLNSLVPYIGVQWSRAT 293 
sp|P10384|FADL_EC_K12       DLNRAFNNYGLPIPTATGGATQSGYLTLNLP-EMWEVSGYN-----R----VDPQWAI-- 314 
                            :  :.::. .:*:** :* ** :*  : .:  . *:*..            :. **:    
 
sp|P27455|MOMP_CP_AR39      FDADNIRIAQPKLPTAVLNLTAWNPSLLGNATALSTTDSFSDFMQIVSCQINKFKSRKAC 353 
sp|P10384|FADL_EC_K12       --------------HYSLAYTSWSQFQQLKATSTSGDTLFQK--------HE--GFKDAY 350 
                                             *  *:*.     :**: *    *..         :    :.*  
 
sp|P27455|MOMP_CP_AR39      GVTVGATLVDADKWSLTAEARLIN------ERAAHVSGQFRF------------------ 389 
sp|P10384|FADL_EC_K12       RIALGTTYYYDDNWTFRTGIAFDDSPVPAQNRSISIPDQDRFWLSAGTTYAFNKDASVDV 410 
                             :::*:*    *:*:: :   : :      :*:  : .* **                   
 
sp|P27455|MOMP_CP_AR39      ------------------------------------ 389 
sp|P10384|FADL_EC_K12       GVSYMHGQSVKINEGPYQFESEGKAWLFGTNFNYAF 446 
                                                                 
 
Figure A1.2. Sequence alignment of C. pneumoniae AR39 MOMP with E. coli K12 FadL. 
























































































Figure A3.1. Coomassie blue stained SDS-PAGE gel as a loading control for Western 
blotting detected expression of his-tag mutants. 1, His-tagged protein standard; 2, Blank; 
3, C41 (DE3) control; 4, C41 (DE3) His-6; 5, C41 (DE3) His-8; 6, C41 (DE3) His-10; 7, Blank; 8, 
BL21 (DE3) control; 9, BL21 (DE3) His-6; 10, BL21 (DE3) His-8; 11, BL21 (DE3) His-10. 
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Figure A4.1. Coomassie blue stained SDS-PAGE gel as a loading control for Western 
blotting detected expression of whole LS6164 knockout cells expressing pBADaMOMPH6. 
1, MW marker; 2, LS6164 control cells; 3, 0% 1h; 4, 0% 3h; 5, 0% 5h; 6, 0.005% 1h; 7, 
0.005% 3h; 8, 0.005% 5h; 9, 0.01% 1h; 10, 0.01% 3h; 11, 0.01% 5h; 12, 0.02% 1h; 13, 0.02% 
3h; 14, 0.02% 5h. All percentages refer to rhamnose concentration (w/v) and hours to time 
of harvesting.  
 
 280 




































Figure A5.1. Coomassie blue stained SDS-PAGE gels as loading controls for Western 
blotting detected expression of cysteine mutants. A, 1, MW ladder; 2, C41 (DE3) control; 
3, native MOMP; 4, MOMP C201A; 5, MOMP C203A; and 6, MOMP C201/3A. B, 1, MW 
ladder; 2, C41 (DE3) control; 3, native MOMP; 4, MOMP C201A; 5, MOMP C203A; 6, 
MOMP C201/3A; 7 MOMP C136A; 8, MOMP C136/201A; 9, MOMP C136/203A; and 10, 
MOMP C226A. A, Figure 5.12 control; B, Figure 5.15 control. 
 
